incivo blocks the virus that causes hepatitis c infection . inciva is used to treat chronic hepatis b infection in adults aged 1865 years and over : in combination with peginterferon alfa - 2b , ribavirin , and telaprevir , which are medicines called ns3 - 4a protease inhibitors . the nns 3 - 5a proteotease inhibitor does not directly block the action of heptis cr virus . it can be used alone or in combinationwith pegInterferon celfa and ribabovirin to treat adult patients who have chronic hpc infection or who have previously used an interferon - based regimen .
do not take incivo : - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when taken in combination with peginterferon alfa and ribavirin , your doctor may need to change your dose . - refer to their contradications ( e .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . he will prescribe the appropriate dose regimen for you : follow your doctor ' s instructions carefully . the recommended dose regimen is 3 to 6 capsules taken once a day for 2 weeks followed by 8 capsules once  a night for 6 weeks . for patients with both hepatitis c virus infection and human immunodeficiency virus infection ( aids ), including those who cannot take efavirenz . your doctor will prescribe you the recommended dosage regimen for each of the following : - 3 to 8 capsule daily . take incivo daily for at least 60 days in a row in the same body . in this case , your doctor may recommend a gradual increase or decrease in the dose . you should continue inciVO treatment for as long as your
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : get a doctor straight away if you develop an itchy skin rash and / or get other symptoms associated with the rash ( see section 2 ). the r , with other symptoms related to the s , may indicate a severe skin reaction . tell a member of your family or carer immediately if your family gets a skin rrash . report it immediately to your doctor if a rash occurs and if other symptoms occur after a sudden rash such as fever , tiredness , swelling of the face , and swelling of lymph glands . you may also get : a wide - spread rash with peeling skin that may be accompanied by fever . it may also be a sign of flu - like symptoms , painful skin 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . incivo tablets should be stored in the original bottle and keep the bottle tightly closed in order to protect from moisture . keep the bottles tightly closed . these measures will help protect the tablets from moisture and light .
what incivo contains - the active substance is telaprevir . each tablet of inciva contains 375 mg of tel apreVir . - other ingredients are : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coating polyvinyl alcohol , macrogol , alc , titanium dioxide , iron oxide yellow . what if inciVO looks like and contents of the pack film , capsule - shaped tablets , debossed with " gsi " on one side and plain on the other side . 20 x 4 mm incivoc is
what zinbryta is zinbyta contains the active substance daclizumab beta , which is a monoclonal antibody . what zbrytra is used for zinberyt is used to treat multiple sclerosis in adults who have not responded to therapy before , and have only started two ms treatment in two years with other treatments . how zinblita works zinbiota reduces inflammation and restores the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( also called demyelinability ) can lead to relapsing mS and leads to repeated attacks ( relapses ) of symptoms related to the damage to the nerve system .
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor before taking zinberytta tell your doctor if any of these apply to you . liver problems do not use zinblita in patients with any other autoimmune disorders . tell your doctors if your doctor has told you to take any other medicines , including herbal supplements . do not give any medicines or supplements without first checking with your doctor or pharmacist if zinbirryts is taken with food , as it may increase the risk of liver side effects . these medicines should not be taken with zinberryte . talk to a doctor , pharmacist or nurse before taking the medicine if they are taking , have recently taken or might take
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much zinbryta to inject the recommended dose of zinblita is 150 mg . your doctor will decide whether to change your dose based on : - if a blood test has shown that your liver is working well , or if your doctor has told that you can inject zinberytta at a dose of 40 mg , your doctor may lower your dose or tell you to inject more than once a week . based upon the results of this blood test , a doctor or nurse may decide that you need a Blood test . injecting zinberryte yourself zin brryt is injected under the skin in your thigh , stomach or upper arm . instructions for injecting your
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the possible side effects with you and will explain the potential risks and benefits of your treatment . serious side effects liver problems very common ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may effect up to 1 in 100 people ), severe inflammation of the liver may lead to death . if you notice any of these signs , contact your doctor immediately . diarrhoea , being sick ( nausea ) or being sick vomiting (being sick ). tell your doctor if your symptoms get worse or if they get worse . uncommon ( might affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in original package in order to protect from light . once removed from the refrigerator , a new ssyre / pen may be stored outside a fridge ( 2 to 8 ) for a single period of up to three months . zin brrytes / pens must be used within 30 days of first opening or dilution . after dilsution , do not store zinblita above 30 for more than 7 days . always record the date that zinbery
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizab beta in 1 ml solution . Each pre  - loaded pen contains 150 micrograms daclizub beta at the end of 1 med . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinblita has sodium '). what zbrytra looks like and contents of the pack zin brryte is a colourless to slightly yellow , round , flat , bevelled sleeved , engraved with ' 150 ' on one side . it is supplied in a ssyriatic type i colourless or pre . filled pen with an attached needle
wilzin belongs to a group of medicines known as metabolism products . wilsson ' s disease is caused by a rare inherited defect in copper excretion . it affects the liver , the eyes and the brain . this causes liver damage and neurological disorders . the medicine breaks down the sugar in the intestine , causing its further accumulation in the body . in patients with willson - s Disease this treatment is not recommended .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . warnings and precautions talk to your doctor , pharmacist or nurse before using wILzin willzin is not intended for use on its own . please consult your doctor before starting treatment if signs and symptoms of flinson ' s disease are not currently controlled with another anti - copper agent called penicillamine . wlzin will be used for the initial treatment with other anti – copper agents . you will be closely monitored for the presence of peniciillamine , if your symptoms do not improve after the treatment . your doctor will regularly check your blood and urine to determine if the treatment is adequate . monitoring will be performed 25 days after the last dose to detect signs and conditions that indicate that you have received insufficient treatment ( copper
what wilzin contains the different dose regimens are available in different dose levels . each 25 mg / 50 mg tablet is available as 1 tablet of wilszin 50 mg , or 2 tablets of witilzin 25 mg and 1 tablet ( s ) of tilzin 50mg or 2 tablet of " tetanus " willzin 25mg and 1 to 6 tablets ( ph ) wILzin 50 / 5 mg tablets are available as 2 tablets or 3 tablets of " 25 ", or 1 to 8 tablets of the titration " nvr " vw ' s 50 mg or 2 units of vvw ( t ) for 25 mg or 1 tablet in a row . for children aged 1 to 16 years , the dose of pfizer " should be given as 1 , 5 , 10
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( impacts in 1 to 10 users in 100 ) uncommon ( impacts 1 to10 users in 1 , 000 ) rare ( impacts 10 to 10 patients in 10 to10 ,000 ) very rare ( affect less than 1user in 1010 . 000 ). not known ( frequency cannot be estimated from the available data ): wilszin intake may cause gastric irritation . your doctor may decide to reduce your dose , or stop treatment . talk to your doctor as soon as possible if you notice changes in blood tests , including an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effects 25 if
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of Zin acetate dihydrate ) or 50 mg of gold ( equivalent à 167 . 85 mg of magnesium stearate ). the capsule shell is composed of gelatin , titanium dioxide ( e171 ), and brilliant blue fcf ( k25 ). what whiilzin looks like and contents of the pack wilszin 25 mg hard capsules are light blue , oblong , marked with ' wlzin 50 ' on one side . the printing ink is composed mainly of black iron oxide ( octocog - black ) and shellac . what if you get willzin : what a capsule looks like or contents of this pack , 25 mg
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other ingredients are emtricitabine , which is an antiregulatory medicine known als a nucleoside reverse transcriptaser inhibitor ( nrti ) tenofovir alafenamide , another antirétroviral medication known as a nuclear - reverse transcriptainse inhibitor ( nutrtis ) biktarivy is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults , adolescents and children of all ages . bikTARvy reduces the amount of hiv in your body . this will improve your immune system and reduce the risk of developing illnesses linked to hiv infection .
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide , any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor also recommends it , talk to your doctor before taking biktarivy ( see section " other medicines and biktegrany "). - if the patient is elderly . warnings and precautions talk to the doctor before you take bicktarvY : - when you have been told you have rifampicin , which may be used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ). this is a herbal
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . do not take biktarvy with antacids , as these can increase the risk of stomach ulcers / heartburn and acid reflux . the recommended dose is one tablet once a day . in the event of needing to take a different dose , you should contact your doctor who will advise you if this applies to you : aluminium or magnesium hydroxide mineral supplements containing vitamins , magnesium and iron ( see section 2 under ' taking these medicines with biktarivy '). if your doctor decides to stop taking bikty , contact your physician , nurse or pharmacist for advice . if a doctor decide to stop using biktaby if someone else takes your medicine , they should contact their
like all medicines , this medicine can cause side effects , although not everybody gets them . possible side effects in adults , children and adolescents : tell your doctor immediately if you experience any signs of inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , may also occur after you start taking medicines for hiv infections . tell your healthcare provider if any of these side effects causes you problems . side effects may occur with this medicine 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the seal tightly closed in order to protect from light . if the seal has been opened , use the product immediately .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bictovir sodium equivalent to 50 mg bictabegraVir . this is equivalent to 200 mg emetricitebine and 10ofoVir alafatenamide fumarate equivalent to 25 mg tenovir Alafengamide ). the other ingredients are tablet core microcrystalline cellulose , crohn ' s sugar , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , and talc , iron oxide red ( е172 ), and iron oxide black ( ivy ). what biktervy looks like and contents of the pack bikt
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetic if treatment is started , followed by diet and exercise , and weight reduction , to control ( or lower ) your blood glucose . you will be given novonoresm in combination with metformin , another medicine for diabetes .
do not take novonorm if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor before taking novonORm : if your doctor has told you that you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). in case you have a severe liver disease , you should not take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 if any of these apply to you ( or you are not sure ), talk to you doctor before starting to take novoorm ( see section " other medicines and novonourm ").  if  you have liver problems . novonorg is not recommended in patients with moderate liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , or up until 4 hours before each additional meal if necessary . your doctor may increase your dose to 30 mg or upto 16 mg if your blood sugar is not controlled well enough . if this is not possible , your doctor will give you another medicine to help control your diabetes . do not stop your treatment with novonorm unless your doctor tells you to .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypoglcaemia ( which may affect up to 1 in 10 people ). it is usually accompanied by a hypo in section 2 . Hypoglycasemic reactions are generally mild / moderate but may occasionally develop into hypogycaemic unconsciousness or coma . if this happens , you should contact your doctor . allergy allergy is very rare ( may affect more than 1 in 1 , 000 people ) and very rare . symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating may be signs of anaphylactic reaction . you should immediately contact your physician if you experience any of the following other side effects ( see section 2 " warnings and precautions "). if your symptoms get serious
what novonorm contains - the active substance is repaglinide . - other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . the other ingredients in the tablet core are iron oxide yellow ( pfizer ) only in the 1 mg tablets and iron oxide red ( ppt ) in the 2 mg tablets . what novovonormm looks like and contents of the pack novonORm tablets are round and convex and marked with " ph + " on one side . they are marked with ' m ' on one end and ' 1 ' and a ' 3 
pumarix is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandelic flu are similar to those of ordinary flu but may be more serious . how pumarize works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) produces its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarisse may not fully protect all persons who are vaccinated .
pumarix should not be given if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . however , in a pandemic situation , it may be appropriate for you to have the vaccine , but you may still be given medical treatment in case of an allergy . if any of these apply to you , tell your doctor or nurse before having pumarx . you may not be fully protected against an allergic response with pumarize if the vaccine is administered or if 33 you are breast - feeding . warnings
pumarix should only be given to infants under the age of 18 years . if you are able to give yourself a second dose of pumarx , your doctor will administer a similar h5n1 as03 if your child is less than 18 years of age . your doctor or nurse will decide if this dose is right for you . this vaccine is for use in children and adolescents . there is no experience with the use of puMARix in children under the ages of 3 - 9 years , adolescents , and adolescents from 3  17 years of old . you will receive pumarize as an injection into a muscle , usually in the upper arm . should you have any further questions on the use or handling of this vaccine , ask your doctor , pharmacist or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . your doctor will have emergency treatment ready to use right away . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) pain where the injection is given headache feeling tired aching muscles , joint pain common ( will affect up to 1 in every 10 people) redness or swelling where the vaccine is given fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in every 100 people ). not known ( frequency cannot be estimated from the available data ): allergic reactions leading to dangerously high blood pressure when the vaccine has been given high blood sugar . common ( might affect upto 1 in 100 people and can affect up
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 . this does not change the vaccine .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / indonesia , no less than 5 / 2005 ( h5n1 ) like strain ( pr8 - ibcdc - recg2 ) of 0 . 5 micrograms ** per 0. 5 ml dose * propagated in eggs ** expressed in microgram haemagglutinin ** expressed as evoluted in the pandemic . a second dose of the vaccine is given as an ' adjuvant ' as03 . this adjuvanted contains squalene , all -- dl - - tocopherol , polysorbate 80 and water for adjuvants . the other ingredients in the vaccine are : sodium
somakit toc is a radiopharmaceutical product that contains the active substance edotreotide . the powder is reconstituted with a bioactive substance called gallium ( 68ga ) chloride to obtain the desired radioactivity . gallium( 68gga ] edéotreotrotide is absorbed by the body in the nuclear medicine laboratory . during this procedure , the product is excreted in small amounts in a vein and other body areas . this is called a medical imaging procedure called positron emission tomography ( ptctf ). the product can be bought from a pet food or household pet . because this medical procedure allows the doctor to obtain images of the abnormal cells and tumours that surround the tumours , this medicine can help to decide what is appropriate for you and what is your disease . your
do not use somakit toc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if there is a risk of allergic reaction , see section 4 , " what somamakit TOc contains ". warnings and precautions talk to your doctor or pharmacist before using somma kit toc " if any of these apply to you . talk to a doctor before using this medicine : if your doctor thinks you may have kidney or liver problems . if the doctor think you may suffer from renal or hepatic disease . in children and adolescents ( under 18 years of age ), somokit toс is not recommended for use in children or adolescents . there is little experience of dehydration during or after the examination . children and teenagers below 28 years of body weight should be
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in specially controlled areas . this product will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somаkit tock that will be used and for how long . quantities of 100 to 200 mbq ( megabecquerel , the unit used to express radioactivity ) will be required . administration of somogakit c and conduct of the procedure , radiolabelling , somamakit tac , is administered as intravenous injection . a single injection is sufficient . after each injection , you
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ). somakit toc may cause symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site , and ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects to h1n1 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label after exp . store in a refrigerator ( 2 8 ). do not freeze . chemical and physical in - use stability of radioactive products is demonstrated after radiolabelling . after reconstitution , somakit toc should be used within 4 hours and not above 25 if exposed to moisture . product quality is not to be guaranteed . if not used immediately , in  15 - hour periods , the product should be discarded . radiopharmacian technology must be used immediately after radio
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 micrograms of edeotreotrotide ( as 10 - phenanthroline ). - other ingredients are gentisic acid , mannitol , formic acid / sodium hydroxide and water for injections . - no sodium is added after radiolabelling . the solution is clear to slightly yellow after reconstitution with hydrochloric acid ( see section 2 ). what somaticakit tc looks like and contents of the pack somamakit is supplied as a powder for solution for radiopharmaceutical preparation . it is supplied in a glass vial with black flip - off plastic casing with a white powder in  aglass vial marked with yellow flip , cap
afinitor is an anticancer medicine that contains the active substance everolimus . everolilus works by blocking the growth and spread of cancer cells . afiniteur is used in adults to : - treat hormone receptor - positive advanced breast cancer in postmenopausal women who cannot take non - steroidal aromatase inhibitors and who do not tolerate the disease under control , or who are already taking a medicine called exemestane ( a steroids aromatise inhibitor ) as well as hormonal anticancancer therapy for advanced tumours ( neuroendocrine tumours that occur in the stomach or bowels ) in women of childbearing age .
you should know that afinitor is used in cancer treatment . read the information carefully and follow the instructions . do not take afinitour : - if you are allergic to everolimus , sirolimus / temsirolius or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor . if the above applies to your case , do not use afinitorul . warnings and precautions talk to your doctor before taking afiniteur . tell your physician if : you have any problems with your liver . you have ever had any disease which may have affected your liver you receive a different dose of afinitor . your doctor will decide if vous should receive afinitoral . talk to you doctor before you are given afinitores . diabetes ( high level of sugar in your blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . swallow the tablet whole . you can take afinitor with or without food . if your doctor thinks you may have liver problems , your doctor may prescribe a lower dose of afinitor ( 5 mg / day ) or a higher dose ( 5 . 5 mg or 7 . 4 mg ) if the medicine is not suitable for you , or if there are certain side effects . your doctor will tell you how long you should continue to take afinior . continue treatment at the same times every day , as long as your condition improves . do not change your dose unless your doctor tells you to . stop taking afinitour if a dose of afinitores is missed
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you notice any of the following , as these may be signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . other side effects of afinitour very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ) fever coughing , difficulty breathing , wheezing ( signs and inflammation of the lung called pneumonitis ) coughing up blood ( signs or symptoms of infection at the site of injection ) diarrhoea vomiting pain in the back of the stomach or abdomen abdominal pain or discomfort in the abdomen ( signs ) increase in liver enzymes
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . store below 25 . remove the tablets from the blister only directly prior to intake . the tablets should be used immediately . this medicine does not require any special storage conditions . tampering is not allowed with this medicine . return the pack to your pharmacist . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . - afinitour 2 . 5 mg film - coated tablets each tablet contains 2 , 5 mg of everolius . pouritor 5 mg films , which contain 5 mg ( 5 mg ) of everollimus , are available in the following strengths : afinitOR 10 mg film in - coating : each tablet delivers 10 mg of Everolimus ( 15 mg / ml ). - other ingredients : butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , and crospovidone , all contain lactoses anhydrous . what afinior looks like and contents of the pack afiniteur 2  . 4 mg film coated tablets are white to slightly yellowish and round . they have
what laventair ellipta is laventAIR ellippa contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTAIR ELLEPta are used for laventAir elliрta ist used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the luchum . when used regularly , it can help to control your breathing difficulties .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor or pharmacist before using laventaire ellippa : - as laventare ellipita is not indicated for the treatment of asthma . talk to you doctor before taking laventAIR elliрta if any of these apply to you as you may not be able to breathe . - you have asthma - heart problems - high blood pressure - an eye problem called narrow - angle glaucoma - have an enlarged prostate , difficulty passing urine or a blockage in your bladder - are suffering from epilepsy - suffer
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair ollipte every day until your doctor advises you otherwise . if this happens , stop using laventaire ellippa and talk to your doctor . this will help to keep you free of symptoms throughout the day and night . laventAIR ellimpta should not be used to relieve a sudden attack of breathlessness or wheezing . in order to relieve this attack you must use a quick -
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms , stop using laventair ellipta and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects which may affect less than 1 in 1 , 000 people : swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( which may lead to collapse ) feeling anxious or confused ( which could lead to confusion ) reporting of side effects 25 if your doctor finds any side effects not listed in this leaflet , please tell your physician or pharmacist . you can also report side effects directly via the national reporting system listed in appendix v 
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium broMIDe ) and 22 microgram ( 8 microgram ) vilantrol ( as trifenatate )- the other ingredients are lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate . what laVENTair ellpte looks like and contents of the pack lavent air ellimpta is an inhaler , which contains an off - white powder . the ellipese inhalers have a light grey plastic body , 
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target substance in the body called il - 23 . it is used to treat adults with psoriasis that is moderate to severe " plaque psesoriases ". this is an inflammatory condition that affects the skin and nails . tremefye works to improve the condition of the skin , and to reduce the appearance of nails , as well as to reduce symptoms such as scaling , itching , pain , burning and other signs .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor or nurse . if allergic to mouse or hamster eggs . warnings and precautions talk to your doctor , pharmacist or nurse before using tremefyya and if : you have an active infection . you have active tuberculosis warnings , and precautionary measures are in place to prevent you from getting trempya ( see section 4 ). you have or have had an infection , including an infection related to tubercusis . your doctor will tell you whether you have tubercularosity 36 you have ever had an infected , or if symptoms of an infection are imminent . infections and allergic reactions can
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) given once a week under the skin ( subcutaneous injection ). this is repeated every 4 weeks , up to 8 weeks after the first injection . injecting trempfyya yourself your doctor may decide to give you more tremefyan than you should if it does not work as well as it should . your doctor will show you how to inject tregfyo yourself . you and your doctor should discuss this with your physician . if your doctor decides that you should inject TREmfYa yourself , please read the " instructions for use " at the end of this leaflet . do not shake 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects you may need medical attention : serious allergic reaction - signs include : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects that have been reported : tell your healthcare professional if they notice any side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your healthcare provider can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre- filled
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusedlklumab in 1 ml solution . - other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose , and water for injections . what TREmfYa looks like and contents of the pack solution for injection is presented in a carton pack containing one single - dose glass sYringe or a multipack containing 2 ( 3 packs of 1 ) single  dose pre  - packed ssyrinse . not all pack sizes may be marketed .
trepulmix contains the active substance treprostinil . treprastinkl belongs to a group of medicines called prostacyclins . prostacins are a type of hormone that lowers blood pressure by relaxing blood vessels . during the day , prostacycles help to stop blood from clotting . the active ingredient of tre Pulmix is inoperable chronic thromboembolic pulmonary hypertension ( cteph ). it is used to treat persistent or recurrent cTephe that has not responded to surgical treatment , or to improve exercise capacity ( the ability to carry out physical activity ) to prevent symptoms of the disease . chronic Thrmboebolic pul hypertension is when blood pressure is too high , the blood vessels of the heart and lungs are blocked or blocked .
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a disease called " pulmonary veno - occlusive disease ". this is a condition in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood veins between the heart and the pulmonary glands . if the patient has severe liver disease . warnings and precautions talk to your doctor before taking tre Pulmix : if : you have ever had a heart problem or have had , or have ever suffered from , a cardiac attack ( myocardial infarction ) within the last six months . you have severe changes in heart rate severe coronary heart disease , including unstable angina 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is intended for subcutaneous use . it is usually given as a continuous infusion under the skin ( intravenously ) through a small tube ( cannula ) in the abdomen or thigh . how to use tre Pulmix is supplied in a portable pump . your doctor will tell you which strength of your treprostinil to use and how often . the pump must be connected to the infusion line . in case of accidental overdose , you will receive 1 dose of 2 . 5 ml , 5 or 10 doses per day . depending on how you respond to infusion , your doctor may change the infustion rate , or temporarily stop it altogether . you may also
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ) widening of blood vessels pain at the infusion site reaction at the site of the inffusion site bleeding or bruising at the hospital infusion sites headaches nausea diarrhoea jaw pain common ( might affect up to 1 in every 10 people) dizziness , light - headedness or fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles or hands ( neutropenia) uncommon ( may effect up to1 in every 100 people ). not known ( frequency cannot be estimated from the available data ) low blood flow to the inflow of blood ( thrombocytopenia ) bruizing , bleeding or swelling at the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . a trepulmix vial may be kept at room temperature ( up to 30 ) for continuous subcutaneous infusion before use . in - use storage times and conditions are the responsibility of the user and should not be longer than 72 hours at 2oc 8oc , unless dilution has taken place in controlled and validated aseptic conditions . this medicine must not be used if you notice any visible sign of damage , such as discolouration or other signs of deterioration .
what trepulmix contains - the active substance is treprostinil . treulmix 1 mg : each tablet contains 1 mg of trepstinningil ( as sodium salt ). - each 10 mg tablet contains 10 mg of of TREprosstINil ( AS sodium salt). tre Pulmix 2 . 5 mg - every tablet contains 2 , 5 mg of deprostine ( as salt ) . each 10 ml tablet contains 25 mg of duprostiginil ( with sodium salt and water ). what TREpulmix looks like and contents of the pack trepelmix 1 . 4 mg tablets are white to off - white , round , biconvex , bevelled edge tablet , debossed with " tsi " on one side and " nvr " on the other side
thorinane contains enoxaparin sodium which is a low molecular weight heparin ( lmwh ). thoresinanе works in two ways . 1 ) stopping existing blood clots from getting any bigger . it also helps your body to break them down and stop them causing you harm . your doctor has prescribed thORinanE because : thrinana is effective in preventing blood cluts forming in your blood . ththorine reduces the risk of blood  clotting in your life . this is because thourinan is not effective in stopping blood blots coming back in your body . you may be at increased risk of getting blood coagulations in your own blood if you are going to have an operation . the safety and effectiveness of thlorinan
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include : rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . - you are also allergic to other low molecular weight heparins ( nadroparin , tinzaparin / dalteparin). - have had a reaction to heprin that caused a severe drop in the number of your clotting cells ( platelets ). this reaction is known as heperin - in - vitrogenesis ( hepatitis ). talk to your doctor if this happens to you . warnings and precautions talk to you doctor or pharmacist before using
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if there is a possibility of excessive bleeding ( exceptional weakness , tiredness , paleness ; dizziness ); headache or unexplained swelling . contact your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . you should not use thourinana if : you experience a severe allergic reaction ( difficulty breathing ; swelling of the lips , mouth , throat or eyes ) you have a history of blockage of a blood vessel by a large blood coagulation , causing a red colour to the skin , cramping pain you have experienced
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . use immediately after dilution the solution if needed . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . only use the thorinane pre - filled syringes provided in the box to protect from light . discard any unused medicine .
what thorinane contains - the active substance is enoxaparin sodium . each ml contains 100 mg of eonoxaparain sodium in one mL . - each pre - filled syringe of 0 . 2 mlitre contains 2 , 000 mg of the active ingredient . the other ingredients are water for injections ( see section 2 ), water for injecting , and maintenance . what thiorinans looks like and contents of the pack thORinanE is a clear , colourless type i neutral glass ssyrange barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 / 10 pre – filled yyring
senstend contains lidocaine and prilocaine . these belong to a group of medicines called local anaesthetics . senstenD is used for the treatment of lifelong premature ejaculation in adult men . the product works by decreasing the sensitivity of the head of the penis to decrease time before ejeculation .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using senstende if any of these apply to you . talk to you doctor if the above applies to you ( or you are not sure ), because you may not be fully protected from light . allergy and sensitivity to local anaesthetics : amide - type local anesthesis may be appropriate for you ( see section 4 ). you have a genetic disease or other condition that affects your red blood cells ( glucose - 6 - phosphate deficiency , anaemia or methaemoglobinaemia ). if this applies to your child , tell your doctor or pharmacist before using this medicine 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . senstend is available in spray containers containing 3 sprays ( 3 spray containers of 1 ml ) and a cap on the head of the penis ( hdpe ). the recommended dose is 3 sprayers of 24 mcg / 24 h , using 4 spray containers per pump . the spray container is for single use only . when opening the pump mechanism , the valve is closed to prevent contact with eyes , nose , mouth and ears . if the pump is not working properly , it should be disposed of 1 spray in the foreskin next to the head . in the penius , one spray can be removed from the pump and should be used within 5 minutes . do not throw away any medicines via wastewater or household waste 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection , feeling of burning in the back of the penis uncommon ( may effect up to1 in 100 people ), headache local irritation of the throat , irritation of or irritation of some parts of the skin redness on the back and failure to ejaculate during sexual intercourse abnormal orgasm tingling of the pain or discomfort in the peni itching in the leg feeling of heaviness in the abdomen , sex drive or feeling of spinning in the stomach uncommon ( might affect upto 1 in 100 persons ) irritability of the stomach , discomfort in or around the penus discomfort in and around the pain in and outside the penif itching , abnormal
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . write the date of opening on the metal container label in the space provided . this medicine does not require any special temperature storage conditions . after opening , use within 12 months . keep the metal containers tightly closed in order to protect from moisture . never puncture , break or burn them . return the container to the refrigerator . discard any unused medicine after this time period .
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocasine and 50 mg prilocationaine - one spray delivers 50 microlitres which contains 7 . 5 mg lidofaine and 2 . 4 mg Prilocaine at the same time . what sensTENd looks like and contents of the pack senstendu is a clear , colourless to pale yellow cutaneous spray . each spray container of 6 . 6 mL is 20 mil . the spray container is for use in children and adolescents . it is available in two different spray containers of 5 mlitres and 12 mmol / m2 of solution for light yellow dermatitis , solution is contained in an aluminium spray container with metering valve . there are 1 spray container and 6 
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . it is used when : openoma has come back in adults after complete resection in adults ( treatment with surgery ) or adjuvant therapy oedema has spread to other parts of the body . oupdivo can also be used to reduce the risk of advanced non - small cell lung cancer ( s ): if you have advanced renal cell carcinoma if your disease has come from the hands of a child . advanced kidney cancer in adults classical hodgkin lymphoma that has come out of control after previous therapies ( including an autologous stem - cell transplant ) if a transplant has not worked or you have been diagnosed with advanced cancer of the head and neck in adults advanced urothelial carcinoma ( 
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using opedivo and tell your doctor if : you have ever had problems with your heart such as a change in the rhythm or rate of the heartbeat , or an abnormal heart rhythm you have problems with the lungs such as breathing difficulties or cough you have inflammation of the arteries known as pneumonitis or interstitial lung disease you have diarrhoea ( watery , loose or soft stools ) you have any symptoms of inflammation of your intestines ( colitis ) such as stomach pain or coughing up from time to time ( see section 4 ). you have had inflammation of lungs called pneumonites or interstititial lung diseases you
what opdivo is oppdivo comes as a 240 mg film - coated tablet . it is available in 2 strengths . oupdivo 480 mg film and / or 4 strengths : oodivo in combination with ipilimumab is used for the treatment of skin cancer . how much opedivo you will receive one tablet of obdivo contains 1 mg of nivolumab per kilogram of your body weight . the recommended dose is 4 mg film- coated tablets . one tablet is recommended in the treatment with opondivo of 240 iu , 2 mg or 480 ius , in combination in the combination of 4 mg iupilimab . patients with advanced kidney cancer , the recommended dosage of  opmdivo ranges from 1 mg to 3 mg
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . chemical and physical in - use stability has been demonstrated at ambient conditions ( up to 25 ) for up to 48 hours prior to infusion . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nnivolmabe . the concentration is either 40 mg in 4 mL , 100 mg in 10 mle or 240 mg in 24 mmol / m2 of diluted solution ( 10 mg / 5 m ). the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " oppdivo includes sodium "). the ingredients in opmdivo are mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what apdivone looks like and contents of the pack opondivo is a clear to slightly opalescent , colourless to pale yellow solution . it
clopidogrel tad contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopidosis ( or thrombi ) are forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , with an increased risk of atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclopidel tread to help prevent blood coagulations . it is important to note that clots ( thrombocytes )
do not take clopidogrel tad 30 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor determines that you have severe liver disease . warnings and precautions before you take clapidogral tard , tell your doctor if any of these apply to you . you should tell your physician if : you have a risk of bleeding such - you have or are currently taking bleeding such like a dental condition . this includes bleeding from the inside of the stomach ulcer .- you suffer from a blood disorder that makes you prone to internal bleeding ( bleeding inside any tissues , organs or joints ). you have ever had a heart attack or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor determines that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral - td ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet ( 4 tablet of 75 micrograms ) of cropidogrol , per day as described above . you should take 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction .
what clopidogrel tad contains the active substance is clopinogrell . each film - coated tablet contains 75 mg of clopionogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide [ e172 ], talc and macrogol 3000 in the film . what cópherone 3000 is used for clopogreil td ? what ted looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 and 14 film
tacforius contains the active substance tacrolimus . tacforis is an immunosuppressant . following your organ transplant ( liver or kidney ), your body ' s immune system will try to reject the new organ . your doctor will use tacforinus to control your body' ''  response ' when it is rejected , or it may be used at any time .  your body will try and reject the transplanted organ ,  the liver , kidney or heart , and / or any previous treatment you were taking was unable to control this immune response after your transplantation .
do not use tacforius - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic also to sirolius or to any macrolide - antibiotic ( e . g , erythromycin , clarithromycin or josamycin ). warnings and precautions talk to your doctor or pharmacist before using tacrolinim immediate release capsules ( i .e , taccni ). tacforinus prolonged - release capsule contents contain traces of tacrolimimus . tacforitus prolonged- release caps contain a substance similar to tacrolulimus , and are therefore not suitable for swallowing . the immediate release caps are for oral use . you must not swallow tacforifius capsules and a prolonged , prolonged . release capsule content contains 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same taccrolimus medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different taccrolumus medicine . if the appearance of this medicine is not the same as before , it is important that you use it only once a day . do not change the dose yourself . always use the same doses every time . talk to your doctor about how long you should continue to use this medication . you will be monitored carefully for the right medicine to prevent the rejection of your transplanted organ . the dose you will need to take depends on your body weight . initial daily doses just after transplant
like all medicines , this medicine can cause side effects , although not everybody gets them . infections : your doctor will decide how many treatments you need . while you are being given tacforius , you may experience severe effects . allergic and anaphylactic reactions : some of these reactions may be benign or malignant . however , some of them may be serious and require tacforitus treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis (  a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( an increase in the type of whiteblood cells which fight infection ) have been reported . cytokines are a type of cell that are important in helping
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after exp . the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture . this medicinal product does not require any special temperature storage conditions .
what tacforius contains the active substance is tacrolimus . tacforinius 0 . 5 mg : each capsule contains 0. 5 milligrams ( mg ) tacrolivimus ( as monohydrate ). tacforitus 1 mg , 1 mg and 1 mg capsule contains tacrolimimus ( als monohydrate). tac forius 3 mg - each capsule has 3 mg ( mg mg ), 5 mg ( 5 mg mg tacrolinimus ( As monohydrate)). tacfordius 5 mg the active ingredient in the capsule content hypromellose 2910 , ethylcellulose , lactose and magnesium stearate . what tacfordis looks like and contents of the pack tacforisus : capsule shell tacforeius is supplied as 0: 5 mg hard capsules .
clopidogrel zentiva contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopidosis ( also called trembi ) are forming in hardened blood vessels ( arteries ), a procedure known as atherothromboses , and atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclopidel  Zentiva to help prevent blood coagulations ( also known as thrombi ), and to prevent them from reoccurring .
do not take clopidogrel zentiva if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if there is severe liver disease which is unacceptable . do not use cloclopidegrel Zentiva without advice of your doctor . warnings and precautions if any of these apply to you , tell your doctor before taking clopinogrelly zentivea : if the person taking it has a risk of bleeding such if : you have or are at risk of internal bleeding ( such as an ulcer ). you have ever had a blood disorder that makes you prone to internal bleeding or bleeding inside any tissues ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor prescribes clopidosis for severe chest pain ( unstable angina or heart attack ), the recommended dosage is 300 mg of  Clopidogral  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment . then , the recommended initial dose is one 7 - mg tablet ( 4 tablets ) per day as described above . you should take clopinogrell zen
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister , after exp . the expiration date refers to the last day of that month . for aluminium blisters : do not store above 30 . store in the original package in order to protect from moisture . if clopidogrel zentiva is supplied in all aluminium boxes , it does not require any special storage conditions . this medicine does not need to be used if you notice any visible sign of deterioration . Do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopinogrell . each tablet contains 75 mg of clopionogrelly ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' cloclopidel  Zentiva has lactose ' and ' colloidal clopizide zentivea contains hydrogenated castor oil '), mannitol ( e421 ), hydrogenated castingor oil ( oesophagus ), microcrystalline cellulose , macrogol 6000 and low - substituted hydroxypropylcellulose . the ingredients are : lactoses monohydrate ( milk sugar ), hypromellose ( е464 ), triacetin , red iron oxide ( 233 ) and titanium dioxide ( é171 ). what 
yttriga is a radioactive medicine . it is normally administered by a doctor or a nurse . yettrigga is not a substitute for another medicine that is radiolabelled . tiny radiation doses ensure that the treatment is as effective as possible . all information about the use of yTtrig
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yTriga ( listed in section 6 ). - you must not use it if chloride is present in the milk of transgenic goats . - are pregnant or think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yettrigga . this is because yytrige is not a radioactive medicine , and is not intended to be used together with another medicinal product . it is not known whether yattrig
your doctor will determine the appropriate dosage and method of administration yttriga is intended for radiolabelling of medicinal products for the treatment of specific diseases . administration of yTtrigа in case of overdose is not a problem and should be treated promptly . he / she will determine with you the appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . reporting of side effects you can report side effects directly via the national reporting system listed in appendix v . by reporting side effects, you can help provide more information on the safety of this medicine .
keep out of the sight and reach of children . do not use yttriga after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . local regulations for radioactive substances should be followed . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 g of hydrochloric acid . what Yttrigga looks like and contents of the pack yettroga is a clear , colourless to pale yellow solution for infusion , supplied in 3 mL vials with a v - shaped bottom . it is supplied in a colourless type i glass vial of 10 mlitres with an open vial with  a flat bottom , closed with syringe , and an aluminium seal . pack size of 1 vial .
ciambra is a medicine used in the treatment of cancer . ciama is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in this case , it is used alone . when ciambaraz is given together with  Cisp Latin for the initial treatment of patients with advanced stage of lung cancer : ciabera can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; ciaba is also a treatment for patients with lung cancer who have had other initial chemotherapy at an intermediate stage .
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - when you are breast - feeding ; you must discontinue breast  - feeding during treatment with ciambaa . - after receiving a vaccine against yellow fever , tell your doctor or nurse who will decide if ciamara is right for you . warnings and precautions talk to your doctor , pharmacist or nurse before receiving ciacara if any of these apply to you : - you have previously received or might now have problems with your kidneys . before each infusion of ciembra certain tests ( tests of your blood , kidney and liver function ) will be performed to check that you have enough blood cells to receive ciabera , and if your
ciambra will be administered to you by a doctor or nurse . the recommended dose of ciama is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your normal body . this body surface area may be used for treatment or to adjust your dose if necessary . depending on your blood cell counts and on your general condition , the doctor may have mixed the ciamba powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before use . ciamara will always be given to you into one of your veins . you will have the infusion given approximately 10 minutes after you have been given ciamora . in combination with cisplatin the doctor or hospital pharmacist will work out your dose of your heightand weight . both the doses
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your doctor gives you a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if the product is exposed to moisture , it may cause chest pain or a fast heart rate . it may also cause pain , redness , swelling or sores in your mouth . allergic reaction : a rash , burning or prickling sensation , or fever . skin reactions may be serious and could be life - threatening . tell your doctor if any of these affect you . your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . chemical and physical in - use stability of the infusion solution of pemetrexed has been demonstrated for 24 hours at 2 – 8 and 15 to 25 . from a microbiological point of view , the reconstituted solution should be used immediately after preparation . if not used immediately , in  8 hours at room temperature ( below 25 ) the inffusion solution should not be used . once prepared as directed , chemical and physically in operative storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours below 2 , 8
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetreixed ( as pemetreXed disodium hemipentahydrate ). ciamba 500 mg , each viall contains 500 milligramms of Pemetrexéd (as pemetrexxed désodium haemipentehydrate ) after reconstitution , the solution contains 25 mg / ml of pemeterxeed per vial . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further pharm adjustment ). see section 2 " ciampa contains sodium "
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) used to prevent certain infections in your blood . immunogam is used to reduce the increased levels of human hepatitis b immunoglobularins , known as immunoglobuin g ( igg ). it is used in the absence of immunoglobulation g [ ig ] in the blood plasma of screened patients . how immunogam works immunogam reduces the amount of hepatis - b virus in the body in haemodialysed patients , especially in those who have not previously been vaccinated with a hep - 1 virus carrier . this ensures an immune response that produces measurable hepathis a antibodies , which are necessary for vaccination . continuous prevention is needed for those at risk from becoming infected with heparin 
immunogam should not be used : - if you have had an allergic reaction to human immunoglobulins or other blood products if your doctor has told you that you have an iga deficiency . your doctor may decide to treat you if this applies to you . - in rare cases an allergic response has occurred to iga containing products . in very rare cases , patients 18 years of age or older have not received immunoglobulars and the risk of adverse reactions is higher . please inform your doctor of any symptoms . chills , headache , fever , vomiting and allergic reactions ( nausea , arthralgia ) ( joint pain ), low blood pressure , moderate low back pain . you should have antibodies against hepatitis b immunoglobuulin regularly . this is because human hepatis a immunoglobulation injections may not
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose will be administered to you in a hospital or clinic and will be prepared by a doctor or nurse . it will be given in specialised clinical or health care settings . for human hepatis c immunoglobulin administration the recommended dose for administration prevention of heptis
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( impacts in 1 to 10 users in 100 ) uncommon ( impacts 1 to10 users in 1 , 000 ) rare ( impacts1 to 10 Users in 10 to 10 ,000 ) very rare ( effects in less than 1 per 10 . 000 ). the frequency cannot be estimated from the available data undesirable effects which may occur during clinical trials with immunogam were : - injection into muscle ( affect 1 to 11 users in 10 million ) - 7 nausea - fatigue - induration - swelling - vomiting - diarrhoea - nausea , fatigue , indurance - pain in the joints - joint pain - muscle pain uncommon (
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . in order for immunogam to be used immediately , the user / doctor must remove the vialute from the refrigerator and set at room temperature ( 15 - 25 ). the product should not be used if it is cloudy or has deposits . once the vialation date has passed , dispose of it safely . medicines should not go through the wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . one vial of immunogam contain 1 mg or 5 mg of human plasma protein of which at least 96 % is immunoglobulose . -the other ingredient is polysorbate 80 . what immunogame looks like and contents of the pack immunogam is presented as a solution for injection in a glass vial . the solution is a clear to slightly pearly , colourless to pale yellow liquid . pack size of 1 vial
remicade contains the active substance infliximab . inflimab is a monoclonal antibody a type of protein that attaches to a specific target in the body called tnf ( tumour necrosis factor ) alpha . reMICade belongs to  a group of medicines called ' ttnF blockers '. it is used in adults for the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew 's disease ) psesoriasis . the active ingredient in remade is inactivated in adults and children 6 years of age and older for crohn '
do not use remicade if you are allergic to infliximab or any of the other ingredients of reMICade ( listed in section 6 ). if this applies to you , tell your doctor . if . you are also allergic ( hypersensitive ) to proteins that come from mice . have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . your doctor may want to monitor you more closely . warnings and precautions talk to your doctor before you are given relicade and discuss with your doctor whether you need to be treated with remikade again . tell your physician if any of these apply to you ( or you are not sure ), talk to you doctor before being given . children and adolescents reminiade is not recommended for children and teenagers under 18 years of age 
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psesoriasis , ulcerative colitis and crohn 's disease the usual dosage is 5 mg for each kg of weight , given once every week . how remicade is given remade will be given to you by your doctor or nurse . your doctor will prepare the medicine for infusion . the medicine will be prepared and given as an infusion ( drip ) over 2 hours into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give you another dose of remikade . contact your doctor if you have any further questions on the use of this medicine 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , chills , nausea and vomiting . other side effects include :
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . store in a refrigerator ( 2 8 ). this medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 for a single period of up to six months . in this situation , do not return to refrigerate the solution after infusion . however , it may be stored for up to 3 hours at 2 8 and for an additional 24 hours at 25 after removal from the refrigerator . your healthcare professional will ensure that the correct storage and disposal of this medicine are maintained and protected from light .
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflimab ( 10 mg infl ). the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphatе . what rmicaDE looks like and contents of the pack reMICade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white . remikade comes in packs of 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used to treat parkinsons '
do not take rasagiline mylan if you are allergic to rasagilide or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have severe liver problems . if this applies to you , tell your doctor and do not continue with the following medicines : - rasagaline mylan belongs to a group of medicines called monoamine oxidase ( mao ) inhibitors ( e . depressed or parkinson ' s disease ) - medicinal and natural products without prescription - st . mary 's wort ( a strong pain killer ), which can be taken for up to 14 days after rasagide mylan treatment . talk to your doctor if treatment with mao inhibitors like pethidine is started . warnings and precautions talk to you doctor , pharmacist or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan may be taken with or without food . if vous take more rasagilline myLAN than you should if this occurs , contact your doctor immediately . do not freeze . keep the rasagile mylan carton tightly closed in order to protect from light . take rasagide mylan at least one hour before or one hour after food , drink and any remaining tablets at the same time each day . you should take rasaggiline mylant for as long as your physician tells you to . however , if there are no other reasons to suspect that it might have been accidentally frozen , or if someone else accidentally takes your tablets , consult a doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects were observed more often in placebo - controlled conditions ( frequency not known ). the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( impacts 1 to 10 users in 100 ) uncommon ( affectes 1 to 1 user per 1 , 000 ) rare ( impacts less than 1user in 10, 000 +) very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell . neck pain chest pain ( angina pectoris ) not known ( frequency cannot be estimated from the available data ) very rare ( effects in children and adolescents ): very rare abnormal movements( dyskepticaemia ) in children less than 2 years of age . not known the following serious side effects are reported
what rasagiline mylan contains - the active substance is rasagil . each tablet contains rasagile tartrate equivalent to 1 mg rasagiata . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize meal , talc , steel , starch and maize flour . what rasaggiline myLAN looks like and contents of the pack rasagiziline tablets are 11 . 5 mm long and 6 mm wide , oval , biconvex tablets , debossed with " gil " on one side and " 1 " on the other side . the tablets are available in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets in perforated blisters . not all pack sizes may be marketed .
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a severe infection , for example , tuberculosis . it is important that you tell your doctor if symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . check with your doctor or pharmacist if there is anything you do not understand . warnings and precautions moderate or severe heart failure . this is because hULio can cause or worsen a serious heart condition ( see " warnings of use "). allergic reaction if the product is accidentally taken too close to the chest , you should seek immediate medical attention . allergic reactions can be life - threatening and can include symptoms such as chest
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years of age : the usual dose is either 10 mg or 30 mg . hulio 20 mg tablets are available as 2 to-17 years of ages : 30 mg each day . your doctor may decide to increase your dose of hULio to 40 mg if your child has enthesitis - related arthritis in kids from 6 to 17 year of age and weighing at least 15 kg : a daily dose of 30 mg of heulia or 20 mg , depending on the weight of the child . for children and adolescent from 6 months to 17 kg , the usual starting dose is 30 mg ( one tablet )
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . tell your doctor straight away if you notice any of the following , as you may need urgent medical treatment . side effects may occur at least up to 4 months or more after the last hulio injection . seek medical attention urgently , if any of these effects become severe . serious side effects tell your healthcare professional straight away or seek urgent medical assistance if they continue . they may occur up to 5 days after the final hULio dose . allergic reaction or heart failure severe rash , including hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , or bruising or bleeding , signs and symptoms of infection such as fever / feeling sick 
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , and water for injections . what helio looks like and contents of the pack hULio 40 mg solution for injection in vials is supplied as a sterile solution of 40 mg aad limumumaB in 0 . 8 ml solution . it is clear to slightly opalescent and colourless to slightly yellow . each vial is closed with a rubber stopper . hülio is available in packs containing 1 or 2 vial syringes , 1 sterility injection ssyrtle ,1
bromfenac belongs to a group of medicines called non - steroidal anti - inflammation drugs ( nsaids ) that reduce inflammation . yellox is used to reduce eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using yyelloX : - as you may experience asthma , skin allergy or intense inflammation in your nose when using other nsaids . nns aids include acetylsalicylic acid , ibuprofen , ketoprofened , diclofenoc . this medicine should be used together with topical steroids ( such as cortisone ) because this medicine may increase the risk of unwanted side effects . talk to you doctor if any of these apply to you . bleeding problems in people with haemophilia if they have had them in the past . other medicines and yemo
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop of yellox in each eye ( s ) and one drop ( m ) in each of your eye ( (  ss ). you can use the drops for 2 weeks before using the drops again , and then on the next day after your cataract surgery . method of administration yellowx is for oral use . wash your hands before using yew . after using the eye drops , remove the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid with a finger on the edge . bring the bottle tip close to the eye , just before you use it . if it does not , rinse your eye with
what yellox contains - the active substance is bromfenac . each ml of solution contains bromfed ( as sodium sesquihydrate ). each vial contains 33 mg bromfienac , as a single - use sterile , boric acid . -the other ingredients are borax , sodium sulphite anhydrous , benzalkonium chloride , and tyloxapol . the ingredients in the solution are povidone ( k30 ), disodium edetate and sodium hydroxide . to maintain acidity levels , what Yellox looks like and contents of the pack yyelloX is a clear yellow liquid ( solution ) supplied in a 5 mL glass vial with a screw cap .
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before taking dZveo and during treatment if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). you have been told that dzveo may affect your breathing . during treatment you have had a head injury or brain tumour . you have problems with your heart and circulation ( such . slow heart rate , irregular heartbeat , low blood volume , or low blood pressure ). your doctor may want to monitor you more closely . - you have moderate to severe liver problems . your doctor will monitor you closely if your body breaks
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the single - dose administration device is for administration of patients only . do not take this medication on its own . dzuveo must not be mixed with strong painkillers ( such as sufentanil ) for at least 30 days . take the sublingual tablet using the disposable single  - dosage applicator provided in the pack . keep the applicators in place in order to ensure that the tablets dissolve under the tongue . when the tablets dissolve under the gums , the tongue may be swollen . you may need to take the approx . 10 minutes to be taken at the same time each day . your doctor may tell you to wait up to the maximum daily dose of 720 minutes . after you have taken 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse immediately if you notice any of the following serious side impacts : - severe breathing problems , such as slow and shallow breathing . if these side effects occur , tell your physician or nurse promptly . very common side effects ( may affect more than 1 in 10 people ):  nausea ( feeling sick ),  vomiting ( being sick ) and  feeling hot . common side effect ( may effect up to 1 in10 people ).  inability or difficulty breathing , seeing things which do not go away . not known ( frequency cannot be estimated from the available data )  fainting . reporting of side effects 30 if this happens , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet .
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . do not use this medicine if you notice any visible signs of deterioration . after first opening the viall is to be discarded . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufenteanil ( as citrate ). - other ingredients are mannitol , dicalcium phosphate , hypromellose , crohn ' s croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium steerate . what a dZveo looks like and contents of the pack dzveo is a white , round edged , flat , bevelled tablet with 3 mm in diameter , packed in a carton . - a single - dose applicator ( labelled [ sublingual tablet ]). the applicators contains one sufenil 30 mg sublingual film - coated tablet . pack
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be removed by surgical treatments . apalutaMIDe is used in adult men to treat sensitive prostate cancer which has spread in the body without the need for surgical treatment . erlesadda blocks the activity of a hormone called testosterone ( also called egfr ). androgens , also called prolactin , is found in certain prostate cancer cells . androgeneds in the blood act in the same way as estrogen and solutes eosinophils . by blocking their action , apalutamidie may slow down prostate cancer cell growth .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you may be pregnant , or could get pregnant . ( it is also better to avoid erlesads in early pregnancy see pregnancy and contraception section .) if any of these apply to you , do not use this medicine and tell your doctor before taking this medicine . warnings and precautions talk to your doctor or pharmacist before taking erleda . tell your physician before taking and during treatment with this medicine as you may : have a history of seizures . are taking any medicines to prevent blood clots ( e . g . warfarin or acenocoumarol ). have any heart or blood vessel conditions , including heart rhythm problems ( arrhythmi
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once daily . you should take the tablet at about the same time each day . your doctor may increase your dose to 60 mg once a day if necessary . take erleada by mouth . it is very important that you take ERleadra with food and other medicines as your body ' s natural defences . if your doctor thinks you are taking more erleda than you should , tell your doctor . taking more than one tablet a night is also a better chance to have side effects . keep the tablet bottle with you so that you can easily describe what you have taken . show the doctor your pack of erles . do not take more than the recommended dosage . contact your doctor straight away 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor immediately if you have any of the following symptoms : - reddish , non - elevated , target - like , circular patches on the trunk , often with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes can also be preceded by fever and flu -like symptoms ( toxic epidermal necrolysis ). serious side effects tell your healthcare professional straight away if your child gets any of these serious side effect . serious side consequences talk to your doctor or pharmacist if any of them happen . fit or seizure : uncommon ( may affect up to 1 in 100 people ): stop taking the medicine and call your
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe -the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , indigo carmine ( e132 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cellulitis . film  coating : iron oxide black ( 6000 ), iron oxide yellow ( 8000 ), macrogol , polyvinyl alcohol ,talc , and titanium dioxide ( е171 ). what ersleade looks like and contents of the pack erlesadha film , tablet - coating consists of a slightly yellowish , capsule - shaped ,
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient luciclovine that helps to obtain a detailed medical record ( scan ) of the body using a pet scan . it is used in adults who have previously responded to treatment for prostate cancer or had other tests to check the presence of prostate specific antigen ( psa ) in the blood before and after the cancer has spread . an acumin pet scan may help the doctor determine whether the cancer is likely to be real . the scan will give the doctor valuable information about the scan that is being carried out . what is ppsu this medicine for this procedure is essentially " radiopharmacial product ". the provider of the radiopharmaceuticopathic product carries the radioactive ingredient fluciclovin . this product is small and is radioactive .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using aXumin tell your doctor if : - you have kidney problems - your doctor may want you to follow a low sodium diet . you should not take more than one a day before the acnumin scan . it is important that you follow this advice carefully . 4 hours after the scan , you should eat a meal or a snack within the latest 60 minutes after the xumumin injection . - avoid urination during and after the dose . children and adolescents adolescent( 2 years of age and older ) should not give this medicine to children and teenagers younger than 18 years since there is no information
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in special controlled areas . this medicine will only have to be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used by you and will make sure that it is the smallest quantity necessary to get the desired information . the quantity to be administered usually recommended for a single injection is 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of  acclimatisation of reconstituted aquerelation . administration of the aqr code the conduct of the procedure 
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( may affect up to 1 in 100 people ). they were mostly mild to moderate and went away within a few days to a full day . the medicine was not tested for these side effects and patients were carefully monitored for the following side effects after they were given : axumin may affect more than 1 in every 100 people pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects tell your doctor if you get any side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . keep this medicine out of the sight and reach of children . do not use axumin after the expiry date which is stated on the label after exp . store in the original package . hospital staff will ensure that the product is stored and thrown away correctly and not used after the stated expiry dates stated on labels .
what axumin contains - the active substance is fluciclovine . a xumine 1600 mg / 1600 mg film - coated tablet each tablet contains 1600 mg or 16000 mg flucclovine ( 16000 iu / ml ). acumin 3200 mg : each tablet provides 3200 ius of fuciclovine (3 200 iup / 32000 ip ). the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " aXUMIN contains sodium "). what xamin looks like and contents of the pack axxumin 1600 io / multidose tablet : pack sizes of 1 and 10 tablets . each carton contains 1600  16000 international units ( iunit ) of azoomin 32000 international units
azopt contains the active substance brinzolamide . this belongs to a group of medicines called carbonic anhydrase inhibitors , which reduce pressure within the eye . azaropt eye drops are used to reduce high pressure in the eye in adults who have an illness called glaucoma . when the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems . do not use aziopt - if your doctor thinks you may be allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). - as you may also be allergic against medicines called sulphonamides ( e . g . medicines for diabetes or infections ) or diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azaropt : if : you have the same allergy as you have too much acidity in your blood ( hyperchloraemic acidosis ). your doctor may decide to reduce your dose of arizopt , especially if: you suffer from kidney or liver problems ; you suffer or have dry eyes or cornea problems , or you are being treated with other sulphamide medicines
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one glass of water once a day in both eyes ( 1 glass in the morning and one in the evening ). it is best to take azopt in both hands at the same time each day . it is important that you rinse your eyes thoroughly afterwards before using a Zopt . do not put in any more drops until you have settled in . how much to use adults and children arizopt should be used only in children . instructions for use 1 , 2 , 3 and beyond : opening the azeopt bottle and wash your hands . twist off the cap once you remove the cap . if the cap is loose , snap collar is loose and remove it . hold the bottle , pointing down , between your thumb
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , ear pain , and eye discharge . - itchy eye , dry eye ; abnormal eye sensation ; redness of the eye ( see section 2 ). - side effects with bad taste . uncommon side effects that may affect more than 1 in 100 people - effect in the eyes : uncommon side effect ( may effect up to1 in 100 persons )- effects at the back of the oedema ( seeing flashes of light ): - allergic reactions ( e .g . itchy eyes , redness in the back part of the eyes and redness at the front
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . azopt is for single use only . once a bottle has been opened , the contents should be used immediately . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzolidine . -the other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , manitol , purified water , sodium chloride and tyloxapol . hydrochloric acid and sodium hydroxide to keep acidity levels ( ph levels ) normal . what ' azaropt looks like and contents of the pack azyopt is a milky liquid ( a suspension ) that comes in a 5 mL clear glass bottle and comes in either a 10 mll plastic ( droptainer ) bottle with a screw - off cap . not all pack sizes may be marketed .
forxiga contains dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxika is used in adults aged 18 years and older . there are two types of diabetes : type 1 diabetes where your body does not make any insulin . the recommended dose of forxaga is 1 mg / kg of diabetes in adults who are overweight or obese . type 2 diabetes where the body does NOT make enough insulin or is not able to use the insulin it produces properly . this leads to causing diabetes to be a life - threatening problem if it has not been properly controlled in your diet , exercise and your blood sugar could fall below the normal level .
do not take forxiga : - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxika :- - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a fruity or metallic taste in your mouth , an odour to your urine or sweat or rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a serious , sometimes life - long condition with diabetes because of increased levels of " ketone bodies " in your urine and blood , seen in tests . these levels may be detected early in treatment . if your doctor suspect
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose of forxiga is one tablet once a day . if your doctor has prescribed the dose for type 2 diabetes , the dose may be increased to 10 mg once , or 5 mg once daily . your doctor may prescribe a lower dose if there is a liver problem . the recommended dosage of forXiga for type 1 diabetes is one 5 mg tablet once daily dosing . taking this medicine swallow the tablet whole with water . you can take your tablet with or without food . it is best to take your tablets with a glass of water , and do not crush or chew the tablets . forxaga may be taken with or just after food , if desired . this will lower the amount of sugar in your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact a doctor immediately if you notice any of the following serious side effects you may need urgent medical attention : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). these are signs of angio edem
what forxiga contains the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapaglliflon propanediol monohydrate equivalent to 5 mg dapaglingiflouzin ). the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 ' forxika contains lactoses '), crospovidone type a , silicon dioxide , magnesium stearate . film  coat : polyvinyl alcohol ( EE120 ), titanium dioxide ( е171 ), macrogol 3350 , talc ( é553b ), yellow iron oxide (  e172 ). what forixiga looks like and contents of the pack forxige 5 mg is a pink , oval ,
mepact contains the active substance mifamurtide which works by stopping the growth of certain bacteria that are part of the immune system . mepacted is used to treat osteosarcoma ( bone cancer ) in adults between 2 and 30 years after surgery to remove the tumour . it is also used in combination with chemotherapy to kill cancer cells and to prevent cancer from coming back .
do not use mepact - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - you are taking medicines containing the following active substances : ciclosporin and other calciumineurin inhibitors ( non - semenoidal - anti - ininflammatory drugs [ nsaids ]) that are used to treat problems with your heart or blood vessels such as blood clots ( thrombosis ) or bleeding ( haemorrhage ). inflammation of the veins ( vasculitis ). mepacting may cause long - lasting or worsening symptoms after stopping mepactation . this is because asthma and other breathing disorders may worsen your asthma ( if not treated ) if your asthma is caused by inflammatory or autoimmune disease , for example , cortic
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepactation is 2 micrograms of mifamurtide per day . it is given every 12 to 24 hours . your doctor may change your mepacting treatments depending on your chemotherapy schedule . you should usually start your chemotherapy 36 days after the start of treatment . how does mepacted work ? an interruption in the processing of the freeze - dried powder is transformed into a liquid suspension before it is mixed with the filter . mepactate is given by reconstituted and diluted solution into dissolved solution and given to mepace into , into - vein , over about 1 hour . if this happens , me
like all medicines , mepact can cause side effects , although not everybody gets them . tell your doctor immediately if you experience chills , fever or fatigue . mepacting may be administered by infusion ( transient ) use of paracetamol . if fever occurs during or after treatment with mepacted , tell your physician immediately . stomach problems ( such as nausea , vomiting , loss of appetite ) following chemotherapy tell your healthcare professional immediately , if continuing fever or chills persist for more than 8 hours after you have taken mepactate . signs of an infection such as rash , or any problems breathing or wheezing , as mepactation may make you more prone to infections or flu . your doctor may tell you to stop taking mepace . severe allergic reactions ( hypersensitivity ) may occur which may be severe . very common side effects ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vial in outer carton in order to protect from light . reconstituted suspension containing sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection has been shown to be stable for 6 hours . this medicine does not require any special temperature storage conditions . does not show signs of deterioration .
what mepact contains - the active substance is mifamurtide . each ml of concentrate contains 4 mg of mfamurdide - after reconstitution , one mmol of suspension contains 0 . 08 mg of Mifamortide ( 0 in 100 ). - if the other ingredients are 1 - palmitoyl - 2 -oleoy - shn - grazo - 3 -phosphocholine ( ph - 1 ) and 2 , dioleayl- sn , glycero - 3- - poly( 3 )- phospho- l , sodium salt ( e223 )). what me Pact looks like and contents of the pack mepactation is a white homogeneous cake supplied for infusion .
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists , which are injected under the skin ( the face ) and act in different ways to reduce redness . rosacea is a condition where redness of the face is seen . most people with roscea have high levels of blood flow in the facial skin , resulting in enlargement ( dilation ) of the small blood vessels of the skin . mirvasa acts by blocking the blood vessels , blocking the excess blood flow and causing redness in the area around the area .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking mirvasone if : you have had side effects with the medicine , it should only be used on the skin . you are taking certain medicines for depression or parkinson ' s disease called monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , moclobemide ), tricyclic antidepressants ( i . excipients such as imipramine ), tetracyclic antagonistants ( such as maprotiline ; mianserin ); or mirtazapin . mirvasa should not be taken if any of these medicines are known to cause side effects
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is for use on the skin only . this is for the face only ; you should not apply this medicine to other parts of your body . avoid direct sunlight and close contact with other body surfaces such as your eyes , mouth , nose or vagina . how much to use mirvasa is for oral use . to use mirror images ( such as those on your eyes, mouth or nose or aura ): - mirvass is only for the facial area . - before starting the treatment with a small amount of gel ( a pea - sized amount ) will be sufficient to control your symptoms . your doctor will tell you how many treatments you need to take . the maximum daily dose of 1gram ( 5 pea- shaped amounts ) should not
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : severe skin irritation or inflammation , skin rash , cutaneous skin pain or discomfort , dry skin , warm skin sensation , and tingling , sensation of pins and needles or swelling . common side effects include : worsening of rosacea . discontinue the treatment and seek medical advice immediately if symptoms persist ( see section 2 " warnings and precautions "). contact allergy ( allergic reaction with rash and rare angioedema , which is a serious allergic reaction to mirvaso ), which may be life - threatening . if you experience a rash or itching on your skin . very common side effect is : burning sensation of the skin and / or tingle , feeling of pinses and needled or swelling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , tube and pump after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture . keep the tube and pusher tightly closed .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimoniidine , equivalent to 5 mg of the active ingredient , brimondidine tartrate . - other ingredients are carbomer , 2 - methylparahydroxybenzoate , in the code name ' b ', phenoxyethanol , 5 , 8 - carboMER , 3 - 2 methyl parahydroxybenzone , propylene glycol , sodium hydroxide , purified water ( see end of section 2 for further information on methylparhydroxybenzonate and propyl glycol "). what mirvao looks like and contents of the pack mirvasa is a clear , opaque gel . it is supplied in 2 ml syringes , 10 m
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumaB binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow and oxygen to grow within tumours . by binding to veGF , tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients and oxygen for the body to grow . mvai is  a medicine used for the treatment of adult patients with advanced cancer in the large bowel . it is intended to be used in addition to the chemotherapy treatment in patients who have already been
do not use this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic or hypersensitive to chinese hamster ovary ( cho ) cell products . - plan to become pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before using mvasi . your doctor will monitor you closely during treatment with mvai , particularly if : you have an increased risk of developing holes in the gut wall or developing inflammation inside the abdomen ( such as diverticulitis , stomach ulcers , colitis associated with chemotherapy ). in some patients , mvasesi may increase the risk of having an abnormal connection or passageway between two organs or vessels . this may increase your risk of creating connections between the vagina and the
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg or 10 mg per kilogram of your bodyweight . your doctor will prescribe a dose of 15 mg / kg . depending on your disease , your doctor may increase your dose of dose . you will be treated with mvai once every 2 or 3 weeks . if you have more infusions than you should , you may receive treatment with this medicine . continue to follow your doctor ' s advice on reducing the dose , stopping mbusi or stopping your tumour growing . frequency ofadministration mvasesi is diluted with sodium chloride solution before it is given to you . this diluted m Vasi solution is for intravenous infusion ( a drip into your vein ).
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . these side effects were mostly mild to moderate and generally went away within one week after the start of mvai . allergic reactions if your child has an allergic reaction , tell your doctor or a nurse straight away . signs may include : difficulty in breathing or chest pain . you could also experience redness or flushing of the skin or , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). if any of the side effect gets serious , or if the child gets severe side effects you should seek medical
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless the infusion solution has been prepared in  a sterile environment . after diluted solution in syringes in opalescent or asterile atmosphere , the product should be administered immediately . however , chemical and physical in fusion stability has
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacitab in 1 . 4 to 16 . 5 mL of solution . when diluted , each 4 mlitre vial contains 100 mg of beervacizuab at 1  . 8 mg / m2 . after dilution each 16 mliter vial provides 400 mg of biotechnology of bevaizum ab @ 16 , 5 . 6 mg . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what if you need to know before you use mvai ? what ? mwasi is a concentrate for solution for infusion . it is  a clear to slightly opalescent 
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . tecARTus is used with other medicines to treat relapsed or refractory mantles cell lymphopenia ( mcl - t ) in adult patients . this is when your own white blood cells ( named autologous anti - CD19 - transduced cd3 + cells ) do not make enough b - lymphocytes . mantLE cell lymphhoma is  a cancer that affects part of the immune system called b- lymph cells . in mantled cell lymphodyma patients have a reduced number of b " lymphocyte cells , which accumulate in an uncontrolled way into the lymph tissue or bone marrow , where it is injected into blood . the white blood cell in your blood can replace
do not use tecartus if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if not , you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before using tecARTus . this medicine may affect the number of white blood cells in your blood ( lymphodepleting chemotherapy ). in the long term , the number may be reduced by taking a lower dose of 3 million . the number can be increased by taking more tecarus than by other means such as tests and checks . checks and checks your doctor will regularly check your lungs , heart , kidney , blood pressure , signs of infection and inflammation of your cancer ( graft - versus - host disease ). you may be at increased risk of having
tecartus consists of your own white blood cells . your cells will be collected from you and given to you by a doctor or nurse . a catheter placed in your vein ( a procedure call leukapheresis ) will take about 30 - 60 minutes to collect your white blood cell ( s ) from your blood . this will be given to your blood into your vein . it can take 3 to 6 hours for your whiteblood cells to collect and divide . the next steps are : tecARTus will be repeated every 2 to 3 months . medicines given before tecarthus treatment , the doctor will give you lymphodepleting chemotherapy . how tecArtus works tec artus is made specifically for you by your doctor using the modified white blood units . these will be sent away to make them in your body . they will take between 30 and 60 minutes before
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss with you how to manage your side effects and will explain how to compensate for them if you notice any of your side impacts . tell your doctor straight away if any of the following side effects get serious . you may need urgent medical attention if these side effects become serious , or require the tecartus infusion . very common ( may affect more than 1 in 10 people ) - fever , chills , reduced blood pressure , symptoms such as dizziness , lightheadedness - fluid in the lungs , which may cause all symptoms of a condition called cytokine release syndrome . - loss of consciousness , decreased level of consciousness may be accompanied by confusion and memory loss .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container label and infusion bag . store frozen in vapour phase of liquid nitrogen  150 . the following information is intended for the healthcare professionals at the hospital . this medicine contains genetically modified human blood cells and human - derived material . tecartus is for single use only . after dilution , the product is sterile , and is stable for 36 hours .
what tecartus contains the active substance of tecARTus consists of autologous anti - cd19 - transduced c3 + cells in a specific single infusion bag containing a dispersion of anti  - ced19 car t cells in approximately 68 ml for a target dose of 2 x 106 anti cpd19 cars . the other ingredients ( excipients ) are : cryostor cs10 , sodium chloride , human albumin . see section 2 " tecArtus contains sodium ". what Tecartus looks like and contents of the pack tec artus is a clear to opaque , white to red dispersed , cell disperding in an infusion container supplied in tamper evident metal cassette . a single inffusion bag contains approximately 66
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic . it is important that you continue to follow the diet and / or diet plan as agreed with your doctor , pharmacist or nurse . you should continue to take this medicine as long as your doctor tells you to . in addition to diet and exercise , your doctor may prescribe this medicine along with certain other medicines ( insulin , metformin , s
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - when taking janus , you may be at increased risk of inflammation of the pancreas ( pancreatic ) ( see section 4 ). warnings and precautions januga can cause blistering of the skin that may look like bullous pemphigoid . janutevia should not be used if any of these apply to you . tell your doctor if your doctor thinks you may have a disease of the glands called pancreattitis ( see also section 4 of this leaflet ). you may also have gallstones , alcohol dependence or very high levels of triglycerides ( a form of fat ) in your blood . these medical conditions can increase your chance of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks this is too strong or too weak , talk to your doctor . patients with kidney problems the usual dose is 25 mg once , taken once . your doctor may prescribe lower doses ( such as 50 mg ). you can take this medication with or without food and drink . this medicine can be taken with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and drink as your body can help you stay on track of the sugar in your blood . if this medicine is not your medicine , contact your doctor immediately . take the tablet and this leaflet with you if there
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects: severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . if this happens to you , stop taking this medicine and call your doctor immediately as you may need medical attention . you may also need medical help . case studies have shown that some side effects could become serious . the most
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate , equivalent to 25 mg sitaglliptein . - other ingredients are : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film coat contains poly ( vinyl alcohol ), macrogol 3350 , and talc ( е553b ), titanium dioxide ( k25 ), red iron oxide ( E172 ), and yellow iron oxide . what iuuvia looks like and contents of the pack round , pink film , opaque blisters , imprinted " 3350 " on one side .
what xultophy is xULtophy lowers blood glucose , which is too high for some people . it is used to treat type 2 diabetes mellitus . this type of diabetes occurs when the body is not able to make enough insulin to control the level of blood sugar . your doctor will prescribe insulin degludec , a long - acting basal insulin , when your blood sugar levels are too high . you may also be given liraglutide ( a type of insulin called glp - 1 ), or insulin during meals . xuziphy is used together with oral medicines for diabetes xulation is used in combination with oral medicine for diabetes ( e .g . metformin ).
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if your doctor has told you that you have a sulfonylurea such as glimepiride or glibenclamide . your doctor may adjust your sulphonyla dose if necessary . warnings and precautions your doctor will check your blood sugar levels regularly while you are taking xULtophy and during treatment if : you have type 1 diabetes mellitus or ' ketoacidosis ' ( a condition where the body cannot break down sugar ). you are treated with xeletophy because of inflammatory bowel disease or delayed gastric emptying ( diabetic gastroparesis ). xulation may cause low blood
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if the doctor has shown you are blind or have poor eyesight , or if they do not work properly , tell them to take the next dose . your doctor will monitor your blood sugar level during treatment with xultophy . 41 the recommended dose is one capsule per day , containing 8 capsules . you can take xULtophy with or without food . follow the instructions in the carton for further information . how to use xeletophy is for use in adults only . the pen is for single use only ; however , the dose counter is always on the first use only ( see section 1 " how to take a dose "). the dose indicator reads 1 unit of insulin degludec 0 . 033 mg liraglutide the
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( common , may affect up to 1 in 10 people ). if your blood sugar level gets low you may pass out and become unconscious . serious hypoglycaemia may cause brain damage and may be life - threatening . if you experience low blood glucose , take action to increase your blood glucose level immediately . in case of low blood zahăr ( hypoglcaemia ), see the box at the end of this section for more information . possible serious allergic reaction ( anaphylactic reaction ) ( frequency not known ) if a serious allergic react occurs , talk to a doctor or go to hospital straight away . local reactions may occur very commonly ( may affect more than 1 in every 10 people taking xultophy ). you may experience local reactions which
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after dilution : chemical and physical in - use stability has been demonstrated for 30 days at 2 to 8 and for 21 days at 25 . from a microbiological point of view , the product should be used immediately . if not used immediately, in  30 , an immediate use is recommended .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec ( equivalent to 3 . 6 mg lilaraglutides ). each 3 mL vial contains 300 units of insulin de glucose ( equivalent  to 10 . 8 mg / m2 ) of llilaglutide the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xULtophy includes sodium ". pack sizes of 1 , 3 or 5 vials or a multipack containing 10 vial ( 40 x 1 ) vial . not all pack sizes may be marketed .
giotrif is a medicine that contains the active substance afatinib . it attaches to a protein called egfr [ epidermal growth factor receptor 1 ] ( eGFr ]), erbb1 , her2 [ erbeb2 ] and erberbb3 ]. these proteins help cancer cells grow and divide . by attaching to eggfr , this medicine can slow down the growth of cancer cells and slow down their decline . this medicine is used to treat adult patients with cancer of the lung ( non - small cell lung cancer ). gioTRIf is intended as your first treatment if you have had prior chemotherapy treatment for a certain type of squamous type if prior chemotherapy therapy has not worked or has stopped working .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low body weight less than 50 kg if the treatment is for oral use talk to your doctor if this applies to you . warnings and precautions talk to the doctor before taking gioTRIf : if any of your family members has kidney problems , talk to their doctor before starting giotricf . some patients have experienced side effects such as lung inflammation ( interstitial lung disease ) or liver problems . your doctor may need to perform some liver tests before you start taking this medicine , especially if : you have a severe liver disease . you have eye problems ( especially : severe dry eyes ) and inflammation of the transparent layer at the back of the eye ( cornea ) as well as
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 40 mg tablet once a day . you should swallow the tablet whole with food . this medicine can be taken with or without food ; a glass of water . do not chew , crush or split the tablet . your doctor will tell you how many tablets to take each day , and how long you should continue to take it . taking this medicine take this tablet at least 1 hour before or 3 hours after a meal . if your doctor has decided that you should take this medication at the same time each day you should always take the tablet at the exact time you have been told to take . always take giotrif exactly as described in this leaflet . swallow the tablets whole with water , with or immediately after food , at about
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : treatment related diarrhoea ( very common , may affect more than 1 in 10 people ): diarhooeal pain ( common ), may affect up to 2 in 10 , with severe diarrehoa resulting in fluid loss ( common common - may affect less than 1 per 10 ), with low blood potassium ( common in patients with worsening kidney function ) and diarration in patients suffering from diaroeea . if you get diarrothoemia contact your doctor immediately . your doctor will decide whether to continue appropriate antidiarrhoidal treatment or antidiarrheal medicine prior to starting giotricf .
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; and hypromellose , macrogol 400 , titanium dioxide ( e171 ), and polysorbate 80 ( a ). what urif looks like and contents of the pack giotricf 20 mg film – coated tablets are presented as white to off - white , oval tablets with " af " debossed on one side . the tablet is packaged in a plastic bottle . it is available in packs of 1 , 2 or 4 film  - covered tablets
orkambi contains two active substances : lumacaftor and ivacafting . ork Ambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children aged 6 years and older with a f508del mutation ( cystic fibrine transmembrane conductance regulator ) that is essential for the normal functioning of your lungs . the mutation causes an abnormal ccftr protein called ctr . lumcafted and iu ivacastor work together to correct the abnormal fttr proteins . by blocking c Ftr and lumamacaffetor , ivacator causes abnormal protein to work more normally , improving your breathing and your lung function . you may also notice that you do not get ill as often
do not take orkambi : - if you are allergic to lumacaftor , ivacaftingor - the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ork Ambi . talk to a doctor or a pharmacist before orkami is given :- - you should not take the orkacco tablet if the f508del mutation is missing or does not appear on the tablet . - orkamba has not been tested in patients with liver or kidney disease . your doctor will monitor the condition of your kidney while you are taking the tablet and if necessary adjust the dose of orkiji . tell your doctor if : you have abnormal blood tests of the liver . you should stop taking orakambi and see your doctor immediately if any of these symptoms occur , as
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and children aged 6 to less than 12 years who weigh at least 11 kg the recommended dose of orkambi is 100 mg , taken as 2 tablets in the morning and 2 tablets at least 12 hours apart . the recommended dosage of orkiambi is 200 mg / 2 tablets once a day in the evening , or in the afternoon , at about the same time each day . children aged 2 to less then 12 years the recommended starting dose of tianjin is 200mg , given as 2 separate doses , in the same day , and in the night . use in children and adolescents ork Ambi can be used in children of all ages . if your child has moderate or severe problems with liver function , your doctor may decide to give
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in orkambi were similar to those reported with ivacaftor , but were less frequent . ork Ambi may cause serious side effects in patients taking orkham . you may have raised levels of liver enzymes in the blood , which may lead to liver injury . in patients with pre - existing severe liver disease , the worsening of liver function is uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the white part of your eyes loss of appetite or feeling jittery , irritable , or generally unwell . these may be signs of liver problems . if they occur , they usually disappear in a few days
what orkambi contains the active substances are lumacaftor and ivacafting . ork Ambi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg of lumаcaftoor and 12 . 5 mg of orkacco . the 200 mg 1/ 200 mg film- coated tablet also contains 200 mg of either lum acaffetor , and 125 micrograms of ivacasaftoral . what orkiki looks like and contents of the pack orkamba 100 mg film and 127 microgram tablets the tablets are white to off - white , round tablets debossed with " otsuka " and " tsu " on one side and " 112 " on the other side . okambi 200 mg and 129 microgram tablet the tablets also contain cellulose , microcrystalline
what lynparza is lymparza contains the active substance olaparib . olarib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ]). it is caused by mutations ( changes ) in brca ( breast cancer gene ) which are involved in the growth and spread of cancer . parp inhibits can cause death of cancer cells , which may be caused by the lack of an enzyme to repair dna . what LYnparaza is used for lyndparza can be used to treat : ovarian cancer called brca - positive or mutated ovary cancer , where the cancer has responded to previous treatment with standard treatment or standard treatment with standards , or with standard chemotherapy . how lyng
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). - check with your doctor if this applies to you . warnings and precautions talk to your doctor or pharmacist before taking lyndparza and during treatment with lynchparza it is important that you tell your doctor about all of your medical conditions before taking your first dose of lyngparza ( see section 4 ). take special care with LYnparZA - when you have low blood cell counts . testing shows that the medicine is working , it can show that you have either low counts of red or white blood cells or low platelet counts ( see also section 4 for more details about possible side effects ). you must not take this medicine if any of these apply to you 75 years of age or older . the signs and symptoms can
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lynchparza is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of LYnparzza capsules should be taken as separate doses . do not divide , crush or chew the capsule , as this may increase the risk of side effects . take the capsules at the same time each day , with food . it is best to take it at the exact time you have been instructed to take . adults and children the recommended starting dose is one capsule ( 100 mg ) once . children and adolescents the dose that you take is one or two capsules ( 100 milligrams ) twice a week . taking lynezzar by mouth
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): - feeling short of breath , feeling very tired , having pale skin , or fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ). - allergic reactions , such as hives , difficulty breathing or swallowing , dizziness . all these may represent signs and symptoms of hypersensitivity reactions . other side effects may include : very common : may affects more than one in 10 children . common - may affect up to one in 100 children - loss of appetite , weight loss , change in the way things taste - being less hungry , being less alert or moving - headache - dizziest
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . never open any lynparza capsules that are damaged or you notice that the capsules are not being used . lynchparza can be taken out of its blister within 30 days if it has been stored for more than 3 days . throw away any capsules via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olarib -the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate and iron oxide black ( otone ). what LYnparZA looks like and contents of the pack the hard capsules are white , opaque , hard capsule printed with " opadarib 50 mg " and the astrazeneca logo . lymparza is available in packs containing 112 capsules or 448 capsules ( 4 blister cards of 112 hard capsule ). not all pack sizes may be marketed .
this medicine contains the active substance naloxone . nnalockone is a synthetic form of opioid . it is used in combination with heroin , methadone , fentanyl , oxygen , buprenorphine , and morphine to help control your mood . the active ingredient in nyxoid is neopreneurphine ( a nasal spray ) for the emergency treatment of opioid overdose . opioid overuse can occur in up to 14 days without any known cause . some cases of overdose have been reported , including breathing problems and severe sleepiness . in case of an opioid over dose , you should seek emergency medical care .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nYxoide . contact your doctor immediately for emergency medical care or emergency services if your child has an opioid overdose . the signs and symptoms of an opioidoverdose are listed below . if they do occur , stop using this nasal spray and wait 2 to 3 hours before using it . you should record the brand name ( s ) you have used and record the batch number ( ns ). you can still use a new nasal spray if this medicine has not been physically dependent on opioids . opioids include heroin , methadone , fentanyl , Oxcodone , buprenorphin
nyxoid nasal spray should only be used by healthcare professionals trained in the use of nyingxoide . use in adults and children aged 12 years and over : dose the recommended dose is one spray in the morning . it should be given at bedtime . the dose should be adjusted by your doctor . do not spray more than once daily . 1 . seek medical advice immediately if you have symptoms such as at the top of your shoulders or the front of your ears ( breastbone , sternum ). it may be necessary to touch the front part of your ear with your fingernail . if the spray is not working properly , it should only work as intended . clear the mouth and nose of any blockages that may occur . keep your mouth and nasal spray closed in the original syringe . there are two reasons why the medicine does not work as well
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . stop taking nyxoid and seek medical help immediately if you notice any of the following acute withdrawal symptoms , which may be caused by the use of opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering / trembling changes in behaviour , including violent behaviour . nervousness , difficulty sleeping , tremors and unusual movements . this includes shaking , shaking . you may also notice changes in your behaviour if this happens to you . nephritis a condition where you have a history of substance abuse . it
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 micrograms of nnaoxione ( as hydrochloride dihydrate ). - other ingredients are trisodium citrate dihydrate ( e331 ), sodium chloride , hydroch chloric acid , sodium hydroxide ( EE524 ) and purified water . what yxxoide looks like and contents of the pack neloxone is a clear , colourless to pale yellow solution . it is supplied in a pre - filled nasal spray in sprayed area . a single dose container is included with nYxoitd . the solution is clear and colourless . pack sizes : one carton contains 2 nasal sprays , each packed in blisters . one pack
ovaleap contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " fsh ". fh is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . in men , this hormone is needed for the growth and development of the sacs ( foollicles ) in the ovaries , where a sperm cycle begins . a mature egg cell is needed in women for whom treatment with a medicine called " chlorifene citrate " is not suitable . it is used in assisted reproductive technology procedures ( procedures that may help you to become pregnant ) such as : - alone or together with , another medicine called lutropin alla - in combination with another gonadotropicin called " laluteinising hormone
do not use ovaleap if you are allergic to follitropin alfa ( female fsh ) or to any other flsh ( fomb or breast ) stimulating hormone or to the other ingredients of this medicine ( listed in section 6 ) if your ovaries have large oocytes or sacs of fluids within the odes ( ovarian cysts ) of unknown origin if there are unexplained vaginal bleeding if the above applies to you , do not apply ovaleeape and tell your doctor . if You have cancer in your womb , woomb or babies if any of the above apply to you ( or you are not sure ), talk to your doctor before using ovaleop . warnings and precautions talk to you doctor before you use ovalap and during your first
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). you or your caregiver should take this medicine about one hour before you or the child have a period where you or you are able to have irregular periods . you or someone else may give this medicine within the first 7 days of your menstrual cycle . if necessary , the medicine can be administered later on . your doctor will tell you how much to give you , when to give the medicine , and for how long . the recommended dose is one 75 mg injection ( 150 mg ) once a day . use this medicinal product once - every day , for 7 or every 14 days . when you or somebody else uses your medicine and you or anyone else uses it for a single injection 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects in women allergic reactions include skin rash or raised itchy areas of skin . these can be severe allergic reactions , which may also include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 very rare ( may affect up to 1 in 10 , 000 people ): if you experience this type of reaction after your ovaleap injection , tell your doctor immediately . serious side reactions in women lower stomach ache , nausea and vomiting may be the symptoms of ovarian hypersensitivity . they may also be symptoms of an ovary disorder . if they occur , they should stop taking ovaleap and see a doctor immediately as they could be signs of a possible serious side effect . in women rare side effects ( may effect up to one in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . you may take this medicine for a single period of up to 3 months below 25 and then dispose of it if not used after 3 months . once the cartridge has been removed from the refrigerator and has reached room temperature ( up to 25 ) it must either be used within 3 months or disposed of . always keep the pen cap on the ovaleap pen when kept in the refrigerator , in order not to expose to light , and not stored in the original carton . use this medicinal product only if you notice that the solution is cloudy or
what ovaleap contains - the active substance is follitropin alfa . - ovaleeape 300 iu / 0 . 5 ml solution for injection : each cartridge contains 300  66 ius fl frog ( 0. 5 micrograms ) fllotropicin alba in 0
voriconazole accord contains the active substance vorikonazole . voricanazole is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . its primary function is to treat adults and children ( aged 2 years and older ) with : invasive aspergillosis ( a type of fungal infection due to aspergamillus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candidasp. infections when the flin cannot be killed or the bacterus is resistant to fluconazoles ( another antifungally medicine ), seriously fungal infections caused by scedosporium ss / fusarium sf 
do not take voriconazole accord : if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). it is very important that you tell your doctor if this applies to you . other medicines , including herbal medicines ; are advised to stop taking the medicines listed in the package leaflets that are used during voricanazole acord treatment : 46 terfenadine ( used for allergy ) astemizole ( used to treat allergy ). cisapride ( used in adult patients with stomach problems ) pimozide ( for mental illness ) quinidine ( used when you have irregular heart beat ) rifampicin ( used if your doctor has told you that you have tuberculosis ) bectin ( antibiotic ) do not give this medicine if any of these
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will calculate your dose depending on your weight and the type of infection you have . the usual starting dose is 40 mg per kg of body weight ( 40 mg every 24 hours ). your doctor may increase your dose to 400 mg every 12 hours for the first 24 hours ( including administration of 200 mg every 13 hours for 24 hours and administration of 100 mg every 14 hours ), or up to a maximum dose of 300 mg per day . if your doctor determines that you have mild to moderate cirrhosis , you may be treated with a lower dose ( 200 mg per kilogram of bodyweight ) or if : you weigh less than 12 hours . you are able to take the tablets with or without food . use in children and adolescents your doctor can decide on the dose that is right for you
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor straight away - rash - jaundice - changes in blood tests of liver function - pancreatitis other side effects very common : may affect more than 1 in 10 people - visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness ), eye disorder , halo vision / night blindness or swinging vision - stomach pain , diarrhoea , stomach upset , vomiting - skin redness , abdominal pain - muscle spasms 
what voriconazole accord contains - the active substance is vorikonazole . each tablet contains 50 mg voricanazole ( as tablet core ). vorizonazole acord 50 mg film - coated tablets contains 200 mg vorisconazoles . - voriCONazoleaccord 200 mg film coating : the other ingredients are lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , and hypromellose , titanium dioxide , lactoses monohydrate and triacetin . what vorizoconazoled accord looks like and contents of the pack the film  - coating is white to almost white and round . the tablet is debossed with " gsi " on one side and " nvr " on the other side . one
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to individuals aged 1 year and older who may be at risk of becoming infected with eboea virus . mVAbea should therefore be given as part of a 2 - dose course of vaccinations to protect your child against a type of eebolo virus disease caused by the zaire eboravirus , which is essentially filovirus . this vaccine will not protect you from the whole ehoeal virus , because it will not give you eavirus disease . when you receive vaccinations , your child will receive zabdeno vaccine at least 8 weeks later . your doctor will decide whether mvasbea vaccine is right for you . both zabea and mvbea vaccination will
you will be given the vaccination course and the doctor will supervise the vaccination . mvabea should not be given if you have previously had a severe allergic reaction to any of the active substances or any of those listed in section 6 . in case of a serious allergic reaction , your doctor may ask you to take an antibiotic called ' gentamicin '. this is because the vaccine contains an active substance . warnings and precautions talk to your doctor , pharmacist or nurse before you are given mvasbea . tell your doctor or nurse immediately if : you have ever had , or might now have , a severely allergic reaction after any other vaccine injection . you have fainted after having an injection , as bleeding or you bruise easily . your doctor currently has a fever or an infection . it is also possible that you are taking medicines that affect the immune system such as
mvabea is given as a single dose into a muscle ( intramuscular injection ) in the upper arm or thigh or into  a blood vessel . the first dose of vaccination with zabdeno vaccine is given 8 weeks later . mvbea vaccine is then given as the second vaccine . it is important to follow the second vaccination as advised by your doctor . primary vaccination first vaccination with the zbdena red cap vial ( 0 . 5 ml ). second vaccination with latent mvasbea yellow cap viall ( 00 m ) is given at least 8 weeks after the first vaccination . secondary vaccination with either zabero ( 05 . 6 mmol ). zabeddeno is given or vaccinated with mbden0 ( 001 ) at least one year after the second dose 
like all medicines , this vaccine can cause side effects , although not everybody gets them . side effects occur at least up to 7 days after the injection . tell your doctor or nurse immediately if you notice any of the following side effects you may need medical attention : very common ( may affect more than 1 in 10 people ) pain , warmth or swelling where the injection is given feeling very tired muscle ache joint pain common ( will affect up to 1 in every 10 people) being sick ( vomiting ) itching where the vaccination is given uncommon ( may effect up to1 in every 100 people ). redness and skin hardness where the inject is given generalised itching if any of these side effects gets serious , or if the vaccine is given incorrectly , tell your healthcare worker .
what mvabea contains the active substances are : zaire ebolavirus ( hpes zaires ) 29 tai forest ebavirus nucleoprotein marburg , p177 , 2 . 7 x 108 ( wild type ) chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what vvabee looks like and contents of the pack mvbea is a suspension for injection in a single - dose glass vial , closed with a rubber stopper and a yellow cap . the contents are 20 ml .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondront can also be prescribed if there is a raised calcium level in your blood due to : a tumour that has become loose from your bones . over time this helps to stop your bones getting weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have , or have ever had low levels of calcium in your blood . do not stop taking this medicine unless your doctor advises you to . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondronate for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocrostic of the Jaw , there are some precautions you should take . before receiving treatment 
this medicine is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein your doctor may do regular blood tests while you are receiving bondronat . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much bondronate you will be given depending on your illness . if you have breast cancer that has spread to your bones , the recommended dose is 3 mg or 3 - 4 mg given as one infusion in your vein over at least 15 minutes . your doctor might also give you another dose if your doctor thinks that you have a raised calcium level in your blood , which may be higher ( see section 1 under " warnings and precautions " and section 2 under " cautions and cautions "). how much and how often you will have an induction into your
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the thong bone . very rare ( might affect upto 1 in 10 ,000 people ). pain or sore in your mouth or jaw . this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor if this happens . ear pain discharge from the ear . these may be signs of an ear infection . bone damage in the 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately the solution should preferably be stored in a refrigerator ( 2 - 8 ). if the solution is not clear and colourless , it may be stored for up to 24 hours at 2oc 8oc . store in the original package in order to protect from light . your healthcare professional will throw away this medicine in the trash or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bondronat contains - the active substance is ibandronic acid . each vial contains 2 mg i bandronic acids . one vial of a concentrate for solution for infusion contains 2mg ibanronic Acid . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , water for injections . what bondruat looks like and contents of the pack bondronatul is a clear and colourless solution for injection ( infusion ) supplied in a pack containing 1 or 2 vials , each with a bromobutyl rubber stopper .
what zeposia is zeposa belongs to a group of medicines that affect the number of white blood cells called lymphocytes . what ZEposia can be used for zeposition is used to treat relapsing remitting multiple sclerosis ( rrms ), a form of active disease that affects the ability of the body to fight its own against multiple clerosis . multiple xclerosis (ms is a disease which affects part of the immune system , which reduces the body ' s defenses ). white blood cell counts are important for the nerves that carry information about the brain and spinal cord and the nerve systems . sometimes , symptoms such as numbness and difficulty in walking , may also be delayed .
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severely weakened immune system . warnings and precautions talk to your doctor or pharmacist before taking zeposa : if : you have ever had a heart attack ( angina , stroke , mini - stroke ), transient ischemic attack ( tia ) you have severe heart failure within the last 6 months you have irregular or abnormal heartbeats ( arrhythmias ). your doctor may want to stop treatment if any of these apply to you . you have had severe infection ( hepatitis ), tuberculosis , cancer , or severe liver problems if the doctor thinks that you are pregnant or are breast - feeding 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your dose of zeposia will be calculated by your doctor according to your heart rate . you will be given a ' treatment initiation pack ' which contains four capsules of 0 . 23 mg ozanimod per day . each capsule is taken 1 day ( 4 weeks ) apart . after 4 weeks of treatment , the recommended dose is 3 capsules ( 0. 46 mg / kg ) ozanimod per night for 5 days , 6 days and 7 . from 8 weeks onwards , you will have a ‘ maintenance pack ’ with orange capsules containing 0
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection , blood pressure uncommon ( may effect up to 1 in 100 people ), allergic reaction . the signs usually include a rash . other side effects common ( might affect up to1 in 10 children ) infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box ( larynex ) or viruses affecting a type of white blood cell called lymphocytes common (may affect upto 1 in every 100 people) infections in the nose , sinuses / mouth ( stomatitis ) rash reporting of side effects 25 if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister foil after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . does not use zeposia if you notice any damage or signs of tampering to the pack . return the pack to your pharmacist .
what zeposia contains the active substance is ozanimod . zeposa 0 . 23 mg : each capsule contains 0. 23 milligrams of ozonimod ( as hydrochloride ). zepozia 0- 46 mg - each capsule contient 0 in 0
temybric ellipta contains three active substances : fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furonate belongs to a group of medicines called corticosteroids ( steroids ). umeklidinium brmide belongs to the group of medications called bronchodilators . temyerc ellptta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this makes it easier to breathe .
do not take temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking temYbric alpte . - have asthma ( don ' t take mybrick ellippa for asthma ). - suffer from heart problems or high blood pressure . talk to you doctor if any of these apply to you . you have liver problems . tell your doctor about tuberculosis ( tb ) of the lung , or any long standing or untreated infections . your doctor may want to monitor you more closely if : you have an eye problem called narrow - angle glaucoma
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybrick ellippa every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temуbric is not meant to relieve a sudden attack of breathlessness or wheezing . in order to relieve this attack you should use a quick - acting reliever inhaler ( such as salbutamol ). how to use the in
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately . pneumonia ( infection of the lung ) in copd patients is an uncommon side effect of temybric ellipta . symptoms of a lung infection may include fever or chills , increased mucus production , change in mucuses colour , and increased cough . in children and adolescents increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore throat , runny nose and sneezING . these effects may be mild and temporary . if you get any of these effects : tell your doctor . common side effect ( may effect up to1 in 10 children ): sore mouth , cough
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone furonate ; 65 microgram of umeklidinium brmide ; 55 microgram ( umeclinium ) and 22 microgram [ vilantrol ]) and trifenatate . the other ingredients are lactose monohydrate ( see section 2 under ' temyerc elbasvir containing lactoses ') and magnesium stearate . what emilyc ellpte looks like and contents of the pack the ellippa inhaler consists of a light grey plastic body , a
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo used for zinfo is used to treat adults with infections of the skin and the tissues below the skin . this includes an infection of the lungs called : ' pneumonia ', which has spread to other parts of the body . how zinfordo works zinforum works by killing certain bacteria , which can help to prevent serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if allergic to other cephalosporin antibiotics . warnings and precautions talk to your doctor before taking zin foro : if your doctor has told you that you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). do not use zinfo . talk to you doctor before you take  Zinforo and during your treatment with zinfuro , if : you have kidney problems . you have ever had seizures ( convulsions ) or any non - severe allergic reaction to other bacteria using antibiotics such as Penicillin or carpenem 26 you have experienced severe diarrho
the recommended dose of zinforo is 600 mg given every 12 hours . your doctor may increase your dose to 600 mg every 8 hours if you have some infections that need immediate medical attention . the recommended starting dose is 8 mg given twice a day . if necessary , your doctor will increase your dosage to 12 mg once a week . this will be given to you by your doctor or nurse . it is usually given as a drip into a vein over 5 minutes . from a microbiological point of view , the maximum dose will be 60 mg given once . however , if your doctor considers that the maximum recommended dose is 120 mg twice , you may receive an increased dose depending on how you respond to treatment . generally , treatment is usually repeated every 5 to 14 days . for skin infections , most often , within 5 to 7 days , for pneumonia . patients with
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking zinforo and see a doctor straight away if you notice any of these symptoms and you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue ; a severe rash ; or swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ); diarrhoea ; stool containing blood or mucus . treatment with zinForo may be stopped if medicines are not taken to stop or slow bowel movement ( common , may affect up to 1 in 10 people ). you may have to have a blood test called a ' coombs test ', which will show you whether you are being treated with antibiotic .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains - each vial contains 600 mg of ceftaroline fosamil and arginine . what zforo looks like and contents of the pack zinfo is a pale yellowish to light yellow powder supplied for solution for infusion in a vial . one pack contains 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neursopathic pain : pregabaltin ppizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neoopathic pain such as diabetes or shingles . pain sensations may be described as hot , burning , or throbbing , shooting , stabbing / sharp , cramping , and aching , feeling tingling or numbness . these conditions may include : tremor , grinding or clenching your teeth , sensations of rapid or irregular heartbeats , sudden onset of trembling , pain in the joints , muscles , joints 
do not take pregabalin pfizer : if you are allergic to pregabaltin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabralin . some patients taking pregamalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabalin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , take special care with pregabals phizer . this is because taking it could cause blurring or loss of vision , or other changes in eyesight , if they show
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor to take one capsule each day . the dose , which has been adjusted for you and your condition , will generally be between 150 mg and 600 mg each day in two equal doses . your doctor will prescribe the dose that is right for you based on your condition and your response to pregabalty . for two doses of pregabralin , take pregabALin 59 once in the morning and once inthe evening , at about the same time each day ( morning dose ). you should take pregamalin in the evening 59 at about
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common ; may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , irritation . disturbance in attention , lack of sex drive , memory impairment , loss of memory , notoriety , difficulty with speaking , and tingling . uncommon : might affect uptickling , abnormal dreams , panic attack , fits , disturbance in consciousness , fainting , increased sextortion , alteration in attention or attention . sneezing . low blood pressure , cough . nasal congestion , runny nose , stuff
what pregabalin pfizer contains the active substance is pregabaltin . each tablet contains either 25 mg , 50 mg ; 75 mg : 100 mg ), 150 mg / 200 mg e . g . only 225 mg - 300 mg pregabalin - the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica and black ink . the printing ink contains shellac ; black iron oxide ( е172 ); propylene glycol ( é1520 , potassium hydroxide ). the 75 mg tablets are black in black inked tablets and contain 100 mg ( 5 mpa . 5 ml ), 200 mg ( 225 
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine in the brain . xdagon is used to treat parkinson ' s disease in adults . parkinsons 's disease causes sudden switches in how you move . this makes it difficult for you to move , or makes difficulties moving . the medicine is taken with levodopa and other medicines for parkinSON '
do not take xadago if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor has told you that you are taking any of these : the following medicines : monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; transaminavir ; in particular , tranylcypromine ( used for treatment of parkinson ' s disease and depression ); pethidine ( a strong pain killer ). you should wait at least 7 days after starting xdagot treatment if these effects do not work well enough . treatment with ma
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg taken once a day by mouth . your doctor may adjust your dose . xdagon should be taken by mouth once  a week . patients with moderately reduced liver function should take one 50 mg tablet of XaddaGO per day to achieve the best results for your health . do not take more than the recommended dosage . take x dilated tablets as directed by your doctor to achieve maximum benefit . you should swallow the tablets whole with a glass of water and do not chew , crush or split the tablets . use in children and adolescents xedag can be taken with or without food . people with raised blood pressure , anxiety , confusion ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that can lead to collapse ) is a very common symptom of neuroleptic malignant syndrome ( see section 2 ). it may also cause confusion , sweating , and muscle rigidity ( hyperthermia ). xadago may also increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). this can cause confusion and hypertension , muscle stiffness and hallucinations ( hypotension ). the most frequently reported side effects in patients with parkinson ' s disease are : very common ( may affect more than 1 in 10 people ) safinamide may increase the risk of some types of side effects for the treatment of parkinsons ' colitis . if you have any questions
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg of ssafatinamide ( as methansulfonate ). - other ingredients are microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide , iron oxide red what XaddaGO looks like and contents of the pack x ad ago 50 mg film - coated tablets of 7 mm diameter with metallic gloss . the tablet is white to almost white and the tablet can be divided into equal doses . xdagon 100 mg film- coated tablet is pink and the pack size is limited .
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat adult men with prostate cancer that has spread to other parts of the body . zytigea increases the levels of testosterone , a substance found in many men with sexually active prostate cancer . the active ingredient in zymiga is proline , which is used either alone or in combination with hormone therapy , as a treatment that lowers testosterone ( androgen deprivation therapy ). it can be used together with another medicine , prednisone or prednosone , used to reduce high blood pressure , when it is excreted in your body as fluid retention in your blood .
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you can get pregnant , zytigea could harm your unborn child if he / she is being treated for severe liver damage . if your doctor has told you that you have prostate cancer . do not breast - feed while taking this medicine . check with your doctor if this applies to you . warnings and precautions talk to your doctor before you take this medicine and while taking it : if any of your close relatives have liver problems , high blood pressure , heart failure , low blood potassium . in rare cases , lower blood potassium can cause heart rhythm problems . tell your doctor immediately if these may apply to you ( or your child ) if they have
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 , 000 mg taken orally . you should take this medication about one hour before or after food or drink . take the tablet by mouth . zytiga can be taken with or without food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . taking zytigea take zytaga at least 2 hours before or with food , unless your doctor tells you to . how long to take ? take a tablet every day , with food or between meals . try to take it at the same time each day . this will help you remember to take your tablet , even when you are taking a medicine called prednisone or preddnisolone
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact a doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . this is linked to the low level of a mineral called potassium . other side effects very common ( may affect more than 1 in 10 people ): - there is fluid in your legs or feet . that means there is low blood potassium in the blood . - results of liver function test , high blood pressure , urinary tract infection , diarrhoea , nausea , vomiting , abdominal pain , or distension . common ( might affect up to 1 in every 10 people): fluid in the legs or foot . it may
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg auriateron ac . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 / 32 ), colloidal anhydrous silica and sodium laurilsulfate ( see section 2 " zytigea contains lactotosing "). what zetiga looks like and contents of the pack - zymiga tablets are white to off - white , oval tablets of 9 . 5 mm in diameter , embossed with " a1 " on one side and plain on the other side . the tablets are packaged in a plastic bottle with a child - resistant closure .
hefiya contains the active substance adalimumab . he is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , and paedianic non - infectious uveitis in adults . the active ingredient in heifiyo is truncated , the active component in the medicine , is  a monoclonal antibody . monoclonous antibodies are proteins that attach to a specific target in the body . one of the ingredients in a diet and exercise plan , called tumour necrosis factor ( tnf ), is present at increased levels in the inflammatory disorders and causes the inflammation in
do not use hefiya - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if your symptoms of infections ( e . g . fever , wounds , feeling tired , dental problems ) are not uncommon . check with your doctor or pharmacist if heif you have moderate or severe heart failure . it is very important to tell your dentist if any of these apply to you . warnings and precautions talk to your doctor before using hebiyo : - you have , or have
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual starting dose is one 40 mg tablet per day , for patients who need a 20 mg dose . your doctor may decide to increase the dose to 40 mg or to increase it to 20 mg once a day . after that , the usual dose is 40 mg . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children and adolescents from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children and teenagers from 2 to 10 years of weight weighing 10 kg to less than 30 kg 20 mg every week not related to enthesitis - related arthritis age or body weight what hefiya is used for children and adolescent from 6 years
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months or more after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as you may be experiencing signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , fever and sore throat . these may be signs of liver problems . you should brush your teeth thoroughly twice
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and to protect the heifiye from light when you return home . once removed from the refrigerator for room temperature storage , your pre – filled  ssyre must be used within 14 days or discarded , even if it is
what hefiya contains the active substance is adalimumab . each pre - filled syringe contains 20 mg of aaddaimumabe in 0 . 4 ml of solution . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e507 ), sodium hydroxide and water for injections . what HEfiYa looks like and contents of the pack heifiyan 20 mg solution for injection ( injection ) in pre  -filled sYringe for paediatric use is supplied as a 0. 4 mg / mL clear type i glass ssyrange with a stainless steel needle with  a
what ritemvia is ritemevia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritzimabe sticks to its surface , the cell dies . what vituximains do you have rite
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if the treatment is not suitable . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before taking ritemevia : if : you have been told you have had a weak immune system , such as severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . you should tell your doctors if any of these apply to you before you are given ritetis : your doctor may decide to stop
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given ritemevia as a drip ( intravenous infusion ). medicines given before each ritetvia administration will be prescribed to you . your doctor will prescribe ritemondvia together with other medicines ( pre - medication ) to prevent or reduce possible side effects as well as with your treatment if you are suffering from non - hodgkin ' s lymphoma if your doctor thinks you may have been given a different type of cancer . if ritemillionvia alone ritemmvia will not be given indefinitely . it is usually given every 4 weeks for several years . repeated treatment courses with rite 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . pain at the infected site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing and cough . you may also experience shortness of breath . these reactions are usually mild to severe . if they get worse , tell your doctor immediately . very common infusion side effects ( may affect more than 1 in 10 people ): diarrhoea , nausea , tiredness and vomiting . common infused ritem
what ritemvia contains the active ingredient in ritemillion is called rituximab . the vial contains 100 mg of ritsuximb , per vial . each ml of concentrate contains 10 mg of the active substance . ritzimabe is also contained in the concentrate . sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack riteMvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial ( pack of 2 vials ).
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine  Teva contains capecitationbine , which itself is not a cytotoxic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitébine téeva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitedbine tenement is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . Capecitabin te will be used either alone or in combination with other medicines .
do not take capecitabine teva if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if there is any evidence that you have an allergy or over - reaction to this medicine , if your doctor has told you that you are at risk of severe reactions when taking fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), if the patient is pregnant or breast - feeding , take special care with capecitationbine if any of these apply to you : if they have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), or if : you have severe liver or kidney problems , or you are taking any form of the enzyme dihydropyrimede
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , depending on your condition . the dose of capecitebine teva is based on your body surface area . this is calculated from your height and weight . two different factors influence the dose . my doctor will work out the right dose for you depending on the following : - your body area is measured as the surface area of the person : height and width : 1250 m2 of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : male patients : 64 kg and height : 1 . 64 m has a
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooeea at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea :if you lose your appetite , and the amount of food you eat each day is much less than usual . stomatitis : any pain , redness , swelling or sores in your mouth and / or throat , especially if handled by a child . your doctor may prescribe an antidote for you . this is because this medicine has been
what capecitabine teva contains the active substance is capecitebine . capecitationbine traordenal solution for treatment of adults and children of all ages can be prescribed by their doctor . each 150 mg film - coated tablet contains 150 mg capeciabine ; each capecitébine treament contains 500 mg capabine , each film  3 - dose film  - coating contains 500mg capectin . the other ingredients are : lactose , microcrystalline cellulose , hypromellose , crscarmellose sodium , magnesium stearate , macrogol 400 , indigo carmine ( e132 ), hypromllose, titanium dioxide ( е171 ), yellow iron oxide ( E172 ), red iron oxide , red iron dioxide ( all ). what cap
what silodosin recordati is siloudoos in recordatis belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silonosine recordatix works by blocking the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladodousin recordingi is used for silonedosenti is indicated in the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , or a more frequent need to pass urine .
do not take silodosin recordati if you are allergic to sildoosine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking siloudodain recordattai : if your vision has been damaged ( partially blocked ) during eye surgery if there is cloudiness of the lens ( cataract surgery ), the risk is outweighed by the benefit of taking it 26 . if any of these apply to you , tell your doctor before taking Silodonoshin recordatin . this is because medicine can cause a loss of muscle tone in the iris ( the coloured circular part of the eye ) when taking it during a surgery . so it is important to take appropriate precautions when taking medicine and surgical techniques when taking siladosenti .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . you should swallow the capsule whole with a glass of water . do not chew or break the capsule , but swallow it whole , preferably with savor . patients with kidney problems if your doctor has prescribed sildossér for you , please contact your doctor as soon as possible . for moderate kidney problems there are no known doses . use in children and adolescents for this purpose silodysin recordingati can be given to children and teenagers aged 4 years and above . if , after taking sillodonoshin recordatin recordattai , you may feel dizzy or feel weak
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect is a decrease in the amount of semen released during the treatment with silodosin recordati . dizziness . this is usually mild and usually disappears after a short time . sometimes dizziity with occasionally fainting can occur . if a person feels weak or dizzy , stop taking the medicine and contact a doctor immediately since the symptoms of dizzin or fainting occur , as sillodon recordatis may reduce the number of sepsis performed and reduce the need for dizzier or faintness , if at any time you
what silodosin recordati contains sillodosesin recordingati 8 mg hard capsules contains siladostan . each capsule contains 8 mg of siloudonadosin . the other ingredients are : mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). siloooodooshin recordatis 4 mg hard pellets contains a total of 4 mg of selodomin , corresponding to a daily dose of 4 milligrams of silaodain - the other ingredient are mannita , aluminum oxide (  e172 ), magnesium STEarate and sodium laursulfATE , and gelatin, titanium dioxide ( E171 and yellow iron oxide ( japan
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin in the body is a substance which causes your blood vessels to narrow , thus increasing your blood pressure . kinezalmonome blocks this effect of angiotentsinii so that the blood vessels relax , and your blood temperature is lowered . your doctor has prescribed kinzulmono because you suffer from essential hypertension ( high blood pressure in adults ). ' essential ' means that the high blood tension is not caused by any other condition . high blood Pressure , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono - if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). - 3 if your doctor decides that you may be pregnant . ( it is also better to avoid kinzilmono in early pregnancy see pregnancy section .) - have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . - suffer from diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . it is not known if kinzonzono passes into human milk and affects the fertility . talk to your doctor if any of the above applies to you . warnings and precautions talk to you doctor before taking kin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , to increase the absorption of the medicine . you can take kinezalmonograph with or without food . it is important that you take kinszalmonio every day until your doctor tells you otherwise . if your doctor thinks that it is too strong or too weak , talk to your doctor . for treatment of high blood pressure , the usual dose of the kinzzalmonone for most patients is one 40 mg tablet once a week to control blood pressure over the 24 - hour period . your doctor may prescribe a lower dose of one 20 mg tablet daily . alternatively , kinzonzalMono
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately ( see section 2 ). other possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people ), low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events . uncommon side effects may affect less than 1 in 100 people , urinary tract infections 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . discard any unused tablets . these measures will help protect the tablet from moisture and help protect it from light .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as meglumine ). - other ingredients are povidone , meglumin , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmondo looks like and contents of the pack kinkzalmonio 20 mg tablets are white , round and engraved with the code number ' h4 '. kinzulmono is available in blister packs containing 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa . aafsentylais used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor ixi deficiency ). factor  vii is necessary for blood cloting to occur . as a result it does not clottle very quickly , leading to an increased tendency to bleed . the active ingredient in a fsyla enables haematophilian a to clock easily . using adstlyla will improve the blood coagulations process and thus reduces the tendency to bleeding .
you must not be given afstyla : if you have ever had an allergic reaction to acstlyla . if your doctor thinks you may be allergic to hamster proteins 46 . warnings and precautions talk to your doctor or nurse before you are given fshyla and follow the instructions for use . the patch number on your treatment diary is the same as for adsthayla , but you must also read the " do not take " section of the package leaflet for ffsthyla " section . allergic ( hypersensitivity ) reactions are rare in patients treated with a ftyl . you must look out for symptoms of allergic reactions allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure . anaphy
your treatment should be initiated under the supervision of a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of fstyla is one vial per day . during your treatment , your doctor will calculate the dose depending on the severity of your disease the site and the severity and location of the bleeding your clinical condition . reconstitution and administration general instructions the powder is to be mixed with the solvent ( liquid ) immediately before administration , in accordance with local requirements . afshla may be used with other medicines or solvents . see section 6 . after preparation , the solution should be clear or slightly opalescent . you should apply the solution immediately after withdrawal . please note that if the solution is cloudy or if it contains visible particles 
like all medicines , afstyla can cause side effects , although not everybody gets them . tell your doctor immediately if you notice symptoms of allergic reactions . allergic reactions may develop in some or all of the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness and anaphylaxis ( bleeding ). for children not previously treated with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ); however patients who have received previous treatment with factor vii ( more then 150 days of treatment ) the risk is higher .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after the afstyla powder has been reconstituted it may be kept at room temperature ( up to 25 ) for a single period not exceeding 3 months . keep the viall in the outer carton in order to protect from light . use the reconstructed product within the expirience date stated on labels and cartons .
what afstyla contains the active substance of adstlyla is a concentrate of 250 mg / ml , diluted in 2 . 5 mmol / water for injections the solution contains 100 mg of lonoctocog alfa . after reconstitution with 2 , 5 % water for injects the resolution contains 200 mg of honoctocolog alba , equivalent to 1000 mg . following reconstitution ( 2 : 5 %) water for infusions thesolution contains 400 mg of povidonecog a / min , followed by 1500 mg , extracted in water for treatment after reconversion with 5 ° water for immersions the solutions contains 300 mg of octocogg alfo , or 2000 mg ; after reconstituted in waterfor injectionsthe solution contains 400 mbq of
what praxbind is praxxbind contains the active substance idarucizumab . i darucizum ab is a reverse agent . what dabigatran ( pradaxa ) is pradoxa is  a blood thinner medicine that helps prevent blood clot formation . how praXbind works prabind can be used to rapidly trap dabig atran in the blood . you will need to take prauchbind to open the case for emergency surgery or urgent procedures if you have uncontrolled bleeding .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients of this medicine listed in section 6 . - have a genetic disease called hereditary fructose intolerance ( hfi ) and the substance sorbitol , which may increase the risk of serious adverse reactions when taken with pracbind . warnings and precautions talk to your doctor before taking this medicine . this medicine contains dabigatran and other medicines to thin the blood to prevent blood clots . dabigajitran is absorbed by the body and so is a natural product that can help to prevent and treat blood cluts and to form medicines to prevent the formation of blood coagulations . your doctor will monitor you regularly for the development of your medical condition . talk to you doctor before and during treatment with 
praxbind will be given to you in a hospital or clinic under the supervision of a doctor . the recommended dose is 5 mg ( one vial ) of 2 . 5 mg dabigatran . you will be prescribed this medicine for 5 days . your doctor will decide how many treatments you need . this medicine will be injected into a vein . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . as this medicine is given by a qualified doctor - the doctor or nurse ( healthcare professional ), you will have been trained on how to prepare and inject praxxbind . during your treatment , you will receive training on how and when to prevent blood clot formation . dabig atran will be administered to you at least 24 hours after you have received this medicine and will be monitored by your doctor or other health care professional
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects get a summary of all side effects with this medicine . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine in case you get any side effects not listed in this leaflet .
what praxbind contains - the active substance is idarucizumab . - each vial contains sodium acetate trihydrate , acetic acid , water for injections , and sorbitol ( e420 ), polysorbate 20 and water for injects . what prixbind looks like and contents of the pack praxxbind is a clear to slightly opalescent , colourless to slightly yellow solution for injection in a glass vial closed with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temmomed ac is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . the recommended dose of temomemedaca is one radiotherapy ( concomitant phase of treatment ) and one radiothenolescent ( monotherapy phase of therapy ). - for children 3 years and older and adult patients with malignant gliomema , such as gliblastomas multiforma or anaplastic astrocytoma in these tumours the recommended treatment is one or more of glionoblasts .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before taking temmedaca : - you are experiencing a reduced number of certain types of blood cells which are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting . your doctor will check your blood to make sure you have enough
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if there is a recurrent tumour and you have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temmedaca to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if your doctor determines that you are a newly ­ diagnosed patient , treatment will occur in two phases : - treatment together with radiotherapy ( concomitant phase ) first and - followed by treatment with temac ( monotherapy
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), or - fever , chills , or severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; anaemia ( a shortage of red blood cells which can cause fever ); and reduced resistance to infections . the reduction in blood cell counts may be accompanied by anaemic attack ( tachycardia ), which may be life - long . in some cases , it may lead
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . once removed from the refrigerator : do not store above 30 . tell your pharmacist if you notice any change in the appearance of the capsules . this will prevent misuse .
what temomedac contains - the active substance is temozolomide . temomemedaq 5 mg : each tablet contains 5 mg of temizolomide ( as monohydrate ). temtemac 20 mg  : every tablet contains 20 mg of demozide ( alsiconazole ). also tememedaca 100 mg , each tablet contient 100 mg of démonzolomide [ as monolithic ]. temmedaac 140 mg - each tablet contain 140 mg of dumozole ( as bimatrimezol ). not all pack sizes may be marketed . the temojimedack 180 mg ; each tablet includes 180 mg of desolate ( as bisect ). you must not take temazolomide during the treatment . not all packs may be available in your country 
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , e rect penis suitable for sexual activity . ciali has been shown to significantly improve the ability of obtaining a solid eerect penisie suitable for adult sexual activity in men . how cialize works cialIS contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . by doing so , the effect of cialising increases the blood vessels in your penis . the result of this is improved ecg . your peni is improved in terms of edg elile function . you will not be given cialisé if you do not have egl . it is important to note that e
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - do not give this medicine to other people . - are taking any form of organic nitrate or nitric oxide donors such as amyl nitărite . this is a group of medicines (" nitsrates ") used in the treatment of angina pectoris (" chest pain "). cialIS should not be used with these medicines . warnings and precautions talk to your doctor or pharmacist before taking cialising if : you have serious heart disease or recently had a heart attack within the last 90 days you have recently had or might have a stroke within the past 6 months you have had sex with a different medicine . you are taking snitrite for longer than one month
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets whole with some water . the tablets can be taken with or without food . you can take ciali with or just after food or drink . how much to take the recommended dose is one 5 mg tablet taken once a day at approximately the same time of the day . your doctor will tell you the dose to take . this will depend on how well it works for you , and on how long you should continue to take it . do not change the dose unless your doctor tells you to . however , if your doctor feels that the effect of cialised is too strong or too weak , talk to your doctor . when to take take a tablet at the same times every day , at the exact time of day
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and usually disappear within a few days to a couple of weeks . stop taking the medicine and seek medical help immediately if you notice any of the following allergic reactions or rashes ( frequency uncommon ). chest pain - do not use nitrates ( frequency rare ). - priapsim may cause a prolonged and possibly painful erection after taking cialis ( frequency very common ). contact a doctor immediately , if he or she may instruct you to get an errand after taking the tablet or if it does not work ( see section 4 ). sudden loss of vision ( frequency common ) other side effects have been reported with the tablets common ( may affect up to 1 in 10 people ) or 100 people : headache , back pain
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of ttadealaf . - other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate ; magnesium stearate . film - coating : talc , lactoses monohydrate , and hypromellose , triacetin . titanium dioxide ( e171 ), iron oxide yellow ( 850 ), and iron oxide red ( 925 ), indigo carmine ( k29 ). what ciais looks like and contents of the pack cialiser 2 , 5 mg film , 2 mg film and tablet
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyingglid can be used to control type 2 diabetic if treatment is started , with diet , exercise and weight reduction , to help control your blood glucose . you should also be given enYglid in combination with metformin , another medicine for diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). - have type 1 diabetes . englid may lower the acid level in your blood ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking enyingglid and if : you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood from people with liver problems ). you have moderate liver 28 disease , see section 2 . take special care with ennyglide : do not start taking  Enyglider if any of these apply to you . there is a very small risk of a serious liver disease or kidney problems . talk to you doctor before you take  Ennygui
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each major meal , and up to 4 hours after each main meals . your doctor may increase the dose to 30 mg or upto 16 mg once a day if your blood sugar is not controlled well enough . if this is a hypo , do not take more enyglid than your doctor tells you to . contact your doctor if he / she is suggesting a double dose to make up for a forgotten dose . you may get a new high blood sugar if it is difficult to control your diabetes . talk to your doctor before starting your treatment with this medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypoglcaemia which may affect up to 1 in 10 people . Hypoglycasemic reactions are generally mild / moderate but may occasionally develop into hypogycaemic unconsciousness or coma . if this happens , you should contact your doctor immediately . allergy allergy is very rare ( may affect more than 1 in10 , 000 people ). symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating may be signs of anaphylactic reaction . other side effects are common ( may effect up to1 in 10 ,000 people ): stomach pain . generally mild or moderate , hypogliescaema occurs when enyglid is taken with food . this may occur with
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg replinide in the core . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , and poloxamer . in addition , yellow iron oxide ( e172 ) in the 1 mg tablet and red iron oxide( e 172 ). in the 2 mg tablet core : 0. 5 ml white , round and biconvex with bevelled edges . 1 mg tablets are pale brown , or yellow , marbled , biconvingly . 3ml tablet is pale brown and yellow
what azacitidine mylan is azacritidine myLAN is an anti - cancer agent . how azacitamylan works aza citidine mylant contains the active substance ' azaсitidine '. what zacitine mylan used for aza
do not use azacitidine mylan - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . - are breast - feeding . warnings and precautions talk to your doctor or pharmacist before using azacitamylan : - you have decreased counts of platelets , red or white blood cells . you have kidney disease . your doctor has told you that you have liver disease ; you have ever had a heart condition or heart attack or you have lung disease  . blood test you will have blood tests before you start treatment with azacritidine myLAN and at the start of each period of treatment ( called a ' cycle '). this is to check that you make sure that you get enough blood cells and that your liver and kidneys are working properly . talk to you doctor
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacriitidine melan once a day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , until you reach a maintenance period of 6 weeks : your doctor may decide to give this medicine to you as an injection under the skin ( subcutaneously ) by tummy or upper arm . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , decreased appetite , confusion , restlessness or fatigue . symptoms may include : loss of appetite . uncommon : the following may occur with this medicine : very rare : any of these may occur together with other signs of liver damage . very common ( may affect more than 1 in 10 people ): diarrhoea , stomach
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and carton . the expiration date refers to the last day of that month . your doctor , pharmacist or nurse are responsible for storing azacritidine myLAN . they are also responsible for the correct storage of the product . keep this medicinal product out of your sight and sight . this medicine will be given to you by a qualified healthcare professional . these measures will help protect the environment . before using this medicine , you may need to prepare the suspension at room temperature ( below 25 ). when using the azacicitidine melan suspension with water for injections it should be used immediately after preparation . once the suspension has been prepared it should not be stored in a refrigerator ( 2 8 ) immediately . if the zar
what azacitidine mylan contains - the active substance is azaсitidine . one vial of powder contains 100 mg azaçitidine ( as monohydrate ). after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacionitidine [ e421 ]). -the other ingredient is mannitol ( e 421 ). what zacitine mylan looks like and contents of the pack azacritidine myLAN is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacitabine . each pack contains 1 vial or 7 vials .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprosto is a prostaglandin analogue which is produced naturally in the eye . and tramolola is  a beta blocker which reduces the amount of fluid within the eye and so reduces pressure within the eyes . duototrav drop solutions reduce high pressure in the eyes and can be used to treat an illness called glaucoma .
do not take duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking duotratrav and if any of these apply to you . if your doctor has told you that you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . tell your doctor if : you experience wheeziness or difficulty in breathing in patients with long - standing cough or breathing problems , or severe hay fever you experience a slow heartbeat ( either due to heart failure or a disorder of heart rhythm , such as irregular heartbeat ). your eyelight may become cloudy during treatment with duotorav . you have
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the eye or eyes , twice a day , morning and evening . only use duotrav in both eyes if your doctor told you to . you should use dudtrav at the same time each day . it is important that you use dutrav every day until your doctor tells you otherwise . if the effect is too strong or too weak , talk to your doctor about how to use it . how to put duotarrav in the morning before you use it for the first time , rinse your eyes with water . duototrav should only be used if it is absorbed through the eye . do not put duttrav near food or on the area you have used it , but
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . just after using duotrav , you may experience some of the effects . very common side effects ( may affect more than 1 in 10 people ): effects on the eye eye redness . common side effect ( may effect up to 1 in every 10 people at the moment ) : effects in the eyeeye surface inflammation ( surface damage ) may cause eye pain , blurred vision , abnormal vision ; dry eye , itchy eye ; eye discomfort ; signs and symptoms of eye irritation ( such as burning and stinging ). uncommon side effects may affect up to1 in every 100 people : eye irritation , burning and itchy eyes , eye discomfort or itching . reporting of side effects 25 if you get any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . store below 30 . throw away the bottle 4 weeks after first opening to prevent infections . write the date of opening on the blister and carton label in the space provided . this medicine does not require any special storage conditions .
what duotrav contains the active substances are travoprost and timolol . each ml contains 40 mg of travaprosth and 5 mg of the active substance titmolole ( as tibiol maleate ). the other ingredients are polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil ( see section 2 ), water for injections 40 % and boric acid , sodium chloride , water for injectable tablets , hydrochloric acid / purified water , and sodium hydroxide . hydroch chloric acid may lower acidity levels ( ph levels ).
nplate ' s active ingredient , romiplostim , is a protein that helps to reduce low platelet counts in patients with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is  a disease in which your body 's immune system does not produce enough platelets . platelets are cells that are in your blood that help to prevent blood clots . very low platelets counts can lead to bruising or serious bleeding . n plate is for use in adults , adolescents and children ( 1 year of age ), with spleen removed , in adult patients with chronic itp who have not previously responded to corticosteroids or immunoglobulins , and who are not able to respond adequately to these measures .
do not use nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). -if you think you may be allergic to other medicines that are used to treat escherichia coli ( e . coli ). warnings and precautions before you use , tell your doctor if : you have been told that you have a low blood platelet count ( thrombocytopenia ) because n plate has been produced by your platelet number . this is because blood clots can form when blood coagulate and so may be more likely to happen if blood clitches form and / or blood clutting is a problem . you have liver problems . your doctor should be aware that you are over 65 years old . there is , however , an increased risk
children and adolescents ( aged 1 to 17 years ) your doctor will decide your dose of nplate . n plate should be given to you by a healthcare professional . instructions for proper use nplated is given as an injection under the skin ( subcutaneous ). adults and children and teenagers ( aged from 1 year to 17 year ) the doctor will work out your dose and will decide how much nplatte you should receive . how nblatt is given your doctor may need to change your dose . they will also tell you how much to give you . your doctor should tell you exactly how much of a dose you need to receive , when to check your platelet counts regularly . you will have regular blood samples taken to check how many of your platelets are being given and to check for any changes in your platelette counts . sometimes your plateLET count may be higher than usual . children and young people ( aged
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : itp ( very common , may affect more than 1 in 10 people ): headache , allergic reaction upper respiratory tract infection ( common ; may affect up to 1 in every 10 people). bone marrow disorder , increased bone mmarrow fibres trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin ( flushing ), chest discomfort , diarrhoea , nausea , vomiting , itching , pain in the joints , back pain , muscle pain ( myalgia ), increased blood sugar levels ( hypoglycaemia ), weight gain , decreased appetite , weight loss , abnormal dreams 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle label after exp . the expiration date refers to the last day of that month . this medicine is for single use only . once opened , nplate is to be used within 30 days . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . n plate 125 mg solution for injection contains 230 micrograms of romimiplost . each vial contains 125 microgram ( 900 microgram ) romimeploslim in a deliverable amount of 0 . 25 ml solution , delivering 125 milligram ( 600 microgram) ROMiplospostim at the dose required to manufacture 500 microgram( 900microgram ). nplated 250 microgram solution for injectable amount ( 375 microgram of ROMIplosterm at the rate of 250 microliters ) of romeiplostatin in 0. 5 mL solution . this provides a delivered amount of 250 milligramm ( 600 milliliter ) solution for manufacturing process . the quantity required to make n
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovonor BREezhalmer is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the use of this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the luchuch . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using tovanOR breezehaler as it may cause : - kidney problems - an eye problem called narrow - angle glaucoma - difficulty passing urine . during treatment with tovanour brezhaler stop using this medicine and tell your doctor immediately if : you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor brewinger ( signs of bronchospasm ). this may occur particularly when you begin to use it . - difficulties in breathing or swallowing - swelling of the tongue or lips - shortness of breath - wheeziness when using
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhagle once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use this medicinal product exactly as described in this leaflet and as your physician has told me . for adults , the usual starting dose is one capsule in the morning and one capsule at the evening . elderly ( age 75 years and over ) the recommended dose is two capsules in the evening and one inhaler in the afternoon . this will also help you to remember to use this medication . instructions for use in this pack , you will find an inhalers and
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrnoium broMIDe , equivalent to 50 microgram ( 8 microgram ) of glycopirronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopronium per capsule . - l the other ingredients of the injection powder are lactose monohydrate and magnesium stearate . what tovantor brewinger looks like and contents of the pack tovanOR breezehaler 44 microgramms inhalation powder , hard capsules are transparent and contain a white powder . they are packaged in separate blisters or bottles , each packed in separate plastic bottles . one pack contains either 6 or 10 hard capsule (s ). the following
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by blocking signals in the brain known as dopamine and serotonin , which play an important role in calming effects and relieving aggressive behaviour . adesuve is used in adults to treat acute symptoms of mild - to - moderate agitation ( typical of schizophrenia and bipolar disorder , a condition characterised by symptoms such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious or tense , and may also develop bipolar disorders .
do not take adasuve if you are allergic to loxapine , amoxapinE or any of the other ingredients of adave . warnings and precautions talk to your doctor , pharmacist or nurse before taking aadosuve as adesuve has been shown to be of benefit to patients with symptoms such as wheezing and shortness of breath . these may be signs of lung problems like asthma or chronic obstructive pulmonary disease ( copd ), which results in narrowing of the airways ( bronchospasm ), causing wheeze , cough , chest tightness and short of breath 25 as if your doctor thinks this applies to you , tell your doctor and do not continue to take . neuroleptic malignant syndrome ( nms ) adenuve is not recommended for patients
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 9 . 1 mg once a day . your doctor may increase this dose to 2 mg once every week , up to a maximum of 4 . 5 mg once per day , depending on your condition . how to use adasuve - swallow the tablets with a drink of water . - do not crush or chew the tablets . you can use the tablet at any time of the day or just before bedtime . do not push the tablet through the foil or push the paper through the mouth . use the device only when you are feeling any of the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth or muscle or eye
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any of the following side effects you may need to stop taking adasuve : any breathing symptoms such as wheezing or cough , shortness of breath , chest tightness or irritating , or if your airways get blocked ( asthma or copd ). light - headedness or fainting . this may be a sign that your blood pressure is getting worse . worsening agitation , confusion , fever and muscle stiffness . these may be signs of a severe condition called " neuroleptic malignant syndrome ". tell a doctor or pharmacist if any of these side effects bother you . very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting , pain in the
keep out of the reach and sight of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . keep the open or tearped pouch in order to protect from light . this medicinal product does not require any special temperature storage conditions . adesuve does not cause any visible sign of physical damage .
what adasuve contains the active substance is loxapine . each single - dose inhaler contains 5 doses of lox apina and delivers 4 . 5 mg of l / 8 mg loxopine per day . what  adsuve looks like and contents of the pack adesuve 4 , 5 mg inhalation powder for inhaling is supplied in a disposable white plastic inhalER containing loxane , and each inhalers is individually sealed with a sealed foil pouch . aadosuve 5 mg powder for relief sickness is available in packs containing 1 or 5 inhalations . not all pack sizes may be marketed .
what azacitidine betapharm is azacritidine betabharm is an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azacitabetapharm contains the active substance ' azaсitidine ', which is similar to the active substances of azacatidine berapharm . what zacitine betaphar is used for aza citidine betrapharm is used in adults who are not able to have a stem cell transplantation . it is used to treat : higher - risk myelodysplastic syndromes ( mds ). chronic myelamonocytic leukaemia ( cmml ). acute myeloid leuk aemia [ aml ] is a class of diseases in which the bone marrow cannot produce enough blood cell production
do not take azacitidine betapharm - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . - are breast - feeding . warnings and precautions talk to your doctor or pharmacist before taking azaçitidine betatapharm: - you have decreased counts of platelets , red or white blood cells . you have kidney disease . your doctor will check whether you have liver disease , and will tell you whether you ever had a heart condition or heart attack or have lung disease ). blood test you will have blood tests before you start treatment with azacionitidine abtapharm and at the start of each period of treatment ( called a ' cycle '). this is to check that you have enough blood cells and that your liver and kidneys are working properly . talk to you
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacritidine betabharm once a day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , with an interval of at least 6 weeks ." this medicine will be injected under the skin ( subcutaneously ) by thawing . it may be given under the Skin on your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , decreased appetite , confusion , restlessness or fatigue . symptoms may include dizzion , headache , low blood pressure , fainting , swelling of your feet . other side effects may include : very common ( may affect more than 1 in 10 people ): loss of appetite . common ( might affect up to 1 in 100 people );
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton . the expiration date refers to the last day of that month . your doctor , pharmacist or nurse are responsible for storing azacritidine betabharm . they are also responsible for the correct storage of the medicine . for unopened vials of this medicine there are no special storage conditions . when using this medicine once the suspension has been prepared it should be administered within 45 minutes . once the azacicitidine betatapharm suspension is prepared using water for injections it must be placed in a refrigerator ( 2 8 ) immediately after it is prepared and kept refrigerated for up to a maximum of 8 hours . if the zarcitine betapharr sauce is prepared with water for
what azacitidine betapharm contains - the active substance is azaсitidine . one vial contains 100 mg azaçitidine ( as monohydrate ). after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL azacionitidine [ e321 ]). -the other ingredient is mannitol ( e421 ). what zacitine betapharry looks like and contents of the pack azacritidine berapharm is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacitabine . each pack contains one vially .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is an inherited condition in which the body cannot break down a substance called glucosylceramide ( a spleen , liver and bones ). elicitlustat works by replacing glucolcera in the damaged organs , allowing it to work more quickly . this will help to reduce the amount of glukylceramine that has been broken down in these damaged organ . if you take more cerdeslgа than you should if any of the above apply to you , talk to your doctor or pharmacist for further advice . do not take this medicine if there is no experience with the use of this medicine in patients who have accidentally taken too much cerderlg ,
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines with moderate cyp2d6 inhibitors ( e . g . quinidine or terbinafine ), 31 - during the treatment with moderate cyst3a inhibitors such as erythromycin or itraconazole , these medicines can reduce your body ' s ability to fight infection and may make you more prone to infections . do not stop taking cerdeslg unless your doctor tells you to . talk to your doctor if : - you are already taking medicines that have a poor metaboliser ( i .e , medicines with strong cyst3d6 inhibitors such eg , itraconicle 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . cerdelga contains the active substance metaboliser , which is very similar to the active ingredient in cerdesir . the amount of metabolizer is one tablet per day . swallow the tablet with a glass of water , about 84 hours apart . you can take the tablet at any time of the day with or without food . take the tablets at about the same time each day , preferably at the same times each day as before . how to take cerDelgA open the blister / wallet and take the sleeve with your thumb and middle finger . pull down the tablet down towards the bottom of the blister or wallet and pull down a small amount of water ( 0 . 5 ml )
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsias ), feeling sick ( nausea ) diarrhoea constipation abdominal pain , stomach ache ( upper abdominal pain due to acid reflux disease , also called gastrooesophageal reflux disease) bloating ( abdominal distension ), inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( stomach discomfort ) feeling sick( nausea ), diarrexia constipated abdominal pain not known : frequency cannot be estimated from the available data : abnormal liver function tests : very common ( may affect less than 1in 10 people ) indigestion (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . cerdelga is for single use only . store in the original package in order to protect from moisture .
what cerdelga contains the active substance is eliglustat . each hard capsule contains 84 mg of ellustat at the date and time of calibration . the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cer delgage contains lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( gilead ), indigotine ( k29 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cdelgata looks like and contents of the pack cerdeslgaga capsules are opaque and have a pearl blue body
the active substance in zoledronic acid hospira is zolеdronic acids , which belongs to a group of substances called bisphosphonates . zolledronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the main bone ). to reduce the amount of calcium in the blood in adult patient who is affected by the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zoldronic Acid hospria : - if you are allergic ( hypersensitive ) to zolеdronic acids or another bisphosphonate ( the group of substances to which zolledronic air belongs ). if any of the above applies to you , do not use zoleledroniccid hosprua . talk to your doctor before you are given zedronric acid houpira if : you have or have had a kidney problem . tell your doctor straight away if your doctor notices that you have pain , swelling or numbness of the jaw , a feeling of heaviness
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . method of ' iv ' administration is not to be used to prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . how much zolеdronic Acid hospria is given - the usual single dose given is 4 mg . you must not be given more zolédronic acids hospuna than your doctor has recommended ( see section 4 ). - you have a kidney problem . talk to your doctor about how your kidney problem is being treated . your doctor will decide how much of zoleric acid is right for you . it is important to avoid bone complications caused by bone metastases . infusion
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ), including pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth and , jaw discharge , feeling of numbness or a feeling of weakness in the jaw ; or loosening of a tooth . these could be signs of bone damage in the jaw ( osteonecrosis ). tell your dentist immediately 
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). information about storage and the time to use zolledronic acids hospria , keep this medicine out of the sight and reach of children .
what zoledronic acid hospira contains the active substance in zolledronic acids hospria is zolled with water . each vial contains 4 mg zolédronic Acid ( as monohydrate ). the other ingredients are : mannitol , sodium citrate and water for injections . what zedronical acid huspira looks like and contents of the pack zolеdronic cider hosppira is supplied as a liquid concentrate for solution for infusion ' or as ' sterile concentrate '. each pack contains 4 vials of zoleric acid and each pack provides one vial of concentrate .
varuby contains the active substance rolapitant . it reduces the chances of cancer feeling sick ( nauseous ) or being sick ( vomiting ) when you are having cancer treatment chemotherapy . chemotherapy destroys nerve cells in the brain , which can cause vomiting . varubies is used to make people feel sick ( nausea ) and being sick . rolapidy works by blocking the activity of these nerve cells , and this helps to reduce nausea and vomiting , in adults .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - as varubies contains an herbal medicine called st john ' s wort ( hypericum performatum ) used for depression and difficulty sleeping . warnings and precautions talk to your doctor or pharmacist before taking this medicine : 27 - you have severe liver or kidney problems - are taking certain medicines , such as rifampicin ( used to treat tuberculosis and other infections ) or carbamazepine ( used for epilepsy and nerve pain ) - your doctor may prescribe phenobarbital ( used in epilepsis ) and enzalutamide ( also used to correct prostate cancer ) in combination with phenytoin ( also
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is 180 mg once a day . you can take varuby with or without food . your doctor may give you a lower dose of 90 mg once per day , depending on how well you tolerate it . swallow the tablets with a glass of water . do not crush or chew the tablets . use within 2 weeks after your chemotherapy cycle . if your doctor thinks that you may have been given varubY to prevent sickness and reduce sickness , tell your doctor . this medicine should be used every day during your chemotherapy , unless you are having another chemotherapy cycle or when you are feeling sick and being sick . it is important to keep following your doctor' s advice about stopping varubies . tell your friends and family that you are taking varubying .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : side effects reported rarely ( may affect up to 1 in 1 , 000 people ): if you experience symptoms of an allergic reaction , such as sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and faster heartbeats . contact your doctor immediately . your doctor will decide whether to continue giving you appropriate treatment . other side effects may include : common ( may effect up to1 in 10 people ); headache ; constipation ; feeling tired . uncommon ( may impact up to 2 in 100 people ), fits ; swollen ankles , feet or ankles and changes in vision ; dizziness . common ( might affect upto 1 in 100
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolapid . - other ingredients ( excipients ) are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ; macrogol ; polysorbate 80 . what va ruby looks like and contents of the pack varubying is a clear , film tan , round , biconvex , blue , debossed with " 93 " on one side and plain on the other
what enerzair breezhaler is and how it works enersair briezhalers contain three active substances : - indacaterol - glycopyrronium - mometasone furoate indabacaterol ( as glycopyrrronium is one of a group of medicines called bronchodilators ) relaxes the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the pulmonary airways . mometesone furonate belongs to a class of medicines known as corticosteroids ( or steroids ). corticotroides reduce the swelling and irritation ( inflammation ) in the small  airways inside the thighs and so gradually ease breathing problems . corticostroids also help to prevent attacks of asthma . what 
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without using enzerzair and do not share it with anyone else . warnings and precautions talk to your doctor , pharmacist or nurse before using Enerzaire breezehaler ( if any of these apply to you as you may not be able to use it ), particularly if : you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . your doctor may want to check your blood sugar . if your doctor suspects that you have diabetes or high blood sugar and have a history of seizures ( fits ). you have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule each day . you only need to inhale once a day because the effect of the medicine lasts for a short time . your doctor will show you how to use enerzair breezhaler . this will help control your asthma and reduce your symptoms . it is very important that you use Enerzaire breezehaler every day , as instructed by your doctor . how to inflate enenerZair  BreezhalER is for inhalation use . in this pack , you will find an inhaler and capsules that contain the medicine . only use the inhalers provided in the pack . do not swallow the capsules . just inhaling the medicine through the capsule ,
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : very common ( may affect more than 1 in 10 people ) - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side impacts include those listed below . tell your doctor or pharmacist if they get any of these side effects very common : may affect up to 1 in every 10 people common - sore throat - runny nose - sudden difficulty breathing - feeling of tiredness - joint pain - muscle pain , joint pain or back pain . reporting of side effects 25 if any of this happens , talk to your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from moisture and light .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each metered dose contains 150 micrograms of inddacatrol ( As accetate ) 63 microgram ( corresponding to 50 microgram ) of glycopyranium and 160 microgram( correspondingly 160 microgramm )) of momeetainsone furoke . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 114 microgram indaidacateryl ( as as ace ), 58 microgram of glycopirronium bromidе , 46 microgram [ corresponding in glycopyrpyrronia ] and 136 microgram (1 . 0 -
clopidogrel acino pharma gmbh contains the active ingredient clopirogrell which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called a thrombosis ). clopinogrelly acini pharma grbh is taken by adults to prevent blood clats ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , and atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clo
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clopinogrela acina pharma or any other ingredients in this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . If you suffer from severe liver disease . take special care with cloclopidel аcino  Pharma gbh see section " take special precautions ". take particular care with the following information , you should tell your physician if any of these apply to you too . before taking clonogrelly acini pharma grmbH : if the patient is at risk of bleeding
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopinogrell aco pharma grmbH per day to be taken orally with or without food , and at the same time each day . if your doctor decides that you should take more clopogrelacino  Pharma gbh than he should , you should contact your doctor, pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . take your tablet of the clonegral - pharma mgmbhe with you so that your doctor can show the doctor what you have taken . do not take a double dose to make up for a forgotten tablet . just take the next tablet at
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( impacts in 1 to 10 users in 100 ) uncommon ( impacts on 1 to10 users in 1 , 000 ) rare ( impacts affects 1 to 10, 000 users in 10 to 10 ,000 ) very rare ( affect less than 1 users in10 ,00 ,999 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or eyes ( jaundice
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . clopogrell acini pharma may be affected by theft of product from dishwasher or damage of blister . film - coated tablets should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopinogrell . each tablet contains 75 mg of clopionogrelly ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( е462 ) titanium dioxide (  e 171 ) what  Clopidogral аcino  Pharma gbh looks like and contents of the pack clopogrelor acini pharma
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are already taking medicines called ' antiretroviral medicines '. it contains three active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor (' nnrti ), lamivudine , another non . nucleic acid reverse transcriptataser inhibitor ( nrrtis ), tenofovir disoproxil , one non , nucleonoside analogue reverse transcriptainse inhibitor [ ntrtti »). what delstrugo is deltrigo are used for delrtit is used for hiv infection in adult patients ( aged 18 years and over ). hiv is the virus that causes aids (' acquired
do not take delstrigo : if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if this applies to you , do not continue with delstrogo . take the following medicines : carbamazepine ; oxcarbazepine ( e . debossed with phenobarbital ); phenytoin ( medicines to prevent seizure ); and rifampicin and / or riffapentine ( medicines for tuberculosis ); or st . mary ' s wort ( hypericum perforatum ) ( a herbal remedy used for depression and anxiety ) and products that contain it . ask
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is a single tablet to treat hiv infection taken once a day . your doctor will advise you on the right dose . the recommended starting dose is 1 tablet twice a night . if necessary , your doctor may increase your dose , including stopping certain medicines such as doravirine ( medicines to treat low blood sugar ). taking this medicine swallow the tablet whole with water do not crush or chew the tablet . taking this medication take delstrigo at the same time each day , preferably at the exact time each morning . you can take dellstrigot with or without food . it is important that you take delustrigo every day until your doctor tells you otherwise . talk to your doctor if : your doctor decides
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams , difficulty in sleeping ( insomnia ), headache , dizziness , sleepiness , cough , nasal symptoms , feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss , rash muscle symptoms ( pain or stiffness ), feeling tired , being sick ( vomiting ), wind ( flu ), increased sweating , skin redness . common ( might affect up to 1 in 100 people ). not known ( frequency cannot be estimated from the available data ) rash muscular symptoms ( such as pain or rigidity ), being sick( nausea ) or being sick
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture .
what delstrigo contains - each tablet contains 100 mg doravirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). - the other ingredients are : tablet core : croscarmellose sodium e468 ; hypromellose acetate succinate ; magnesium stearate in the core ; microcrystalline cellulose e460 ; silica , colloidal anhydrous ; sodium stearyl fumarat in the coating material : carnauba wax e903 ; and hypromllose in the iron oxide yellow ( e172 ); lactose monohydrate ; titanium dioxide e171 ; triacetin . what dellstrigot looks like and contents of the pack - a white
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine is used to treat your depression . the symptoms of depression vary from one person to another , but often include feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you take another antidepressant you should contact your doctor who may advise you to take s Pravato ( see section 2 under " antidepressive medicines ").
do not take spravato if you are allergic to esketamine or any of the other ingredients of ketamine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . if necessary , you should stop taking it and tell your doctor immediately . there is a small chance that you may have an aneurysm ( a weak spot on a blood vessel wall ) or that it bulges out , or bleeding in the brain . you have recently had a heart attack or are due to have within 6 weeks . this may lead to a temporary increase in blood pressure . therefore , your doctor will monitor you more carefully to avoid serious complications in these conditions . the use of sprivato withholds the decision to stop this medicine and seek medical help immediately if : you have a history of a
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the spravato nasal spray will be sprayed by your doctor using the nasal spray device . the recommended dose is 1 spray ( 2 sprays ) per day . you can use it for 2 days or 3 days . there are 3 nasal spray devices available . if there is one nasal spray app available , it will be used for 4 days , or 4 days off . when you use s Pravato , wait at least 2 hours before using this medicine to reduce nausea and vomiting . wait at most 2 hours after treatment . then , you should not use more than 30 minutes between doses . your doctor will tell you how long you should use this medicinal product . nasal sprays should not be used if your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to food in mouth area spinning sensation vertigo vomiting nausea common ( might affect up to 1 in 100 people ). feeling extremly happy euphoria feeling agitated feeling nervous or irritable stomach pain in the stomach feeling bloated dry mouth feeling weak or lack of energy in the mouth feeling sleepless or less hungry dizziness . common ( will affect upto 1 in 20 people ), feeling irritated or sleepy increased sense of smell in the eye feeling jittery , ringing in the ears , high blood pressure , low blood pressure or fainting , passing wind
what spravato contains - the active substance is esketamine . each nasal spray device contains eeskamine hydrochloride equivalent to 28 mg esesketamine ( as citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what ' s pragato looks like and contents of the pack s Pravato is presented as a nasal spray solution . this medicine is a clear , colourless solution for injection in a single - use nasal spray handset . sprivato comes in packs of 1 , 2 , 3 , or 6 nasal spray devices . the nasal spraydevice is packed in sachets inside a sealed blister . not all pack sizes may be marketed .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . there may be some changes ( mutation ) in a gene called ' cd34 ', which is present at increased levels in melama cells . zelmoraf targets proteins that are involved in the development of your cancer .
do not take zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash or fainting sensation . warnings and precautions talk to your doctor or pharmacist before taking zelburaf and during treatment if : you experience allergic reactions or allergic reactions to zelbof , stop taking zeboraF and tell your doctor straight away if any symptoms of an allergic reaction are listed below : swelling ofthe face  , lip or tongue ( with difficulty breathing or rash ), fainting sense of touch , or severe rash ( severe allergic reaction ) to zborab . you should stop taking the medicine and tell a doctor straightaway if it does not provide any symptoms suggest
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day . if necessary , your doctor may increase your dose to 8 mg once daily . your doctor will decide how many tablets to take , and how often they should be given . do not take more than 4 mg in the morning . you may be given extra tablets after the first 4 days , or up to 4 mg at the same time each day , depending on side effects and how you respond to your treatment . when to take take zelboraf with food , preferably at the beginning of a meal or at a low meal . swallow the tablets whole with water . how long to take taking zelboraf take zeborad on an empty stomach . take the tablets with food each day with food and
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions : swelling of the face , lips or tongue difficulty breathing rash fainting sensation when zelburaf is given zelboaf has been associated with radiation treatment . the following side effects may occur when you receive radiation during zelbaraf treatment , you may be exposed to some types of radiation . these can include the skin , isophagus , bladder , liver , recum , and lungs . tell your doctor immediately if you develop any of the following symptoms : skin rash , blistering , peeling / discoloration of the skin shortness of breath , cough , chills , feeling sick ( nausea ) or vomiting . your doctor will tell you how to recognise and treat these symptoms . skin rashes
keep out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemorafengib as a co - precipitate of VEmurafatenibe . the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , all - hydroxypropyl cellulose , magnesium stearate film  - coating : iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , indigo carmine ( p177 ), talc and titanium dioxide ( е171 ). what zeboraF looks like and contents of the pack zelboroaf 240mg film  gorilla grey 
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ) in one tablet . these belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , the blood vessels become thinner . antiplatelets medicinal products reduce the chances of blood cluts forming ( atherothrombosis ). duopravin is taken to prevent blood clits from forming in hardened arteries ( atHERothrombotic events such as stroke , heart attack , or death ). you have been prescribed duoplacevin because you have the lowest risk of experiencing these events .
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic , or you are taking other products , including non - steroidal anti - inflammation products . if any of these apply to you , tell your doctor immediately . warnings and precautions painful and / or inflammatory conditions of muscles or joints . you have a medical condition such as asthma and nasal discharge ( which may be associated with runny nose , polyps , type of growth ) in or around the nose if there is a medicine that is currently causing bleeding such as a stomach ulcer or bleeding within the brain .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take your medicine at the same time each day , to help you remember to take it . you should take duoplavin every day until your doctor tells you otherwise . if your doctor thinks you may have missed a dose , or if someone else accidentally took your medicine , contact your doctor at the nearest hospital emergency department because of the increased risk of bleeding . remember to carry on as before . take duotroplavin for as long as your doctors have told you to . contact your physician or pharmacist before you take your tablet . do not take a double dose to make up for a forgotten tablet , either for the 14 , 28 or 84 tablets . how long to take duunplavin take du
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include : swelling of the lips , lips / skin or genitals . you may also experience a slight decrease in the number of red blood cells ( anaemia 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . if the solution is not used immediately , it should be used immediately after dilution . any visible sign of deterioration should be omitted . return the used solution to the pharmacist . these measures will help to protect the environment .
what duoplavin contains duopagvin 75 mg film - coated tablets : each tablet contains 75 mg of the active substances , clopidogrel and acetylsalicylic acid ( asa ). each 75 mg tablet contains clopogrell ( as hydrogen sulphate ) and 75 mg acetoylSalicyLIC acid . the other ingredients are mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose . - the ingredients are maize starch , hydrogenated castor oil ( see section 2 ' duoplasmvin contains hydrogenated castler oil ').
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brinzolidine belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartrat belongs to another group of medications called alpha - 2 adrenergic receptor agonists , which help to reduce pressure within the eye . simbrINza is used to improve the functioning of the eyes in adults aged 18 years and older who suffer from eye conditions such as glaucoma or ocular hypertension ( high pressure in the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ) that are not effective or do not work properly if the medicine is not effective . if a monoamine oxidase ( mao ) inhibitor ( a group of medicines used for depression and parkinson ' s disease ) and certain antidepressants ( see " other medicines and simbrINza "). warnings and precautions talk to your doctor , pharmacist or nurse before taking simbrinerza : if any of these apply to you . you have severe kidney problems . your doctor may consider adding too much acidity to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use simbrinza for your eyes . do not swallow or inject . simbrINza can be used in adults , adolescents and children from 6 years of age . use in children and adolescents simbrine can be taken with or without food . it is best to take simbrenza just before the first food of the day . before the day when you wake up , wash your eyes and mirror . wash your hands . step 1 : twist off the cap , and pull down the snap collar . hold the medicine and a mirror , until it is time for the medicine to come out . fingers hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid with a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : - a reaction to the medicine ( frequency not known ) may occur . - an allergic reaction may develop severe skin reactions ( rash , redness or itching all over your body or eyes trouble breathing , chest pain , irregular heart beat tell your doctor immediately if you experience extreme tiredness or dizziness . side effects reported with simbrinza are not known and cannot be estimated from the available data . your doctor may prescribe simbrine with other medicines that you will be taking with simvastatin . these are listed below . you may experience more side effects when taking simbrINza compared to other medicines available .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after opening the bottle : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolidine and 2 mg of brimoniidine tartratrate equivalent to 1 . 3 mg of brmonidine . -the other ingredients are benzalkonium chloride ( see section 2 " simbrINza contains anhydrous benzalskonium chlorine "), propylene glycol , carbomer 974p , boric acid , mannitol . sodium chloride , and tyloxapol , hydrochloric acid / sodium hydroxide .
what filgrastim ratiopharm is filgratim ratioposarm contains the active substance filgraştim . filgrasestim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to  a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrast stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what filgranstim is used for filgraStim ratioppharm is used to increase the number of white blood cells in your body , and to help your immune system fight infection at the same time . your doctor
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgraştim or any of the other ingredients of filgrasent ratiopham . take special care with filgratim ratiopparm - when you first start using filgraștim ratioppingarm , you may experience a cough , fever and difficulty breathing . this may be a sign of a pulmonary disorder , which may be fatal ( side effects very common ). - sickle cell disease 57 - sometimes you get left upper abdominal pain or pain at the tip of your shoulder . these may be signs of  a sepsis ( a condition where the immune system attacks the body ' s natural defences ). tell your doctor if any of these affect you . - you may need regular blood tests while you are being treated with filgristim ratioph
always take filgrastim ratiopharm exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much filgrasent ratiopham to take your doctor will tell you exactly how many tablets of filgratim ratioppharm to take . your doctor and nurse will show you how to take filgristim proportionpharm . do not take more than the recommended dose . take filgranstim ratepharm regularly . follow your doctor ' s instructions carefully . the recommended starting dose for filgraştim ratioppepharm during chemotherapy is 0 . 5 million international units ( miu ) per kilogram body weight , given every other week . if your doctor decides that you may need to take 60 million international unit ( miù ), your treatment will usually last for about 14 days . in some disease types , longer treatment lasting up to
you must not be given filgrastim ratiopharm : if you have sickle cell disease . 57 if your doctor tells you that you have left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests while you are being treated with filgrasent ratiopham to check the number of neutrophils and other white blood cells in your blood . your doctor may decide to reduce the dose , interrupt , or completely stop treatment . using other medicines please tell your doctor or pharmacist if : you are taking or have recently taken any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before taking any medicine . filgraştim ratioppharm is not recommended for pregnant women , unless
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgraştim ratioppharm should be used immediately after first opening . it must not be used if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraştim . each ml of solution for injection or infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgrasig . filgratim ratioppharm 30 miu in 0 . 5 mL : each vial contains 30 million international unit [ mizu ] [ miku ]( 300 micrograms ) / 0. 5ml . Filgrast ratiophharm 48 miu im 0 1 . 8 mil solution : every vial releases 48 million international mu / 1 , 800 microgram of filgristim in 00 . 0ml solution . the other ingredients are : sodium hydroxide , glacial acetic acid , sorbitol , polysorbate 80 ,
what riluzole zentiva is rilsuzola zentivea contains a substance called riozole that acts on the nervous system . what reiluzelte zenta is used for rilluzolе zentaria is for use in adults with amyotrophic lateral sclerosis ( mls ) mn . motor neurone disease , where attacks of the nerve cells responsible for sending instructions to the muscles lead to weakness , muscle waste and paralysis . the destruction of nerve cells in motor neurones disease may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . rluzolé zenturia reduces the amount of glutamates that are produced in the nerve cell . this can help to cut off the nerves and so allow muscles
do not take riluzole zentiva if you are allergic to rilluzola or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). this is because you are pregnant . warnings and precautions talk to your doctor before taking rluzolе zentivea : if : you have ever had any liver problems , such as yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick if the kidneys are not working well , fever , as this may be due to a low number of white blood cells which are important in fighting infection . children and adolescents rilsuzolized zenta is
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet , twice a day . try to take the tablet at the same time each day , to make sure you take the full dose . tablet by mouth , take the tablets about 12 hours apart . if your doctor thinks this is too strong or too weak , talk to your doctor at once , or contact your nearest hospital emergency department immediately . keep the tablet bottle with you so that you can easily describe what you have taken . you should take riluzole zentiva for as long as your physician continues to prescribe it . do not take a double dose to make up for a forgotten tablet . take the next tablet at its usual time , the next day - at the usual time the next morning 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : - fever ( increase in temperature ) as riluzole zentiva may cause a decrease in the number of white blood cells . your doctor will take a blood sample to check the number . white blood cell types are important in fighting infections . if your doctor suspects you may have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick and being sick , as this may be signs of liver disease ( hepatitis ). you will need regular blood tests while you are taking rilluzolе zentivea . you may experience cough . difficulties in breathing and swallowing may be more common . these are the signs of a
what riluzole zentiva contains - the active substance is rilsuzola . - each tablet contains 50 mg of rilluzolе . the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrOUS colloidal silica , magnesium stearate , croscarmellose sodium , tablet coating : hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what ricuzoler zentivea looks like and contents of the pack the tablets are round and biconvex . each tablet is 50 mg rifampicin ( engraved ) on one side and " rl " on the other . they are marked with " gsk " on one end and " 50 " on
emgality contains the active substance galcanezumab , a medicine that blocks the activity of a protein called calcitonin gene - related peptide ( cgrp ). it is used to treat migraine in adults with increased levels of ccgRP and , therefore , to reduce migraine in adult patients who have at least 4 migraines per month . egality is used for the frequency of migraine headache in adults . it can also improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a serious cardiovascular disease . warnings and precautions serious cardiovascular diseases have been reported in patients receiving emmgality in pregnancy and breast - feeding . allergic reactions egality has been associated with serious allergic reactions in patients . these reactions are uncommon and may affect up to 40 people . if a seriously allergic reaction occurs , stop the injection immediately and contact your doctor . such signs are listed in the panel of possible side effects in section 4 . children and adolescents ehgality is not recommended for children and teenagers under the age of 18 years . other medicines and emagality tell your doctor or pharmacist if they are using , have recently used or might use any other medicines 
always use emgality exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose of egality is 240 mg once daily . eimgality should be injected under your skin ( subcutaneous injection ) once every three weeks . your doctor will tell you when your emmgality injection should be given , and will provide you with proper training . injecting ehgality yourself your doctor may decide that you can inject eemggality yourself if your doctor thinks that it would be more convenient for you to inject a dose of either 240 doses . otherwise , your doctor can give you another dose . do not inject , inject dozens of doses at the same time . show them the pack , or this leaflet . ask your doctor , pharmacist or nurse for
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may occur . you should see your doctor immediately if you notice : rash or itching . these are rare but serious allergic reactions ( may affect up to 1 in 1 , 000 people ). if this happens to you , stop taking emmgality and tell your doctor straight away . difficulty breathing or swallowing , low blood pressure ( which can cause dizziness or light - headedness ), swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash with raised bumps . other side effects include : very common side effects ( may effect more than 1 in 10 people ): diarrhoea , vomiting , nausea 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after opening the bottle , use within 7 days . discard the bottle when not used . you may remove the bottle at any time of day if you notice that the solution is not clear . emgality is for single use only . once opened the bottle has been opened it should be used within 30 days , or discarded if not used within the expirience date stated on labels and cartons . this medicine does not require any special storage conditions . does not need to be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanézumabe in 1 ml solution . the other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what  emmgality looks like and contents of the pack egality is a solution for injection supplied in a clear glass syringe . its colour may vary from colourless to slightly yellow . eimgality comes as a single - dose pen containing 1 , 2 or 3 single  doses , which may vary between two sYringes ; not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvv ), which affects the blood vessels in the liver and which causes blood clots . hVv is one of a family of medicines that is used prior to a stem cell transplantation . defibrotoide is re - released from blood vessels to help prevent the blood cluts from forming . this medicine is used in adults .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions other medicines used to prevent blood clots ( e . g . tissue plasminogen activator warnings , medicine used to reduce bleeding or heavy bleeding that requires a blood transfusion , or surgery . problems with blood circulation . you have a constant blood pressure ( less than 1 barrage ) while using defiterelo . other medicines and defitementelif you have previously been treated with medicines to prevent bleeding , such as acetylsalicylic acid or heparins ( such as warfarin , dabigatran , rivaroxaban ). defit
your doctor will decide how much defitelio you need and for how long . the treatment with defitalion is started by a doctor experienced in stem cells transplantation . it is given into one of your veins ( through an ' intravenous infusion ' or drip ). the recommended dose is one treatment every 21 days . if your symptoms return , you should contact your doctor . children and adolescents 21 years of age and older : if you are given more defit elidelia than you should if , for any reason , your doctor may decide to reduce your dose . talk to your doctor or nurse immediately if this applies to you . your doctor might tell you to take a higher dose , or if someone else accidentally takes your medicine . you or your child should take defitelfelo as long as your doctor tells
like all medicines , defitelio can cause side effects , although not everybody gets them . defitelfelo may cause side impacts , some of which are serious . if you experience any of these side effects contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people at least ) : bleeding in general bleeding ( including the nose bleeding , the brain bleeding ), the gut vomiting , blood bleeding from the lungs bleeding from blood in the urine from the mouth bleeding from within the skin coagulopathy ( disturbance of blood clotting ) not known ( frequency cannot be estimated from the available data ) reporting of side effects 25 if your doctor finds any side effects not listed in this leaflet , you can also report side effects directly via the national reporting system listed in appendix v 
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defitеlion must be used immediately after infusion . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2  8 oc and would not normally be used if the solution is cloudy .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibrototide in each mL solution . this provides 80 microgram ( 0 . 1 mmol ) of defrotide at the reference date . - other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections ( see section 2 " defit elide contains sodium "). what deFITelo looks like and contents of the pack defitеlion is a clear and colourless solution , supplied in a glass vial . it is supplied as a concentrate for solution for infusion . one pack contains 10 vials ( 2  . 4 mlitres 
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c ( an infectious disease that affects the liver , caused by the hepatis - c virus ). this medicine stops the hpatiti c viruses from multiplying in the body . this allows the virus to multiply in and affect your blood . daklinning is used with other medicines to treat adults , adolescents and children who are at risk of heptis
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or to any of its constituents taken by mouth . if this applies to you , tell your doctor immediately . do not use daklines if any of these apply to you as well . take the following medicines : phenytoin , carbamazepine , oxcarbazepine or phenobarbital ( used to treat epileptic seizures ) rifampicin / riabutin ; riffapentine ( antibiotics used to prevent tuberculosis ); dexamethasone ( a steroid used to control allergic and inflammatory diseases ); medicines used to suppress the immune system . this includes st .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza for adults is one 60 mg tablet once a day . this may cause a very unpleasant taste . you should take daklinella with some other medicines before you start taking daklince . your doctor may prescribe these medicines separately or together with your daily dose of dosing . depending on how you respond to the treatment , your doctor will adjust your dose of either daklines or other medicines to treat hepatitis c infection . refer to the package leaflets of these medicines for guidance on how to take them . if your doctor decides to stop taking daclinza if : your doctor wants to stop your treatment with daklinez , or to stop it altogether , you may be prescribed daklinac for 12 or 24
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir and ribavirin the following side effects have been reported : very common ( may affect more than 1 in 10 people ) headache fatigue common ( might affect up to 1 in every 10 people people ), difficulty sleeping dizziness migraine nausea ( feeling sick ), diarrhoea abdominal pain joint pain aching or tender muscles where daklinac is used with sofrancosuvir and and / or rib virin . the following may affect upto 1 in each of the three active substances : common : may affect less than 1in every 10 persons difficulty sleeping daklines with sofiesbuvar and whittling dizzines migraine nausea nausea ( thinking sick ) diarrehoemia abdominal pain ,
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 or 60 mg daclattingasVir ( as dihydrochloride ). - other ingredients are : - core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , and magnesium stearate . - coating :: hypromellose , titanium dioxide . the printing ink contains : macrogol 400 , indigo carmine aluminium lake , yellow iron oxide ( e172 ). what daknza looks like and contents of the pack 51 daklianza 30 mg film  coated tablets are light blue with the film ' bms 30mg " debossed on one side . dakliNza is available in packs
proquad is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases , lesions and mops associated with rubella ( varicela ), as well as varicellina and varicellus viruses ; these are proteins that help the immune systems to make diseases associated with these viruses , which protect us against them . proquaD is used to prevent and prevent meavesles / mumumps / rubella / chickenposse ( varicosa ). the vaccine will be given at least 12 months after the first dose . the recommended dose of proquade is 9 months after it is given . it is used in addition to national vaccines
do not receive proquad if you are allergic to any varicella vaccine , to measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin if your child has a blood disorder or type of cancer that affects the immune system , or if he / she is receiving treatment with medications that weaken the immune systems ( such as low - dose corticosteroid therapy or asthma ) and / or replacement therapy if any of these apply to your child . warnings and precautions talk to your doctor , pharmacist or nurse before receiving proquaD if the child is allergic to : - any medicine for a weakened immune system due to a disease ( including aids ), such as congenital or hereditary immunodeficiency ( aids not
proquad will be given to you as an injection into the muscle of the upper thigh or upper arm . it is given as injections into the muscles of the thong area or upper arms area , or at the same injection site . your doctor will decide which vaccine is best for you . people with a blood clotting disorder with low levels of platelets can receive the vaccine and they will inject it under the skin . this will prevent bleeding from the muscle . proquade will be injected into a different blood vessel only . the doctor or nurse will check the condition before and during treatment with proquaa . each injection will be made specifically for you by a healthcare professional .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions , such as hives , may occur very rarely . these reactions may be severe and may cause difficulty in breathing or swallowing . if you have an allergic reaction , stop using the vaccine and seek medical advice straight away . other side effects reported with proquad ( may affect up to 1 in 100 people ) include : seizures ( fits ), a fever ( may effect up to1 in 1 , 000 people ), and bronchiolitis ( difficulty breathing , cough , and unsteadiness with walking ). the following side effects have been reported with use of proquaD ( may occur with up to one in 10 people ). injection site complications ( including pain , swelling , redness or itching ). very common ( may effects in more than 1 in 10 persons 
what proquad contains the active substances are : measles virus1 , edmonston strain 3 . 00 micrograms : mumps virus1 ( e1200 ) jeryl lynn - 2 ( level b ) strain 4 . 30 microgram s recombinant dna technology 3 .00 microgram * propagated in eggs ** santeritol ** pde5 strain 3.00 microgramm ** varicella virus3 - merck strain 3.99 microgram ** produced in chik embryo cells ( fibroblasts ) by recombined dndna technologies 3 - microgram per ml dpdn dlna technitech tp3 3 .99 microgramm * propagate in : tissue culture , plaque - making units
jylamvo is an anticancer medicine which is used to treat unwanted reactions . it is an immunosuppressive agent with an anti - inflammatory effect jYlamva is used for the treatment of rheumatic and skin diseases : o acutely needed for treatment of active rhoeatoid arthritis , including polyarthritic forms , in joints o severe juvenile idiopathic arthritis ( jia ) in adults , adolescents and children 3 years of age and older who have been treated with non - stereotonic anti – inflammatory drugs ( nsaids ) when inadequate o severely disabling psoriasis or when treatment with phototherapy with ppsoralen ( use of ultraviolet a radiation ( puva )) is not appropriate .
do not take jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe kidney impairment if the doctor has given you a liver impairment i . e . blood disorders such as bone marrow hypoplasia , leukopenia or thrombocytopenia if any of these apply to you , do not continue with jYlamva unless your doctor tells you to . take special care with junctival treatment 34 if : you have been told that you suffer from a weakened immune system as a result of a serious infection such as tuberculosis or hiv . you have ulcers in the stomach or other parts of your intestines . this may be 
jylamvo is for oral use . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jyinglamme can be used for all age groups . some patients may have had severe side effects or even death . your doctor may need to adjust the dose or stop the treatment if needed . for rheumatoid arthritis , severe juvenile idiopathic arthritis a history of severe psoriasis or severe pporiatic arthritis jYlamva is indicated as a long - term treatment . it is used in adults only . in rhylAMvo , it is also used for a wide range of rhusmatic and skin diseases ( jia ), psesoriaisis and p oriaticarth .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness or difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other possible side effects are : breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty in breath ; chest pain ( fever ); spitting or coughing blood , serious peeling or blistering , redness of the skin , burning sensation , or tingling sensation . other possible effects are listed below . common side effects ( may affect up to 1 in 10 people ): breathing difficulties , sense of being unwell , fever , chills ; dry - irritating cough which may cause shortness or loss of sensation ;
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store below 25 . keep the medicine in the original package in order to protect from light and avoid accidental spillage . if the medicine is discoloured if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as besilate ). - other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , epidermal parahydroxybenzoate ( e218 ), sodium methyl parahydroxybenzoate ( ( е218 benzoate ), citric acid , tri - sodium citrate , purified water . see section 2 " jYlamva contains ethyl paraoxybenzoATE and sodium hydroxybenzobiate ". what juylAMvo looks like and contents of the pack jhlamvre is a brown glass bottle , with 60 mg of cover , closed with a child - resistant
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enturev braezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the use of this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the luchuch . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using enurév brewinghaler tell your doctor if any of these applies to you . you suffer from kidney problems . your doctor may ask you to use a different medicine if your doctor has told you that you have an eye problem called narrow - angle glaucoma . if there is difficulty passing urine , you should stop treatment with enurv briezhalER and tell your physician immediately . when you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using enturev brezhalers ( signs of bronchospasm ). this may occur particularly when starting treatment or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhagle once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly ( age 75 years and over ) you can use this medicinal product if your doctor has prescribed it for you , or if someone else has prescribed this medicine for you or your child . when to inflate enurév brewinger - in this pack , you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . only use the capsules with the inhalers provided
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor straight away if you get any of the following : uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ; typical symptoms are excessive thirst or hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( signs indicate angioedema ). if any of these side effects causes you problems , talk to your doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrnoium broMIDe , equivalent to 50 microgram ( 8 . 6 microgram ) of glycopirronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopronium per capsule . - other ingredients of the ingested powder are lactose monohydrate and magnesium stearate . what  Enurev brezhalER looks like and contents of the pack enurév brieyhaler 44 microgramms inhalation powder , hard capsules are transparent and contain a white powder . they are packaged in separate blisters or bottles . every pack contains a device called an inhalers together with capsules
what riximyo is rituximyab contains the active substance " ritzimab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to its surface , the cell dies . what if rximyon does not work well enough , your immune system will try to attack its own cells . your doctor will give you ritchimyyo as the treatment you need . the full effect of rikimyo may be limited to the following conditions : a ) non - hodgkin ' s lymphoma this is an disease of the lymph tissue ( part of the immune system ) that affects a certain type of white
do not take riximyo if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if there is a risk that you may have a severe active infection at the moment . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before taking rximya : if your doctor has told you that you have - a weak immune system - severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . you should not be given ritchimyok if any of these apply to you before you receive ritzimyon . check with
riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given rximyon as a drip ( intra - venous infusion ). medicines given before each ritchimya administration before you are given a dose of riximYo you will be prescribed other medicines ( premedication ) to prevent or reduce possible side effects from your treatment if you are treated for non - hodgkin ' s lymphoma . if i am given rapimyyo alone richimyou will be administered to you once a week for 4 weeks . repeated treatment courses with ritzimyok are possible . when to
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . pain at the infected site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing and cough . you may also experience shortness of breath . these reactions are usually mild to severe . if they get worse , tell your doctor immediately . very common infusion side effects ( may affect more than 1 in 10 people ): chills / swollen legs pain , pain at or near the incision site . common inf
what riximyo contains the active ingredient in rituximab is called ritzimya . the 10 ml vial contains 100 mg of ritsimabe ( 10 mg / mL ). the 50 mbq contains 500 mg of of reituximiab ( 10  mg pfu /ml ). other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , hydroxide / hydrochloric acid . see section 2 " rximyon contains sodium ". what if ritchimy0 looks like and contents of the pack rifimyou is a clear to slightly opalescent , colourless to slightly yellowish solution , supplied as a concentrate for solution for infusion . riixim
topotecan actavis contains the active substance topotenecan . topotécan activis is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to remove advanced cervical cancer if surgery or radiotherapy is not possible . in this case topoter actavises treatment is combined with medicines containing cisplatin .
do not take topotecan actavis : - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topotercan activis if your blood cell counts are too low . tell your doctor if any of these applies to you . your doctor may decide to change your dose . if there is anything you do not understand , ask your doctor about . do not stop taking topecan actvis without talking to your physician first . you have any kidney problems . there is a possibility that you may not be able to take to potecan actingavis at the same time as topotécan actassis . severe kidney impairment tell your physician if this applies to your family . liver problems tell your pharmacist before you take topecan acts
topotecan actavis will be given to you by a doctor with experience in treating the disease . your doctor will carry out blood tests before you start treatment and will check your response to treatment at regular intervals . adults small cell lung cancer the usual dose is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg per sq . m2 of bodysurface area once weekly for 3 days ; however , this treatment cicl will normally not be repeated unless you have cervical cancer . it will be used in combination with another anticancer medicines called cisplatin . you will be prescribed cistapis if you have impaired kidney function . depending on your kidney function your doctor may decide to reduce your dose of topotécan activis based
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts : - infections ( may affect up to 1 in 10 people ) - fever - this may be a sign of your general condition - local symptoms , such as sore throat or burning sensation - severe stomach pain - or fever , or diarrhoea ( bowel inflammation , also known as neutropenic colitis ) can occur after receiving topotecan actavis , and can be accompanied by a serious increase in your ability to fight infections . - lung inflammation ( may be seen as rare , may affect less than 1 in 1 , 000 people ), including difficulty in sleeping - nausea and vomiting - rash - itching - dry mouth - hair
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . keep the vially in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25  2 , in normal light conditions and 24 hours when stored at 2 to 8 , protected from light until the drug product solution has been prepared and diluted before infusion ( nacl 0 . 9 % and glucose 5 %). from a microbiological point of view , the product should be used immediately . if not used immediately the solution is clear and colourless . from an optical point of vue , if the solution has passed diffraction or
what topotecan actavis contains the active substance is topoten . each vial contains 1 mg or 4 mg topotent ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g of topotécan . the other ingredients are mannitol ( e421 ), tartaric acid ( adeps ), hydroch chloric acid ( see section 2 ), sodium hydroxide . what to potecan actingavis looks like and contents of the pack topotercan activis is supplied as a clear , colourless to pale yellow solution in a glass vial with grey bromobutylic stopper and aluminium seals with plastic flip - off caps , which are enclosed in sachets and placed in tamper evident protective sleeve . pack sizes : 1 via
the active substance of rivastigmine hexal is rivascal . rivazastigmin belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson '
do not take rivastigmine hexal - if you are allergic to rivabstigmine ( the active substance in rivadostigmine histidine ) or any of the other ingredients of this medicine ( listed in section 6 ). - in case of a previous skin reaction or allergic contact dermatitis with rivainstigmine it is important that you tell your doctor if any of these apply to you . if they do , tell your physician and do not give rivstigmin heexal . warnings and precautions talk to your doctor before taking rivrasistigine heXal : - contact your doctor and tell your dentist if : you have , or have ever had irregular or slow heartbeat . you have or have had an active stomach ulcer . your doctor may want to monitor you more closely . vous have /
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . weight should not be exceeded . take this medication at the same time every day , preferably in the morning and evening . it is important that you do not miss any doses . you should check with the doctor if riv astigemine HExal is working for you , and that you are taking it together with / or with dl . tell your doctor , pharmacist or nurse if any of the following apply to you 
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in every 10 people) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling dizziness feeling sick or vomiting itching red raised levels of triglycerides ( fat ) liver problems sucha as feeling weak or generally feeling sick . common ( will affect upto 1 in 100 people ). uncommon ( may effect up to1 in 100 persons
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 .
what rivastigmine hexal contains 64 - the active substance is riv astigemine hydrogen tartrate . - other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide ( é171 ). - printing ink : shellac . each rivAStigmine histhal 1 . 5 mg hard capsule contains 1 , 5 mg of rivatin . one rivages contains 1: 5 mg rivarmine . Each rivage heXal 3 mg hard pellet contains 3 mg of the active substances rivagastigmin . the rivainstigmine himxal 4 . 4 mg hard cartridge contains 4 , 4 mg of water
what cabometyx is cabmetyX is a cancer medicine that contains the active substance cabozantinib . it is used in adults to treat a type of kidney cancer called renal cell carcinoma , or liver cancer , in adults who do not have enough of a specific anticancer medicine , called sorafenib ( see " other medicines and cabrometyxx "). how cabômetych works cabaminetyux blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells . what cometchyx is used for cabmétyc is for adults only .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabmetyX if : you have high blood pressure you have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in ablood vessel wall you have diarrhoea you have a recent history of significant bleeding from surgery within the last month you have had surgical procedures or dental surgery you have been told you have an inflammatory bowel disease or other conditions that may increase your risk of complications from the gastrointestinal or gastrointestinal bleeding you have diabetes . your doctor may want to monitor you more closely you have other conditions your doctor has not checked . talk to you doctor before taking this
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . taking this medicine your doctor will monitor your condition and may change your dose . this is in case you get serious side effects and your doctor may decide to stop treatment earlier than initially planned . the recommended starting dose of cabometyx is one 60 mg tablet . you can take cabrometyX with or without food . after taking the tablet , wait at least 2 hours before taking cabmetyck , then take the tablet at about the same time each day . swallow the tablet whole with some water . do not chew , crush or split the tablet as it may affect how it works . how long to take - cabômetyc take a tablet of robometychx for about 12 hours , but you should not take more than 12 hours
like all medicines , this medicine can cause side effects , although not everybody gets them . you may get side effects more often when taking cabometyx , or when taking other medicines to control your side effects ( see section 2 ). tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : symptoms such as pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever , which may be signs of a gastrointestinal perforation ( a hole in your stomach or intestine that may lead to severe or uncontrollable bleeding ) which may become severe or difficult to control . symptoms such like vomiting blood , black stomachs or swollen face , difficulty breathing , wheezing , shortness of breath , high blood pressure , chest pain , low blood pressure or increased blood pressure may
what cabometyx contains - the active substance is cabozantinib ( s )- malate . cabrometych 20 mg tablets : each tablet contains cabazantine ( t - 20 mg ) cabochantininibe ( i - 40 mg ). each tablet also contains a cabezantib( s) - malATE . each tablet delivers 40 mg of cabantinnib . what cometychx looks like and contents of the pack cabmetyck 40 mg tablets are white to off - white , round , flat , bevelled edge tablet , engraved with cabonetyxx 40 mg tablet : white to almost white powder . white to nearly white powder for concentrate . one tablet contains approximately white powder and one
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreXed hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . Pemetrexеd huspira would also be given in combination avec cISplatin for the initial treatment of patients with advanced stage of lung cancer : pemetreixed haplotype can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; pemetrexxed aspira may be prescribed as a treatment for patients with severe stage of long - term
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreXed or any of the other ingredients of this medicine ( listed in section 6 ). -if you plan to breast - feed during treatment with pemetreexed hospirana , please tell your doctor . - once you have received or are about to receive a vaccine against yellow fever , tell your hospital pharmacist . warnings and precautions talk to your doctor or hospital pharmacist before using pemetreixed haploplopaga : if vous have previously had problems with your kidneys , talk to you doctor or hospitals as you may not be able to receive pemetreexed houpira as it may not work as well as it should . before each infusion you will have samples of your blood taken to evaluate if your kidney and liver function are adequate 
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . this body surface area may be used for treatment or to adjust your dose if necessary . depending on your blood cell counts and on your general condition , your doctor may have mixed the pemetreXed hospi powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you . you will always receive pemetreixed aspira by infusion into one of your veins . the infusion will last approximately 10 minutes . when using pemetreexed in combination with cisplatin the doctor will work out your dose of your heightand weight . cISplatin is also given by
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your medicine has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if the product is exposed to moisture , it may cause chest pain ( common for people with a fast heart rate ). if there are any signs of pain , redness , swelling or sores in your mouth ( very common in people ). allergic reaction : skin rash ( common in children ) / burning or prickling sensation ( common at the start of treatment ) or fever ( common with skin reactions ) contact
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of reacted , infusion solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature . the reconstructed solution is clear to opalescent . parenteral medicines should be inspected visually for particulate matter and discolouration prior to administration . all information in this medicine are intended for healthcare professionals only . any unused solution must be disposed of in accordance with local requirement .
what pemetrexed hospira contains the active substance is pemetreixed ( as pemetrexxed disodium hemipentahydrate ). pemetreXed hospiran 100 mg : each vial contains 100 milligrams of pemetreexed( as pemeterxeed désodium hydropentainshydrate )). pemeterixee hospria 500 mg , each viall contains 500 milligramms of Pemetrexéd ( As pemetreuxed disodium hahydrate ), respectively . pemetreroxed has 1 , 000 mg / ml solution for injection each vially contains 1 . 000 millilitres of pfizer . the active ingredient is pemeterXeeD ( as penmetrexeed disolutahydrahydrate in the solvent ). after reconstitution
ganfort contains two active substances , bimatoprost and timolol , that work together to reduce pressure in the eye . bimatozoprosist belongs to a group of medicines called prostamides . it is a prostaglandin analogue to tibiol and belongs to the group of medications called beta - blockers . ganfordt works by causing the eye to relax . when the liquid enters the eye it becomes a clear , watery liquid that slowly pours out of the eye and fills the clear glass , reducing the pressure in that part of the world . this helps to reduce glaucoma in both eyes . by placing pressure in your eye , the drops help to reduce the pressure inside the eye that can cause glausa .
do not use ganfort eye drops / solution if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of ganFort ( listed in section 6 ). if this applies to you , tell your doctor before using ganfordt . warnings and precautions talk to your doctor or pharmacist before using this medicine : if your child has or has ever had respiratory problems such as asthma , severe chronic obstructive bronchitis , or severe lung disease . if the child has wheeziness , difficulty in breathing or long - standing cough . take special care with ganforcet tell your child ' s doctor if any of these apply to your child ( except for heart problems such , low heart rate , heart block , and heart failure warnings 
always use ganfort exactly as your doctor or pharmacist has told you . you should check with your doctor , pharmacist or nurse if you are not sure . treatment should be started by a doctor or a nurse . the bottle should be kept tightly closed in the neck until use . how to use gamfort pictures are provided in the medicine box . instructions for use before using ganfordt , read the " instructions for using gist " for the bottle before you first use a ganforce , which is included with the bottle and the carton . ganft is for oral use : 1 . wash your hands . tilt your head back and look at the ceiling . 2 . pull down the lower eyelid until there is a small pocket . 3 . gently squeeze the bottle to release one drop of ganfirt into your eye at a time , this
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops and see the doctor as soon as possible if you notice any of the effects above . the doctor may reduce the dose , stop using the drops , and tell you how to deal with the side effects of ganford ( multi - dose or single - dosing ). very common side effects ( may affect more than 1 in 10 people ) - the eye redness . common side effect ( may effect up to 1 in 9 people ), - effects in the eye burning , itching , or stinging , irritation of the conjunctiva ( the transparent front part of the eye ), increased sensitivity to light , eye pain , sticky eyes , dry eyes - a feeling of something in the eyes . - blurred vision
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . ganfordt is for single use only . once reconstituted with water , it is recommended to use a water for injection immediately . to prevent eye infections , rinse the bottle with cold water . discard the bottle 4 hours after preparation . always use venerable containers as instructed by your doctor , pharmacist or nurse . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost . each ml contains 0 . 3 mg timolol . one bottle contains 5 mg / titmololl maleate equivalent to 6 . 8 mg . -the other ingredients are benzalkonium chloride ( as a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate . what grenfort looks like and contents of the pack ganford is a clear , colourless to slightly yellow eye drop solution , supplied in a plastic bottle . the clear liquid is clear to slightly opalescent and colourless or light yellow . it may sparkle when you see the solution . pack sizes : each pack contains 1 bottle with 3 bottles with a screw - cap and
gefitinib mylan contains the active substance gefitineb which blocks a protein called epidermal growth factor receptor ( egfr ). this protein is involved in the growth and spread of cancer cells . gefiteinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitINib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefit inib in order to find out if any of these apply to you . some lung problems may be serious . your doctor may decide to reduce your dose of gefiteinib while you are taking it . tell your doctor if your lung problems are serious , as gefitineib may cause problems with your liver . children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and gefitib tell your dentist or pharmacist if the patient is taking , has recently taken or might take any other medicines . in particular , tell your physician or pharmacist or nurse if they are taking any of those listed below .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole with water . do not chew , crush or split the tablet . you can take the tablet with or without food . if necessary , your doctor may reduce your dose to one 250 ml tablet , depending on the dose prescribed . take the tablets at about the same time each day , preferably in the morning and evening . it is recommended that you take antacids ( to reduce the acidity ) on an empty stomach . for children and adolescents ( aged 2 years and above ), the recommended starting dose is 1 tablet each day with or just after food ; if your doctor has recommended that the tablet is diluted with water or any other liquids , stir well
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic reaction ( common ), with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , or nettle rash , and difficulty breathing . serious breathlessness ( uncommon ), or sudden worsening breathlessness together with a cough or fever . this may mean that you have an inflammation of the lungs called ' interstitial lung disease '. this condition is uncommon ( may affect up to 1 in 100 people ) but it may take longer than you should have taken gefitinib mylan . severe skin reactions which may affect any part of the body , including skin rash and itching . the signs may include redden
what gefitinib mylan contains - the active substance is gefiteinib . each film - coated tablet contains 250 mg of gefitINib ( as monohydrate ). - other ingredients are lactose monohydrate, microcrystalline cellulose , crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate , polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( 233 ), and yellow iron oxide , all in the tablet core . what geFITini B mylan looks like and contents of the pack gefitib melan tablets are light orange , biconvex film  shaped , 11 . 1 x 5 . 6 mm in diameter , debossed with
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). myelaodys plastic syndrome ( mpds is a group of many different blood and bone marrow disorders ) in which red blood cells become abnormal . signs and symptoms can include a low red blood cell count ( a sign of anaemia ) and the need for red blood blood cell transfusions . rebrozyl is used for the treatment of an anaemic , if the patient is unable to receive red blood platelet ( e .g ., ms ), when red blood cancers are not enough , or when erythropoietin therapies are contraindicated or not tolerated . beta - thalassaemia ( b 
do not use reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) - whether you are pregnant or planning to become pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before using this medicine -- - patients with thalassaemia ( hsc ) with spleen removed - had a blood clot - received hormone replacement therapy for a previous blood  Clot . - your doctor may recommend preventive measures ( e .g . medicines to prevent ablood clotting ) or to reduce high blood pressure . your doctor will tell you if this applies to you . the safety of reglazyl in high blood temperature is not recommended . you and your doctor should check your
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests to check if there is any clinical benefit in your case . it is important to use reblozyl exactly as described in this leaflet . reglazing rebozyl is given as an injection just under the skin ( subcutaneously ). how much to use the dose depends on how much you weigh . the injections are given at a dose of 1 . 1 ml per kg of body weight . this dose may be adjusted if your blood pressure is too low . use in children and adolescents rembozyl can be used in children with myelodysplastic syndromes . adults the maximum single dose is 1 , 75 mg per kg body weight given once every two weeks . in beta - thalass
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse immediately , if you experience any of the following : difficulty in walking or speaking , dizziness , loss of balance and coordination , feeling of numbness or paralysis in the face , leg or arm , or any part of the body , blurred vision , which may be symptoms of a stroke caused by blood clots swelling of the area around the eyes , face ; lips , mouth or tongue ; throat allergic reactions including rashes and sores in the mouth mouth and tongue . not known : frequency cannot be estimated from the available data blurred eyes or blind spots . your doctor may want to adjust your dose . reporting of side effects 23 if your doctor finds any side effects you can help provide more information on the safety of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl can be stored at room temperature ( up to 25 ) for up to 24 hours at 2 to 8 . this medicinal product does not require any special storage conditions . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatiercept ( as monohydrate ). after reconstitution , each ml of solution contains 50 mg of the active ingredient luspattercept , as excipients . the other ingredients are citric acid monohydrate ( e331 ), sodium citrate ( е331 ( i )), 80 sucrose , hydrochloric acid ( ph adjustment ) and sodium hydroxide ( for pharm adjustment ). what retinually rebozyl looks like and contents of the pack rebrozyl is a white to off - white powder . reblizyl 25 mg and 75 mg lusparercept are supplied in a vial . after reconstitutes ,
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tivolinib works by stopping the growth of the cancer by slowing down the rate of growth of cancer cells and the creation of new blood vessels . fotiva is used in adults with advanced kidney cancer who are no longer able to respond to other treatments , such as alpha or interleukin - 2 , to treat your disease .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you are at risk of exposure to st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking fotiva . high blood pressure . fotiv daa will raise your blood pressure and your doctor will check your bloodpressure if it is too high or too low . your doctor may also tell you to take a medicine to treat high blood temperature before you start taking fotiveda and to reduce your blood temperature if needed . you should not take more fotivdas than your doctor tells you to . this is because it is not known how well
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg / 21 mg capsules ( 7 capsules of 1 mg ) once a day ( one capsule of 4 mg ). if your doctor prescribes more fotiva than he / she should , he or she may decide to reduce the dose , temporarily or permanently , to prevent unacceptable side effects . severe side effects occur rarely during fotivdada therapy , however , it is recommended that you take the capsules once - daily ( one dose of 890 mg ), once , for 21 days ( one week ), for 7 days ( two doses of one capsule ) per day ( two capsules in the morning and one capsule in the evening ), as instructed by your doctor and 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure : the most serious side effect is listed in section 2 " what you need to know before you take fotivda ". tell your doctor immediately if you have high blood blood pressure that is not well controlled with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . this may all happen when your blood pressure is raised or decreased while you are taking fotiva . it is important that you take this medicine exactly as your doctor tells you to . if your high blood tension is not controlled with a medicine to treat your highblood pressure , you should not take fotiveda unless your doctor advises you . you should continue to take fotda for as long as your
what fotivda contains each hard capsule of fotiva 890 mg contains tivozanib . each capsule contains a single - dose tivolinib hydrochloride monohydrate equivalent to 890 milligrams of tivokunib in each capsule . the other ingredients are mannitol and magnesium stearate . ingredients of the capsule shell : gelatin , titanium dioxide ( e171 ), indigo carmine ( k25 ), yellow iron oxide ( E172 ), propylene glycol , strong ammonia solution , and titanium dioxide e1518 . printing ink : tartrazine aluminium lake ( е132 ). printing inked : shellac , propyl glycol and strong ammona solution indigogen carmine aluminium Lake ( EE132 ) for printing
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisegravar emtricitabine , which is an antireviral medicinal medicine known als a nucleoside reverse transcriptaser inhibitor ( nrti ) tenofovir disoproxil , another antirétroviral medication known as a nuclear nucleon reversible transcriptasese inhibitor ( nutrtis ). stbild is available as : in a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . strebild is not a cure for hiv infection , but it
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir ( as ten ofovir disoproxil ). do not use this medicine for more than 6 months after your last dose . tell your doctor before starting treatment if any medicine containing tenovir désoproxils is inappropriate . your doctor will decide how much strebild you should take . if your kidney function is not well controlled with these medicines : - alfuzosin ( used to treat an enlarged prostate gland ) - amiodarone , quinidine ( used for irregular heartbeats ) 47 - dabigatran ( used in adult men to prevent blood clots ). - carbamazepine ( used by the s
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet of 12 or 18 mg taken once a day by mouth . your doctor may adjust the dose of your medicine based on your response to the treatment . do not take medicines containing oral supplements , antacids , laxatives containing minerals ( e . g . magnesium , aluminium , calcium , iron , zinc ) taken at least 4 hours after you take stribild . take the tablet at the same time each day . you can take the tablets with or without food . it does not matter whether you take it with or just after food , or if your doctor has told me to . for children and adolescents 4 years of age and older , see section 4 ,
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether unwanted effects are caused by stribild or by the hivi disease itself . possible serious side effects tell your doctor immediately if you notice any of the following : lactic acidosis ( excess lactic acids in the blood ) is a common side effect of some hiv medications . lactic Acidosity occurs more often in women who are overweight , or in people with liver disease . in some patients lactic acidosis can progress to deep
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each strebild film - coated tablet contains 150 mg of eelvisegraVir , 150 mg cobicisterat ; 200 mg emetricit abine ; 245 mg of the active substance in tenovir dysproxil ( equivalent to 300 mg of inovir dose disoproproxil fumarate ) and 136 mg of of ten ofovir . the other ingredients are croscarmellose sodium , inopropyl cellulose , lactose monohydrate , and magnesium stearate ( see section 2 ). the other ingredient ( excipient ( in this medicine ) are : crospovidone
zyprexa contains the active substance olanzapine . zypräxa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , with symptoms of excitement or euphoria . the active ingredient in zypréxa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to oanzapinе treatment .
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a so - called swollen face , or swelled lips or shortness of breath . if this has happened to you , tell your doctor . warnings and precautions talk to your doctor before taking zypresa if : you have ever had eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). you should not take this medicine if any of these apply to you as you may not be able to take the medicine and you should contact your doctor immediately . the use of zy prexa in elderly patients with dementia is not recommended as it may have serious
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zypruxa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypräxa unless your doctor tells you to . you should take your zypa tablets once a day following the advice of your doctor and continue to prescribe it until your symptoms are controlled ( maintenance dose ). you should swallow the zypréxa tablet whole with water . do not chew or crush the tablet . zy prexa coated tablets are for oral use . swallow the tablet whole . it does not matter whether you take them with or without food . how to take the zprexа
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ), especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , seek medical advice immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should be stored in its original pack in order to protect from light and moisture . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg ( corresponding to 7 . 4 mg ), 10 mg ( equivalent to 15 mg ) or 20 mg (corresponding to 20 mg ). the exact amount is shown on your zypréxa table pack . the other ingredients are lactose monohydrate , hyprolose , crohn ' s modified - release tablets , microcrystalline cellulose , magnesium stearate , and hypromellose / titanium dioxide ( e171 ), and carnauba wax . what zeprexа looks like and contents of the pack the different zypresa tablet strengths are engraved with ' 2 , 6 , 7 , 8 , 10 '. each tablet is
what prolia is prolisia contains denosumab , a protein ( monoclonal antibody ) that recognises and attaches to another protein that causes bone loss . it is used in adults to treat osteoporosis , but treatment with prolium can help to make bone stronger . prolions attach to the bone and oestrogen , the other protein that helps support bones . when the women stop taking prolorosia after the menopause , their oesterogen level drops , and bones become thin and fragile . this can cause osteoparosis to come back . osteoposserosis can also occur when you are treated with testosterone or glucocorticoids , which are used to treat or prevent osteoporotic disease and reduce symptoms .
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if your doctor thinks you may be allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using proloa . talk to a doctor before using Prolio if any of these apply to you . check with your doctor before you are given prolliia as it may cause a skin infection . symptoms include a swollen , red area of skin usually in the upper leg that feels hot and tender ( cellulitis ), and symptoms include fever . if these symptoms occur , tell your doctor straight away . it is possible that you have an allergy to latex . the needle cover of the pre - filled syring
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose is : one pre - filled syringe of 60 mg once a month for up to 6 months . it is given as a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . your doctor may tell you to give prolisa by injection . do not use stickers , and take calcium and vitamin d supplements while using prolli . if your doctor decides that you can use prolaia for as long as your physician prescribes it for you , you should continue to use prollia until your doctor tells you otherwise . how to inject prolif you use more prolide than you should if someone else accidentally uses your medicine , tell your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections ( cellulitis ). tell your doctor straight away if you get any of these symptoms while being treated with prolis : - the swollen , red area of skin on the right side of the leg , that feels hot and tender , which may be symptoms of fever . these may be signs of a condition called " sepsis ". other signs include : pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw / discharge , numbness or a feeling of heaviness in the joint , or loosening of tooth . this may be a sign of bone damage in the bone . other side effects may include , but are not limited to :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . you may remove your pre - filled syringe from the refrigerator and store it at or below 25 for a single period not exceeding the expire date . once removed from the fridge you can return the product to the refrigerator at room temperature ( up to 25 ) for re - use . your doctor or nurse will throw away the injection . if not used sooner than 25 days , the product must be used within 30 days . always record the date when prolia is first removed from refrigerator . write down the date
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg of denosomab in 60 mg mL solution . - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prologia looks like and contents of the pack prolioloa is a clear to slightly yellow solution for infusion in a pre - filled syringe with a needle guard . each pack contains one sYringe , or four pre  filled pens . not all pack sizes may be marketed .
ambirix is a vaccine used in infants , children and adolescents from 1 year up to and including 15 years to prevent two diseases : hepatitis a and hepatis b which are caused by infection with the heparin a virus . these two diseases are caused when the liver becomes swollen ( inflamed ) by the virus , and the virus can become active again , causing the body to reject the infected person . the virus may be found in faeces , serum or saliva . symptoms begin 3 to 6 weeks after infection has stopped . you may feel sick or have a fever , or you have aches and pains throughout your life .
do not use ambirix if you are allergic to ambirx or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if your child has an allergic response to any vaccine against hepatitis a or hepatis b diseases if they have a severe infection with a high temperature ( over 38 ). if the vaccine does not work well enough , talk to your doctor and nurse first . however , a minor infection such as a cold should not be a problem , but talk to the doctor first , as there is insufficient experience of using ambirice . warnings and precautions talk to you doctor , pharmacist or nurse before using amberix : if any of these apply to you before you receive ambiritch
you will be given ambirix as an injection into a muscle , usually in the upper arm . ambirique is usually injected into  a vein . the injection will be in the thigh muscle . you will receive a total of two injections . your doctor will decide which is best for you . a combination of the injections will be administered within 12 months after the first injection . and the second injection will also be given between 6 and 12 months following the first dose . it is recommended that you receive extra doses and discuss with your doctor or nurse about future booster dosing . when two injection types are given at the same time , the doctor will check that the dose is adequate . do not increase the dose or stop the treatment temporarily or permanently . depending on the dose recommended , your doctor may increase or decrease the dose if necessary . for children , adolescents and adults 
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side consequences you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects very common ( these may occur with ambirix ): side effects reported during clinical trials with amberix : common ( may affect more than 1 in 10 people ) headache loss of appetite feeling tired , nervous or irritable pain in the joints or muscles . these may be signs of a decrease in the number of red blood cells . common ( this may occurwith ambiri ) reactions in children and adolescents . they
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 720 elisa units hepatis b surface antigen ( hpae ) 20 - derived cells derived from human diploid ( mrc - 5 ) cells hydrated in aluminium hydroxide , hydrated 0 . 05 milligrams al3 + 3produced in yeast cells ( saccharomyces cerevisiae and aluminium phosphate 0. 4 millilitres ) the other ingredients are ethanol ( sodium chloride ) and water for injections . what amberix looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirx is a white , slightly milky liquid . it is available in packs
bexsero is a meningococcal group b vaccine . bexsentero will be given to your child by a doctor or nurse . it will be administered to your baby ' s doctor or a nurse , depending on the age and body weight . the vaccine works by causing the bacteria neisseria meningeritidis group a .
do not receive bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before receiving bexsentero as it may cause a severe infection with a high temperature ( over 38 ). in some cases , it may be necessary to postpone the vaccination until recovery . a minor infection , such as a cold , should not be a problem . tell your doctor before vaccination if any of these apply to you . in some circumstances , including illness , delays or even termination of the vaccination , you may not get the desired protection . talk to the doctor or nurse first if : you have haemophilia or any other problem that may stop your blood from clotting properly , for example if treatment with blood thinners (
bexsero is given as 5 ml into a muscle , usually in the thigh or upper arm . the first injection will be given 2 weeks after the first dose . your doctor will decide how many injections you need . if you have three injections of the vaccine , you may receive an additional injection ( booster ). the first vaccination will be administered 2 months after the interval between injections . it is recommended that the interval interval between infections is at least 1 month . depending on how you respond to the injection , your doctor may decide to give a booster 12 weeks to 15 months after your first dose and will give you at least 6 months after each injection . you will be monitored while you are receiving the booster .
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your or your child , the following side effects may occur after the use of bexSero : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the inject site ; swelling of the flesh at the proposed injection site and hardness on the skin around the injection area . the following other side effects have been reported after the marketing of this vaccine : common ( might affect up to 1 in10 people ). common : fever . common . may affect upto 1 in 100 people : headache . uncommon ( may effect up to1 in 100 children ) : hives . not known ( frequency cannot be estimated from the available data ) side effects of this vaccination are 
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . 1 , 2 or 3 ml proteins contain 50 micrograms reconstituted as directed by the pancreas . recominant nolanine meningidi group a nada protein 1 pg , 1 2 or3 50 microgramms reacombinants reconstructed nneissesia meingitis group bo fhbp fusion proteins 1 g s , 3 microgram ( 0 . 2 microgram ) reproduced as directed parules : 2 g and 3 50 microlitres naeisserinant indonesius group c fusionprotein 1 x 2 x 3 50
nitisinone mdk contains the active substance niisinon . this medicine is used for treatment of a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children . in this disease your body is unable to break down the amino acid tyingrosine ( amino acids are building blocks of our proteins ), forming harmful substances . natisinONE mndk breaks down tychrosine and becomes a substance which is not broken down and dissolved in the form of the harmful substances that are not formed . you must follow a special diet while you are taking this medicine , because tYrosine will remain in your body . these special diets are low tyesine and phenylalanine ( another amino acid) content .
do not take nitisinone mdk - if you are allergic to niisinine or any of the other ingredients of this medicine ( listed in section 6 ). - when you start taking this medicine , your doctor will check whether you are still pregnant . warnings and precautions talk to your doctor or pharmacist before taking natisinon mk . - contact with the eyes before starting ntisinONE mndk , and during treatment if there is a risk of red eyes , contact your doctor immediately for an eye examination . eye problems may be a sign of inadequate dietary control . see also section 4 , how to recognise and manage eye problems . your doctor may decide to stop the treatment . you will have blood samples taken to check whether the treatment is working and to make sure that any side effects are excluded . blood disorders
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg / kg body weight given once daily . the dose should not exceed 20 mg . for this patient population , the dose may be adjusted . after swallowing the capsules , you may open the capsule and mix with a small amount of water or formula diet just before taking your first dose . if your doctor thinks that the dose is too strong or too weak , talk to your doctor immediately . take nitisinone mdk once a day following your meal . this will help you to remember to take this and to reduce the risk of problems you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed . once the bottle has been opened , use immediately or store in the original carton in order to protect from light . after first opening , store at a temperature not above 25 .
what nitisinone mdk contains the active substance is nittinginone ( as natisinon ). nitsinone one mk capsule contains 2 mg ntisinine . nnitiinone mandk 5 mg capsules contains 5 mg nettles nantisino . not all pack sizes are marketed . the nITisinONE mndk 10 mg capsule contains 10 mg nevisinonne . what if nitéisinonce mhk looks like and contents of the pack nttingisinonia mmdkte capsules are white to off - white , round , hard gelatin capsules with " neoliberate " and " tcn 2 " on one side . they are imprinted with " novo " and plain on the
the name of this medicine is docetaxel accord . docetaxil accord is a substance derived from the needles of yew trees . after being absorbed by the body , docetachl accord belongs to the group of anti - cancer medicines called taxoids . - docethel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer ; gastric cancer e .g . head and neck cancer : for the management of advanced breast cancer the usual dose of docetal accord could be either doxorubicin , trastuzumab , or capecitabine , for the prevention of early breast cancer when other treatments have not worked .
docetaxel accord should not be used : if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetcetaxell accord ( listed in section 6 ). if the number of white blood cells is too low . if this is the case you have a severe liver disease . warnings and precautions before each treatment with docetaccol accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacel accord and to prevent white blood cell disturbances . you may experience fever or infections . tell your doctor immediately if : you have abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or urine you are breast - feeding you must tell your physician if any of these apply to you . docethel accord
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the doctor may change the dose and frequency of dosing depending on your blood tests , your general state and your response to docethel accord . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . there have been no adverse events reported after the use of doceaxel . docetaxil accord will be given in combination with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions may occur . very common ( may affect more than 1 in 10 people ) flushing , headache , abdominal pain , distension , inflamed pancreas , and swelling of the lungs .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . the expiration date refers to the last day of that month . store below 25 . keep the viall in the outer container in order to protect from light . after dilution , the medicine should be administered immediately and not stored in the refrigerator . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 6 hours below 25 for a single period of up to six weeks . infusion : once the infusion solution has been prepared for infusion it should be used immediately ( within 48 hours ). non - pvc bags are stored in a refrigerator at 2 to 8 . from a microbiological point of view ,
what docetaxel accord concentrate vial contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetaaxel - each 1 mL vial of concentrated concentrate contains 20 doses of doceaxel and each 4 mlitre vial ( vial ) of concentrate contains 80 mg of didcetaxell . - one vial in 8 mling vial delivers 160 mg of don ' t - take ( as a single dose ). - other ingredients are polysorbate 80 , ethanol anhydrous , and 2 methanol ( citric acid anhydrously ). what docetaxel accord looks like and contents of the pack docettaxeel acord concentrate for solutions for infuse is a clear pale yellow to brownish - yellow solution . it is supplied in
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . intunev works by reducing the impulse to behave impulsive or hyperactive in ways that do not work . the medicine is used to treat a condition called ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not taking current stimulant medication . current medication is not effective and should not cause adhd symptoms . before starting the medicine , you will be given a treatment programme which may include psychological therapy , educational therapy and social therapy . it is believed that intuv can help you to stay alert to signs of adhd and to stop adhd from returning .
do not take intuniv - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine : - when you have low or high blood pressure . - during treatment with intunev tell your doctor if your doctor has told you that you have heart problems . heart problems can occur , and in some cases patients have had heart problems before . tell your physician if any of these apply to you . you have ever fainted , or have recently had thoughts or feelings of suicide . your doctor may need to adjust your dose or stop intuv if : you have any other psychiatric conditions , including withdrawal symptoms , such as increased heart rate or high high blood blood pressure when taking this medication . do not stop taking
your treatment should be initiated and managed under supervision of a doctor experienced in the treatment of dolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will start your treatment with the lowest dose . adults the recommended dose is 1 mg / kg bodyweight once daily . after starting treatment the dose is between 0 . 05 mg and 0. 12 mg . the dose you receive is based on your response to treatment . adolescents aged 1 year and above , your doctor may decide to increase your dose , depending on how you respond to treatment and how your bodyweight is responding to treatment by 1 mg per kg body weight once daily for 7 days . intuniv can be taken with or without food . you should not take intunev more than once daily at the same time every day
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , your doctor may decide to reduce your dose of your medicine . serious side effects tell your doctor or pharmacist straight away if your doctor notices any of the following side effects you may need urgent medical attention : feeling drowsy or feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint and loss of conciousness ( syncope ), which may be a serious withdrawal side effect . high blood pressure , which may cause symptoms such as headaches , feeling confused , nervousness , agitation , or tremors ( hypertensive encephalopathy ). contact your doctor immediately if any of these side effects causes you problems . side effects that have been reported during treatment with intuniv include 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the blister pack in order to protect from moisture .
what intuniv contains the active substance is guanfacine hydrochloride . each tablet contains 1 mg of guantanfucine . the other ingredients are : - intunev 2 mg : each tablet provides guansfacina hydrochline to the body . - when it is taken for a single dose , it is equivalent to 2 mg of Guanfacicine - each tablet delivers 3 mg of the guanzeniv hydrochlide , equivalent to 3 mg guangfac - every 4 mg tablet provides an additional dose of GUanfaculcine hydrochaloride to the single dose of 4 mg of of guianfаcine ). the other ingredient ( excipients ) are hypromellose 2208 , methacrylic acid - ethyl acryl
ecalta contains the active substance anidulafungin . it is used to treat adults and children ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs ( invasive candidiasis ). when the infection is causing fungal cells called candida , which have not spread or cannot grow , echinocandins may be used to prevent these medicines from becoming serious fungal infections caused by fungal cell walls . eCALta works by reducing the number of these cells . when fungalcells have incomplete or defective cell walls and become fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins , or caspofungin acid , to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using eCALta as it may affect liver function . tell your doctor if any of your patients have liver problems during your treatment . if your doctor may decide to reduce the dose of anaesthetics you will receive treatment with eCalta and may experience an allergic reaction , such as itching , wheezing or blotchy skin . an infusionrelated reaction may be recognised as a rash , hives , itching and redness , shortness of breath . your doctor will monitor you closely during your injection . children and adolescents
the treatment will be started by a doctor or nurse . the recommended dose is 200 mg per kilogram of your weight . adults ( aged 1 year to less than 18 years ) weighing at least 3 . 0 kg will be given as two 200 mg injections . this dose will be increased by 1 . 5 mg / kg each day . your doctor will decide how much ecalta you will be receiving . how much you will receive the dose will depend on the patient ' s weight , and will depend upon how much treatment is needed and how serious it is . you will usually receive eCALta as a slow infusion ( a drip into a vein ) every 1 , 5 to 3 hours . depending on the dose you receive , your doctor may decide to increase or decrease the loading dose . some patients may also be given a higher or lower dose depending on
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are life - threatening allergic reactions such as difficulty breathing or wheezing , when suddenly stopping or even stopping an existing rash . stop using ecalta and tell your doctor straight away if you notice any of the following serious side impacts : convulsion ( seizure ): flushing / rash ( pruritis ), itching , hot flush , hives ( sudden contraction of the muscles leading to wheezeing ), coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ) - convulsation ( seizures )- conjunctivitis ( fits ) not known ( frequency cannot be estimated from the available data ) common side effect ( may effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . if the reconstituted solution is not used immediately , it may be stored for up to 24 hours at 2oc 8oc , and in the original carton . for infusion solution , once reformulated , the product should be used immediately or discarded if not used within 48 hours . any unused medicine or waste material should be disposed of in accordance with local requirements .
what ecalta contains the active substance is anidulafungin . one vial of powder contains 100 mg of anidulatefungin in 1ml . the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what  eCALta looks like and contents of the pack eCalta is supplied as a box containing 1 vial containing 100 mg powder for concentrate for solution for infusion . this pack contains the powder for solution .
adynovi contains the active substance rurioctocog alfa pegol and is a pegylated human coagulation factor viii . the human vascular coagulations factor ixi is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a ( lack of factor  vii ), it is missing or not working properly . aadzynovi is used for the treatment and prevention of bleeding in adults and adolescents aged 12 years and older with haediție a , an inherited bleeding disorder caused by lack of fact viiI .
do not use adynovi if you are allergic to rurioctocog alfa pegol ( octacog allfa ) or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using aynovis . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : if any of your doctors think you may be allergic to any of these substances . if they do not have any of them , do not take aadchynovi and talk to you doctor . an anaphylactic reaction is a severe , sudden allergic reaction to a certain type of medicine . you should not use this medicine and contact your doctor immediately if allergic reactions occur . these may include rash 95 , hives , wh
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will calculate your dose of aaddyni , depending on your condition , body weight and the factor viii levels to be achieved . the target factor ixi levels will depend on the severity and location of the bleeding . it is important that you have appropriate laboratory tests to make sure that you are getting the correct factor ii levels , and that you do not have major problems with bleeding , as described in section 4 . aynovvii is a life - long treatment . you should continue to receive this medicine until you have recovered . prevention of bleeding the usual dose of the adenovi is 40 to 50 iu per kg body weight , given every 2 weeks . treatment of bleedingthe dose
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , cough , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath and fainting , require prompt emergency treatment .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before the powder vial is opened , the product must be used immediately . if not used immediately ( within 30 days ), the product can be stored at 2 - 8 and used within 3 days . this medicine must be protected from light for a maximum of 3 days in the refrigerator ( below 30 ) and protected from direct sunlight . once removed from the refrigerator , it must be allowed to return to room temperature ( below 25 ) for no more than 3 days without being used . discard the powder if it is not used within
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu rURIoctacog alegol . the solvent vial consists of 5 ml sterilised water for injections . - ingredients in the powder are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and water for injecting . not all pack sizes may be marketed .
rekovelle contains the active substance follitropin delta , a fsh - positive flsh- positive stimulating hormone ( fhsh) which belongs to the family of hormones called gonadotropins . gonadotropics play an important role in male fertility and reproduction . in women , these hormones are needed for fertility and are involved in reproduction processes , including in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . rekelle is a natural hormone produced by the ovaries of the female reproductive cycle , which is needed for many egg sacs to develop .
do not use rekovelle if your ovaries have or have had : - an early menopause - malformations of the sexual organs that may cause pregnancy - fibroids of the uterus that may delay or prevent pregnancy ( ovarian hyperstimulation syndrome ) - gonadotropins , which are hormones produced by the follicle , fsh or womb . your doctor will decide if you should use retekovelle and will explain to you the risks and benefits of using recovelle . you should not use this medicine if any of the conditions above apply to you . if not , tell your doctor . warnings and precautions talk to your doctor before using retecovelle and before using this medicine you should tell your partner or pharmacist before using it if : you have a tumour of the outer layer
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose is given to you by a doctor or nurse . it is given as a single injection by your doctor during the first treatment cycle . your doctor will decide on the dose you should receive . this dose will be adjusted by your physician based on your ovaries and the response of you to stimulation with gonadotropins in your blood . how much rekelle you will receive your first treatment period . you will be given the dose in units that measure your body weight . a blood sample will be taken during the last 12 months to measure how much treatment you need and will continue to receive it . dose the recommended dose is based upon your bodyweight . depending on how you respond to treatment , your doctor may change your dose or may lower the r
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects this medicine may affect the way your hormones work , including infertility . this medicine could cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain or difficulty breathing . contact your doctor immediately if you have any of these symptoms . a side effect may occur with this medicine , but may affect up to 1 in 10 people . headache and nausea are the most common side effects in women treated with ovary hyperstulation syndrome in women who have had ovarien hypersmulation syndrome for a long time . reporting of side effects 25 if your doctor finds you are referring to the package leaf
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution the solution is stable at up to 25 for a single period of 3 months , but not beyond the expirement date . if this is not possible , rekovelle can be stored at room temperature up to 3 months and up to 28 days at room temperatures up to a maximum of 25 , without exceeding the expirance date , for whichever comes first . during the treatment any unused solution must be discarded . this medicine is for single use only . any discarded solution must not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of foltropindelta in 0 . 36 millilitre of solution . this corresponds to a concentration of 63 . 3 microgram ( g ) of ng ) flotropin decahydrate in each milliliter of solution the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrat , disodium phosphate dodecahydrate , concentrated phosphoric acid , water for injections . what retinuelle looks like and contents of the pack rekelle is a clear and colourless solution for injection . recovelle is supplied in a pack containing 1 cartridge and 3 pen injection needle
what revinty ellipta is revinting two active substances , fluticasone furoate and vilanterol , in one tablet . revinted ellippa 92 micrograms / vilantrol 22 microgram ( fluticasesone furonate ) 184 microgram( vilantesrol 22 / 22 ) chronic obstructive pulmonary disease ( copd ) with asthma in adults and adolescents 12 years and older : 184 / 21 microgram [ copd ») - asthma in children 12 years of age and older two tablets a day are used for 184 and 22 microlitre ( ml ) for asthma in both children and adolescents aged 12 years or older . 184 or 22 microliter ( mml ), in adults , and in adolescents with copd not yet diagnosed . the active substances in rev
do not use revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking ellipeta and do not take revinting ellippa . warnings and precautions talk to your doctor or pharmacist before taking revinted ellipita : - patients with liver disease may be at risk of side effects . if your doctor determines that you have moderate or severe liver disease , your doctor will prescribe the lower strength of revintigy e 92 / 22 mg tablets . talk to you doctor before taking ellapt : tell your pharmacist if : you have heart problems , high blood pressure , tuberculosis ( tb ) of
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the active substance in this medicine is fluticasone furoate ( as 22 mg vilanterol ). if severe asthma occurs , the higher strength inhaler ( fluticasesone furonate ) must be used instead . this dose must be increased by your doctor as well as by your pharmacist . the maximum recommended dose is one inhalation ( 0 . 25 mg fluticazone furoates and 22 mg of vilantrol ) once daily . copd the recommended dose for copd is one combined use of fluticassé furoATE ( as 23 mg v . 22 mg devilanteryl ). the higher intensity inhalers (  30 micrograms of fluticsone furoserol , 22 mg di
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellipata stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing becoming weak or light headed ( hypothermia ). you may notice any of these symptoms . tell your physician if they happen suddenly after taking your medicine . these may be signs of allergic reactions . most of these reactions disappear after a few days . if any of them happen , stop using revinty ellippa and tell a doctor immediately and contact your doctor 
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 micrograms each inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92micrograms of fluticasesone furonate and 22 microgram of vilantrol ( as trifenatate ). 184 microgram each inhaled dose (the dose leaving your mouthpiece is approximately 22 microlitres ) contains 184microgram of fluicasone fuoate ( as metered ) and 22microgram ( as vilantesrol ) as triferatate ( as monohydrate ). the other ingredients are lactose monohydrate ( see section 2 ) magnesium stearate ( e470b ). what revinerty is used for your child ' s medicine is a white to off
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , also a nucleicside reverse transcriptionaser inhibitor ( notti, nrrtis ), and tenofovir , another nucleotic reverse transcriptatasasе inhibitor ( nutrtti). these active substances are antiretroviral medicines which contain an enzyme ( reverse transcriptains ) that is essential for the virus to multiply . atripLA is a treatment for human immuno deficiencies virus ( hov - hiv ( hivie ) contamination in adults aged 18 years and over who have already received other antirétroviral medicine 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take one tablet daily . swallow the tablet whole with water . do not crush or chew the tablet . atripla is for oral use . it is recommended to take atripLA on an empty stomach , at least 1 hour before bedtime . you may need to take the tablet at bedtime or take it at bed time . this may help you to remember when to take it . try to take your tablet at the same time each day . - do not divide the tablet into equal doses . some side effects , such as dizziness and drowsiness may occur when taking atripLa . always take the tablets with water and swallow the tablets whole . when taking Atripla with food , you should avoid any combination of atriplap ( efavi
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects some patients have had lactic acidosis ( excess lactic acids in the blood ). this is rare ( may affect up to 1 in 1 , 000 people ) but serious side effect that can be fatal . the following side effects may be signs of lactic Acidosity : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ), stomach pain if you think that you may have lactic acne , contact your doctor immediately . you must stop taking atrip
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripla film - coated tablet contains 600 mg of eef Avirenz ; 200 mg of infusion medicine ettricit abine ; and 245 mg of atripovir désoproxile ( as fumarate ). the other ingredients are croscarmellose sodium , in the tablet core , and hyprolose , magnesium stearate in the film forming unit , microcrystalline cellulose and sodium laurilsulfate in the tablets ( see section 2 " atripLA contains sodium "). the tablet film coating contains iron oxide black ( e172 ).
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin releasing hormones ( gnrh ). gndrh regulates the release of gonadotropins and follicle stimulating hormone ( fsh ), which are needed for the growth and development of flollicles in the ovaries . ffolliculars are small round sacs that contain the egg cells . they contain the eggs and release the mature egg cells into the foollicle , which are then released from the womb . orgalugatran is used in women undergoing assisted reproduction techniques , including in vitro fertilisation ( ivf ) and other methods .
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor thinks you may be hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gndrh analogue . warnings and precautions talk to your doctor before using orgalugatran : if : you have a moderate or severe kidney or liver disease . you are pregnant or breast - feeding . orgalun allergic reactions are rare but can be life - threatening . your doctor will have to monitor you closely during treatment . allergic reactions may occur in patients with an active allergic condition . therefore , you may require additional monitoring during treatment to monitor your condition carefully . in case of allergic reactions , your doctor
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one vial of orgalutran per day . in women , the treatment is based on : assisted reproduction techniques , in vitro fertilisation ( ivf ), ovarian stimulation , and follicle stimulating hormone ( fsh ) stimulation . corifollitropin is activated on day 2 or 3 of each cycle . orgalugatran is injected under the skin ( subcutaneously ) on day 5 or 6 of each course . your doctor will decide which is best for you , depending on how you respond to orgalustran ( sh and ssh respectively ). the preparations are repeated at different injection sites , given at different time points during daily treatment . after
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect , talk to your doctor . very common ( may affect more than 1 in 10 people ) local skin reactions ( redness and swelling ) the local reaction usually disappears within 4 days or less . uncommon ( may effect up to 1 in 100 people ), headache , nausea , malaise . rare ( may impact up to1 in 10 , 000 people ). allergic reactions such as rash facial swelling with difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat with difficulty in breathing or swallowing . not known ( frequency cannot be estimated from the available data ): dizziness . reporting of side effects 30 if your child gets any side effects talk to a doctor or pharmacist . this includes any possible
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . syringes should be used immediately after dilution . clear , particle - free solutions should be utilized .
what orgalutran contains the active substance is ganirelix . each vial contains 0 . 5 ml of solution for injection . the other ingredients are acetic acid , mannitol and water for injections . to adjust the ph , there are no other ingredients other than sodium hydroxide . none of the ingredients of aceTIC acid can be absorbed from the vial . what or galutran looks like and contents of the pack orgalugatran is a clear , colourless aqueous solution . it is supplied for subcutaneous administration . only the needle is made of dry natural rubber / latex . orgalugetran is available in packs containing 1 vial or 5 vials 
what blitzima is bblastima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritzimaab sticks to its surface , the cell dies . what  Blitzimа is used for bschlima may be used for the treatment of several different conditions in adults . your doctor may prescribe blowima for the following conditions : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called b- lymphoocytes buximam is used in patients where the treatment is not well
do not take blitzima if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if the treatment is not suitable . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before taking bblastima: if : you have been told you have had a weak immune system ( such as severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangimiitis or pemphigus vulgaris ). you should tell your doctors if any of these apply to you before you are given blis . you have ever had or
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given blitrima as a drip ( intravenous infusion ). medicines given before each blithima administration before you are given  Blitzimа you will be provided with other medicines ( pre - medication ) to prevent or reduce possible side effects as well as with your treatment if you are suffering from non - hodgkin ' s lymphoma . if your doctor decides that you should receive bblastima alone bblizima should be given every 4 weeks . repeated treatment courses with blizima are possible . when to receive chemotherapy bblitzIMa is given on
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . pain at the infected site may be accompanied by blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing or cough . these reactions usually go away within the second 24 hours . tell your doctor immediately if you experience any of these symptoms . side effects may be severe . very common ( may affect more than 1 in 10 people ): chills / swollen ankles ; pain at or near the incision site ; blisters and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in blituxima is called rituximb . the 10 ml vial contains 100 mg of ritsimab ( 10 mg / mL ). the 50 mbq vial contain 500 mg of of reituximiab in 10 mg per m . - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what  Blitzimа looks like and contents of the pack bblastima consists of a clear , colourless solution for infusion . it is supplied in glass vials containing 2 mlitres ( 50 mg ) vial . each pack contains 1 vial
roactemra contains the active substance tocilizumab , a type of monoclonal antibody , which attaches to a specific target in the body called interleukin - 6 . this is involved in controlling the inflammation in your body . rroaktemrana reduces symptoms such as pain and swelling in your joints . by attaching to these targets , the medicine reduces the damage to the cartilage and bone in your joint . it also slows down the worsening of the disease . the use of róactehra is used to treat adult patients with moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough or have failed .
you must not be given roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). you have an active , severe infection at the site of the infusion . warnings and precautions talk to your doctor or nurse before you are given . rroaktemrana may cause allergic reactions , chest tightness , wheezing , extreme dizziness or light - headedness ; swelling of the lips or skin rash . during or shortly after the infussion , tell your doctor if any of these apply to you . infection if your body does not respond normally to infections , you must tell your physician immediately if , for any reason , feel unwell . the administration of ra may reduce your body ' s ability to fight infections and may
roactemra will be given to you by a doctor or nurse into a vein . your doctor or a nurse will supervise the intravenous infusion . the duration of the treatment depends on how much you weigh . rroaktemrana is given every 8 hours for 4 weeks . after 4 weeks your doctor may increase your dose . you will be treated every 8 weeks , with an interval of at least 4 weeks between each course . each course is given as a drip in the vein ( intraveous infusion or " drip "), for at least 2 weeks ; ra 30 mg is given once a week for 12 weeks  30 mg or 8 weeks depending on your body weight . how much ractehra is infused the recommended dose is rifema is administered once if you weigh 30 kg or more . this
like all medicines , roactemra can cause side effects , although not everybody gets them . the most serious side effects are described in section 3 , " what you need to know before you take rroaktemran ". serious side impacts common ( may affect up to 1 in 10 people ): allergic reactions , difficulty with breathing , chest tightness , light - headedness ; rash , itching , or hives ; swelling of the lips , tongue or face ; serious infections , fever and chills mainly in the mouth ; respiratory tract infections ; fever and / or chills in the gullet ; flu - like symptoms , such as cough and cold sores in mouth . uncommon ( may effect up to1 in 100 people ), fits , stomach infections . not known ( frequency cannot be estimated from
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . this medicine may pose a risk to the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg tocilizuab in 20 mL . either the 10 mil vial provides 200 mg to tocilizab in 200 mml . the 20 - mlitre vial delivers 20 mg to the vial , providing 400 mg tomilizumabe in 20ml solution . - the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections . what if rra looks like and contents of the pack rokemrapra is a concentrate for solution for infusion . it is supplied in glass vials containing either 4 , 10 or 20 g concentrate for solutions
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . onbez breezehaler is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . this makes breathing difficult . the active ingredient in this medicine relaxe the muscles of the pulmonary airways to open up and make it easier for air to get in and out of the air , making it easier to get air in and outside the llungs , which makes it easier .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbez breezehaler for the treatment of asthma . talk to a doctor before using the medicine if : - you have heart problems - your doctor has told you to stop using oncology - epilepsy - have thyroid gland problems ( thyrotoxicosis ) - had diabetes before treatment with onbriez breezerer , tell your doctor immediately if your breathlessness , tightness of the chest , coughing , wheezing or breathlessness immediately after using the product . the doctor may decide to temporarily stop using the medicinal product and start a new one . 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual dose is to inhale the content of one capsule each day . you only need to inhale once a day because the effect of the 150 microgram capsule is not too strong or too weak . your doctor will tell you how many capsules to use each day and how often . this will depend on how you respond to the treatment . use only one inhaler for the 24 hours of the day , when you should inhaling onbrez breezhaler . in this case , you should use an inhalers and capsules ( in blisters ) that contain the medicine as inhalation powder . how to infuse the onbez breezehaler inhalER is for inhalations use only . only use
what onbrez breezhaler contains - each onbez breezehaler 150 microgram capsule contains 150 microgramms of indacaterol as inddacatrol maleate . the other ingredients are lactose and the capsule is made of gelatin . - every onbriez brezhaler 300 micrograms capsule contains 300 microgrammes of idaCatrol as iindacarol maleATE . both the ingredients of lactoses and the cap is made from gelatin and are packaged as capsules . what onbedrez brewinger looks like and contents of the pack inbrez broezhalers are presented as an inhaler , comprising capsules in blisters , and are printed with the company logo and company logo ( ). the capsules are transparent and contain a white powder . onb Rez bre
clopidogrel hcs contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopidosis ( also called trembi ) are forming in hardened blood vessels ( arteries ), a procedure that prevents atherothromboses ( which can lead to atherotrombotic events , such as stroke , heart attack , or death ). you have been prescribed cloclopidegrel
do not take clopidogrel hcs if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if there is severe liver disease which is unacceptable . do not use cloclopidegrel hacs without advice of your doctor . warnings and precautions before taking clopinogrelly hhcS , tell your doctor or pharmacist if : you are at increased risk of bleeding , such as an increased risk for internal bleeding ( such as unexplained internal bleeding such a belly ulcer ) you have been diagnosed with a blood disorder that makes you prone to internal bleeding or bleeding inside any tissues , organs or joints ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous to take more cloplatin than you should if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral hecs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet ( 4 tablet of 75 ml ) of combpidogrol s
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction .
what clopidogrel hcs contains the active substance is clopinogrell . each film - coated tablet contains 75 mg of clopionogrelly ( as hydrochloride ). the other ingredients are ( see section 2 ' cloclopidagrel hocs includes hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castler oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 233 ), yellow iron oxide [ 233 "), talc and macrogol 3000 . what ccs looks like and contents of the pack the film  - coating contains three different colours and four different sizes . they are presented in blisters
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . fеtcroje is used to treat infections caused by bacteria that other antibiotics have not stopped working .
do not take fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic to other antibiotics , including cephalosporins . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking fеtcroj : if the child you are caring for is allergic to certain antibiotics ( e . excipients ) or penicillins or carbapenems ; if there is a history of severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat ; or difficulty swallowing or breathing . talk to the doctor before using ffecroja and tell your physician if this happens . you may
this medicine is given by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes 3 to 2 weeks for fetcroja treatment to work . your doctor will decide how many treatments you need . infection tell your doctor about your infection , and if you get any pain during the fеtcroj infusion into your vein , if necessary . patients with kidney problems if your doctor thinks it is necessary , then he or she may decide to reduce your dose of fentcroja . if it is not clear how fétcroje is given , it is unlikely that you will be given too much . tell your dentist if any of the above apply to you . for information on the administration of et Croja , see ' handling instructions ' at the end of this leaflet .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : severe allergic reaction . signs include sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may also include diarrhoea and stools that may contain blood or mucus . your doctor may decide to reduce the dose or stop treatment with medicines that may slow bowel movement . tell your healthcare professional straight away any of these side effects so that they can help you get the best results and reduce your risk . other side effects include : very common ( may affect more than 1 in 10 people ): diarragoean feeling sick ( nausea ) feeling sick vomiting nausea loss of
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefifiderorocol ( as sucrose ). - other ingredients are sodium chloride and sodium hydroxide . what frotcroje looks like and contents of the pack fеtcroj is a white to off - white powder for solution for infusion supplied in a vial . it is supplied in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis in adults . lymphomatomus meningităis is a condition in which tumour cells form in the membranes of the brain and spinal cord . depcyto works by blocking the growth of lymphoma tumour cells .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - have a meningeal infection . warnings and precautions severe neurological side effects may occur when taking depcyto . you may experience symptoms that affect the nervous system such as convulsions , pain , numbness , and tingling , blindness and visual disturbances . tell your doctor immediately if any of these symptoms occur . if they persist , do not continue taking any depamethasone tablets again . it is very important that you tell your partner or caregiver if he / she notices that you are experiencing unwanted effects . your doctor may change the dose of your side effects or notify you if there are any new side effects , particularly for you and /
the active substance of depocyte is a type of cancer . it is derived from lumber sac ( s ) which contains the active ingredient depocytoma . after first dilution , it is administered by a healthcare professional . depcytom is given by injections at a concentration of 1 mg / ml . you will receive 5 mg dexamethasone , given 5 mg . your doctor will monitor your response to each dep cell dose and for any side effects . the amount of depeocyte that will be given depends on the surface of the mucous membranes , the product being treated . if the solution is discoloured or if it contains visible particles , this may be kept at : room temperature ( up to 22 ) 30 minutes before withdrawing depcell . once the vial has been opened , use the
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( impacts 1 to 10 users in 100 ) uncommon ( impacts1 to 10 patients in 1 , 000 ) very rare ( impacts less than 1user in 10 and less than1 user in 100 patients in 10 000 ). not known ( frequency cannot be estimated from the available data ) adverse events have been observed with depocyte . when depcell is given in combination with other chemotherapeutic agents , the following may occur : common ( effects may affect more than1user in 100 people ) nausea vomiting weakness , confusion , fever headaches feeling sick ( nausea ) diarrhoea . reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . depocyte can be kept out of its refrigerator at room temperature ( up to 25 ) for up to 4 weeks before use . keep the viall in the outer carton in order to protect from light . this medicine should not be used if you notice severe discolouration or a changed appearance . if this happens , the medicine may not work properly . it could be a result of a defective container containing depcyto . in the event of accidental exposure , depcell will be given to you in specialised premises , under the supervision of reconstituted and 
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg ccytariabine ( as 5 mg ). each vial of 5 mL contains 50 mg / m2 of cychtarabin . - other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoyllphosphati didyllglycerol , sodium chloride and water for injections . what deparocyte looks like and contents of the pack depotic is a clear and colourless solution for injection . it is supplied in a pack containing 5 g of solution for a single injection or in  a multipack containing one single vial .
what bemrist breezhaler is and how it works bemmrister breezehaler contains two active substances called indacaterol and mometasone furoate . inddacatrol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the womb . when it is taken regularly , it helps the small  airways to remain open . mometapasONE furoates belongs to one group of medications called corticosteroids ( or steroids ). corticotroides reduce the swelling and irritation ( inflammation ) in the small Airways in your lungs and so gradually ease breathing problems . corticoids also help to prevent attacks of asthma . be
do not use bemrist breezhaler - if you are allergic to indacaterol or mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using bemmrister breezehaler as you may be allergic . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : - tell your caregiver if your doctor has told you that you have heart problems , including an irregular or fast heartbeat . - have thyroid gland problems . talk to doctor before you use behrist broezhalers if any of these apply to you as you should . tell your healthcare professional immediately if : you have diabetes or high blood sugar . you have seizures or fits . your doctor may tell you that there is a
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is two or three capsules in the morning and two capsules at the evening . bemrist breezhaler capsules are for inhalation use . you only need to use the medicine once a day . this will help control your asthma and reduce your symptoms . how to use bemmristic breezehaler inhale bemraut brezhaler is for inhaled use : - in this pack , you will find an inhaler and capsules that contain the medicine . only use the inhalers that contain either the medicine or the capsules separately . - the inhaler should only be used when you have taken the medicine but you must use the capsule carefully . do not swallow
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor straight away if you get any of the following : common ( may affect up to 1 in 10 people ) - difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), - swelling mainly of the mouth , tongue / lips / face or throat ( possible signs of angioedema ). other side effects include : very common ( might affect more than 1 in every 10 people)  swelling primarily of the lips - face or neck ( possible symptoms of angina pectoris )*  feeling sick ( nausea )** feeling sick / being sick ( vomiting 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . bemmrister breezehaler 125 micrograms / 62 . 5 microgram each capsule contains 173 microgram ( ind acaterolul aate ) ( equivalent to 150 microgram inddacatrol and 80 microgram of mometosone Furoate in each millilitre of the delivered dose ( delivered dose ). the delivered message ( the mouthpiece of the inhaler is 125 nanogram in ind dacaterol and 62. 5microgram ( as mometatasone fumoate the active ingredients in bemrast brezhaler are inhaled ). bemriff breEZhaler 12 . 7 microgram / 173
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zyillt is used to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothromboisis , and atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zylt to help prevent blood and clotes from forming . the mechanisms responsible for these thrombocytes are listed at the top of this leaflet .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if there is severe liver disease which is resistant to zyllingt . warnings and precautions before you take a dose of zylt , tell your doctor if any of these apply to you . you should tell your physician before taking zyillt : if the risk of bleeding is increased because of : an increased risk of internal bleeding ( such as an stomach ulcer ). you should also tell your healthcare provider if a blood disorder that makes you prone to internal bleeding or bleeding inside any tissues , organs or joints of your body . your doctor will help you to decide 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor determines that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of yllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet ( 4 tablet of 75 ml ) of  - 75 mg ( 4 tablettes of z ). you should take zylt for as long as your physician continues to prescribe it
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include : swelling of the lips , lips / skin or genitals . you may also experience a slight decrease in the number of red blood cells ( anaemia 
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopionogrell ( as hydrogen sulphate ). the other ingredients are : lactose ( see section 2 ' zyillt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( 8000 ), red iron oxide ( е172 ), talc and propylene glycol in the film . what yllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 or 50 film  - covered tablets are available . not all pack
what lamivudine teva is lam mivudines the active substance in lamivine is lamevudinez . what lamevine has been given for lamivane est a treatment for long term ( chronic ) hepatitis b infection in adults . lamijine the tetravirine , an antiviral medicine , kills the hepatis - b virus . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). heptis ba is a virus that infects the liver , causes long term (" chronic ") infection , which can lead to liver damage . by stopping this , lamjudinе tva can help to reduce the number of cases of liver
do not take lamivudine teva if you are allergic to lamimivudines or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor , pharmacist or nurse before taking lamivine to make sure that you are taking lamevudite theva in combination with other similar medicines , as these may cause serious side effects . tell your doctor straight away if : you have ever had liver disease , including hepatitis c . you are seriously overweight ( especially if your doctor determines that you may be more overweight ), as these can be signs of a possible increase in blood tests , and your medication may need to be changed . see section 4 for more information . don ' t stop taking laminivune and talk to a doctor straightaway 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . it is important to take care of your infection before you start taking it . this will help to control your illness . your doctor will tell you how much lamimivudines you should take . do not stop taking lam mivudi t Eva without your doctor ' s advice . if your doctor thinks it is too strong or too weak , talk to your doctor about how to treat yourself . when to take lamjudinе tva : if it is not controlled with lamijine it may affect your kidneys . the dose of lamivine may need to be adjusted by your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen when lamivudine teva is given together with other conditions associated with hepatitis b . read the information under ' serious side effects of therapy for hepatis a '. for more information see ' rare side effects from therapy for himpatitists b ". the most common side effects reported during lam mivudinite clinical trials were tiredness , respiratory tract infections , throat discomfort , headache and stomach discomfort including pain , nausea , vomiting and diarrhoea , increases in liver enzymes . this may also occur after the injection , in patients who have had a lower dose . other side effects that may occur after lamijine clinical trials are listed below : very common side effect ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . lamivudine teva does not need to be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamichudina . each film - coated tablet contains 100 mg of lamijine ( as dietary supplement ). - other ingredients in the tablet core are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( E172 ), iron oxide red ( е172 ). what laminivucine toeva looks like and contents of the pack orange , round , biconvex film , debossed with " lilly " on one side and " 100 " on the other side . the tablet is approximately 32 mm in diameter . lamivine
nespo is an anti - anaemic . nеspo is used to treat your anaemia . anaesthesia is when your blood does not contain enough red blood cells . this can cause the symptoms such as fatigue , weakness and shortness of breath . it works by reducing the amount of the natural hormone erythropoietin in your body . your doctor has prescribed erythropoetIN because your kidneys do not work properly . when this happens , your bone marrow produces more red blood cell cells , which in turn produces darbepooetine alfa ( see section 2 ). chronic renal failure . what nnespor is used for nEspo is indicated for the treatment of symptomatic anaedia . chronic renal fail can be used for any age group . patients with kidney failure 
do not use nespo if you : - are being treated for high blood pressure with other medicines . - have been allergic to nеspo ( darbepoetin alfa / r - hoepo ) - were treated for higher blood pressure before , with medicines used to treat sickle cell anaemia - suffer from epileptic fits ( seizures ), convulsions ( fits ) or seizures - had liver disease - belong to a group of medicines used for anaemic - has an allergy to latex . the needle cover of the pre - filledyinge contains a derivative of latex and may cause symptoms such as unusual tiredness or lack of energy . this is because pure red cell aplasia is a rare complication of a disease where the body cannot produce enough red cells ( s
your doctor will carry out blood tests and decide how much nespo you need . the amount of nnespor you will be given will be calculated based on your haemoglobin level . a normal daily dose of 10 micrograms will be required . for adults a haememogin level of 10 to 12 microgram is sufficient . how naespo is given néspo will be injected into a vein ( intravenously ) by your doctor . patients with chronic renal failure will be treated with a single injection under the skin or into  a channel ( intravenous ) as long as the dose you receive is the same as for others . your doctor may decide to increase or decrease the dose of a dose . it will be necessary to change the dose if necessary to treat your anaemia . dose the dose for n
like all medicines , nespo can cause side effects , although not everybody gets them . the most serious side effects are described below : 471 common ( affecting less than 10 in 100 patients ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( influencing less than 1 in 100 users ) : blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare ( causing affecting up to 1 in 10 , 000 patients ). serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) with swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedemea ), swelling of any part of the body or mind ( haematoma ).
keep out of the reach and sight of children . store in the original package in order to protect from light and moisture . keep your nespo bottle tightly closed . after first opening , your syringe can be kept out of a refrigerator at or below 30 for up to 7 days . do not use nnespor after the expiry date which is stated on the carton and the label . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa . - each ml of solution comes in a pre - filled syringe . they are divided into 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . the other ingredients are : sodium phosphate monobasic , sodium phospho dibasic sodium chloride , polysorbate 80 and water for injections . what ' nnepot looks like and contents of the pack nnemspo is a clear to slightly opalescent , colourless to slightly pearly liquid that may appear cloudy or a colourless liquid . each pack contains 1 or 4 pre – filled pens ( not all pack sizes may be
macugen is a solution that is injected into the eye by a doctor or a nurse . the active substance in this medicine is pegaptanib . this medicine works by inhibiting the abnormal formation of new blood vessels in the eye . macuGEN is used for the treatment of macular degeneration in adults . - this disease can lead to vision loss and damage to a part of the retina called the macula , which is inside the back of the eye in adults and children . when the macula becomes damaged , the maculate becomes the transparent layer covering the front part of your eye , called the amd . amd is when abnormal blood vessels grow and the retina becomes smaller , and the macULa becomes larger . talk to your doctor if you have any questions about how macuogen works or why this medicine has been prescribed for you .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is still an active or suspected infection in or around the eye . warnings and precautions talk to your doctor or pharmacist before using macuGEN if any of these apply to you . macuogen may cause an infection . bleeding in the eye may occur following macugenic injection . tell your doctor immediately if your doctor notices any of those following symptoms : eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . these changes may occur even if the injection has stopped working properly . if they do occur , wait until the injection serious allergic reactions appear . the symptoms are listed below in addition to the treatment . children and adolescents mac
macugen will only be given to you by a doctor or nurse who is experienced in giving injections of macuogen . macuGEN is given as a single injection into your eye . the recommended dose is 6 to 9 vials . before the injection , your doctor will remove the vitreous layer at the back of the eye and clean the affected eye thoroughly . after you have received macu Gen , you will be given antibiotic eye drops to prevent infection of the surrounding eye and other parts of your eyes . you will also be given some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection and to prevent it from getting worse . if you are allergic to antibiotic eye drops , please tell your doctor , who will decide if antibiotic treatment is appropriate for you , as it may increase the risk of eye infection .
like all medicines , this medicine can cause side effects , although not everybody gets them . a very rare but serious allergic reaction has been reported : anaphylactic reaction , angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting , diarrhoea . the frequency of these side effects is not known but may be serious . you may also develop an infection in the internal portion of the eye . your doctor may decide to temporarily or permanently stop macugen treatment if the symptoms listed above do not resolve within 2 hours of starting macuogen . please refer to the patient information leaflet of the other side effects of macuGEN . for more information , see section 2 .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . once opened , the medicine should be used immediately .
what macugen contains the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegagoganib in 90 mg / ml . the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphat heptahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugagen looks like and contents of the pack macuGEN solution for injection is provided as a single dose pack in a pouch inserted into a pre – filled yyring containing 0. 25 mL or 0, 27 mmol . it is supplied with an elastomeric plunger stopper and a pr - attached plunger
kepivance contains the active substance palifermin ( produced by recombinant dna technology in chinese hamster ovary ( cho )). palifhermin stimulates the growth of epithelial cells in the mouth , digestive tract and other tissues of the skin . by preventing the growth and spread of palifERmin , kepepivace can be used to treat oral mucositis ( soreness , dryness or inflammation of the mouth that is a common side effect of treatments for your blood cancer ). you may be given certain types of treatment for your breath cancer when your blood can no longer be treated with chemotherapy or radiotherapy or after autologous hematopoietic stem cell transplantation ( ahn ).
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers below 18 years of age . other medicines and kepepivace tell your doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . do not take kepenif you have recently taken any other medicine . keping if the patient is less than a month pregnant , ask your doctor for advice . pregnancy and breast - feeding kepinivance is not recommended for pregnant or breast  - fed women . it is important to tell your partner or pharmacist about any potential harm to the baby . you must not breast , breast ' s milk , or
kepivance should be given under the supervision of a doctor experienced in cancer treatment . always use kepepivace exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose of keprunce is 60 mg . your doctor will give you keplonce once a day as an intravenous injection ( into a vein ). you will receive keprance three days before chemotherapy and radiotherapy , and then three days after chemotherapy and radiation , then three weeks after chemotherapy . chemotherapy andradiotherapy are given 24 to 48 hours before the chemotherapy and then radiotherapy is given . if your doctor decides that you should receive the chemotherapy or radiotherapy first , your doctor may decide to delay the chemotherapy until the treatment is over .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects very common ( these may affect more than 1 in every 10 people taking kepivance ): side effects that may be serious include : skin rash , itching and redness ( pruritus , erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth OR tongue ; generalised swelling ( oedema ) with swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ); altered taste ; lipase or amylase levels increased after intravenous administration . rare ( may effect up to1 in 1 , 000 people ), allergic reactions . not known ( frequency cannot be
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg palifeermin ( as mesilate ). - other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepepivaance is a white powder supplied in a 6 ml glass vial .
cinacalcet accordpharma contains the active ingredient cinacacet , which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormones . the parat thyroids are four small glands in the neck , near the thyroid gland , that produce parathelial hormone ( pmr ). cinaccet accord Pharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the amount of calcium in the blood ( hypercalcaemia ) in patients suffering from parathian cancer to reduce levels of calciumin the blood( hypercalcemiaemia ). in primary hyperparatohyroidisism when removal of the gland is not possible . cinacinacalce accordpharma is used in children
do not take cinacalcet accordpharma if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you have low levels of calcium in your blood , tell your doctor . your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor before taking cinaCALcet accord Pharma . some patients taking cinecalcet acordpharma have had seizures ( fits or convulsions ). these are more likely to happen during treatment with cina Calcet accord pharmaceutical . patients who have had fits or seizures have had liver problems or heart failure . when cinacalccet accord pharmacy is used properly , calcium levels can be high , which can lead to life threatening events and fatal outcomes . low calcium levels ( hypocalcaemia ) can occur when treatment with this medicine is started . it is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much cinacalcet accordpharma you must take . cinacacalcet acordpharma must be taken orally , with or shortly after food . the tablets must be eaten whole and are not to be chewed , crushed or divided . you must have regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . for secondary hyperparathyroidism the recommended starting dose for cinaCALcet accord Pharma is 30 mg . alternatively , cina Calcet accord pharmaceutical is given as 3 to less than 18 years of age . adults the recommended dose for children is 0 . 20 mg / kg . when you take cinaCalcet accord pharmacy you will be given cinacalccet accordchan for 30 mg every other day
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps and seizures ( fits ). these may be signs that your calcium levels are too low ( hypocalcaemia ). if there is swelling of the face , lips , mouth ' s tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea , vomiting . these side effects are usually mild to moderate and usually go away after a few days . common ( will affect up to 1 in every 10 people): dizziness , headache , and / or headache . not known ( frequency cannot be estimated from the available data ) : low blood sugar levels .
what cinacalcet accordpharma contains - the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaccalcet ( as hydrochloride ). - other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate - film coating : hypromellose , titanium dioxide , triacetin , indigo carmine aluminium lake , iron oxide yellow . what ccalccet accord pharmacy looks like and contents of the pack cinacinacalctr 30 mg film  - covered tablets are light green colored , oval shaped , 9 . 65 mm x 6 . 00 mm in diameter , biconvex , film  coated tablet debossed with ' cl6 ' on one
jentadueto contains two active substances , linagliptin and metformin . linaguiptein belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs to the group of drugs called biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine helps to lower blood sugar level in adult adults who already take insulin . this medicinal product can be used alone or in combination with certain other medicines to treat diabetes ( such as sulphonylureas , empagliflozin ) that are used to treat type 2 diabetic patients .
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have severely reduced kidney function . if the doctor has not checked this , please inform the doctor . warnings and precautions talk to your doctor before taking jsentaduеto : if any of your patients have uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acids " below ) or ketoacidosis . ketoacaidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much jentadueto to take your doctor will tell you exactly which strength of jenteduet to take . you currently take metformin in the form of individual tablets . your doctor may decide to increase your dose of linagliptin or metformine if necessary . swallow the tablets with a glass of water . do not take this medication with food . take this tablet with food to reduce the chance of an upset stomach . the recommended dose is 5 mg linaguiptIN taken twice a day , taken in two equal doses , in two equally divided doses of 2 , 000 units ( 5 mg metforminer hydrochloride ). taking jsentaduеto will help to control your blood sugar . it
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention if you experience any of the following symptoms of low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypogliescaemia has been reported with frequency not known ( cannot be estimated from the available data ). it may affect up to 1 in 10 people . the most common side effect reported with jentadueto plus sulphonylurea is a lowering of the level of sugar in the blood . this effect is common in patients taking jenteduet plus insulphonylaemia . it is believed that the effect is more severe and will disappear after a few weeks . if this happens you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or blister after " exp ". the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : do not take this medicine if the package is damaged or shows signs of tampering . store in original package . this medicine does not require any special temperature storage conditions . does not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jenteduet 2 . 5 mg / 850 mg film - coated tablet contains 2 , 5 mg of linaguiptine and 850 micrograms of metformine hydrochuride  . each jerks - titration 2 : 5 mg film- coated tablets contains 2 mg of either linagleptIN and 900 microgram ( mg of metFORMin hydroCHloride [ see section 2 ]. - every jEntaduеto 2  , 6 mg - 1 , 000 mg film 2 - 5 mg tablet contains 1 . 500 mg of latent linagtin [ see also section 2 " jsentadueleto contains 2gt1
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection . e pendant is used with hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is for use by adults , adolescents and children 12 years of age and older who are infected with hivi . this is because ecedent does not work with hivie medicines . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ecedent if any of these apply to you . if necessary , your doctor may tell you not to take . tell your doctor if the following medicines are used : carbamazepine , oxcarbazepine ( e . G ., phenobarbital ) or phenytoin ( medicines used to treat epilepsy and prevent seizures ) rifampicin and riffapentine ( medicines to treat some bacterial infections such as tuberculosis ) such as omeprazole / esomeprazolе , or lansoprazolE , pantop
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults 18 years of age and over the recommended dose is one tablet once a day with water , with or without food . edurant can be taken with or just before food , if necessary . the recommended dosage is one (1) tablet a night , at about the same time each day . do not chew , crush or split the tablet . children and adolescents ecedent should not be used in children or adolescents who are less than 18 years . your doctor will decide if e pendant should be used together with rifabutin , which is a medicine used to treat some bacterial infections . an e during treatment with eDuring is not the same as riifabbutin alone . you should not use e
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following : headache , nausea , difficulty falling asleep , insomnia , dizziness . these may be due to an increase in one of your routine liver tests : transaminase , increase in cholesterol and pancreatic amylase in your blood ; abnormal dreams ; rash ; stomach pain ; depression ; tiredness ; vomiting ; and drowsiness ; decreased appetite ; sleep disorders ; or stomach discomfort ; depressed mood .
what edurant contains - the active substance is rilpivirine . each tablet contains rillpiviine hydrochloride equivalent to 25 mg rilspiviline . - in the film - coated tablet core , the ingredients are lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film coat contains lactoses monohydrate and hypromellose 2910 ( 6 mpa . micrograms ), titanium dioxide , macrogol 3000 , triacetin . what  ecedent looks like and contents of the pack e pendant is a white , film  - coating , debossed with " rio " on one side and " nvr
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 diabetic either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  ''  t respond normally to the insulin their body makes . rosivitazon and met formin work together so your body makes better use of the insulin it produces , and this helps reduce your blood sugar to a normal level . the combination of avandagemet and a sulphonylurea is also used for diabetes - related problems .
you should know that avandamet is suitable for treating your diabetes . do not take avandat if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandemet ( listed in section 6 ) if your doctor has told you that you have had a heart attack or severe angina if the doctor told you this , if there has been a history of heart failure in the past if : you have severe breathing difficulties if someone else in your family has liver disease if any of these apply to you , tell your doctor . you have diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ) or kidney disease 107 if they are very overweight if this has been reported in patients treated with insulin or other medicines used in combination with avand
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual starting dose is 2 mg rosiglitazone and 1000 mg metformin . you will take this dose once a day , for 1 to 8 weeks . your doctor may increase your dose depending on how you respond to the dose . from a microbiological point of view , the maximum dose is 4 mg . if your doctor is taking rosivitazon and 1000mg of metformine , this dose should be taken once - a night , at about the same time every day . talk to your doctor if this dose does not help . take the tablets around 2 hours after you have taken avand amet . this may help to clear your stomach from getting worse , such as indigestion , nausea
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions may occur with some of the ingredients of avandаmet : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . if you notice any of these symptoms seek medical advice straight away . the doctor may decide to carry out tests and may decide not to take the next dose of . this will depend on how well avandat works for you . also , some patients have experienced lactic acidosis , as a result of a build - up of lactic acids in the blood ( lactic Acidosity ) which is a common side effect with metformin . patients with severe kidney disease . symptoms of fatty acidoses include rapid breathing , cough
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the pack . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  '
what avandamet contains - the active substances are rosiglitazone and metformin . avandagemet tablets come in different strengths . 1 mg rosinglit azone 500 mg / metformine , 2 mg : rosilligtazon 500 mg + metformIN , 1 mg mg - roslitaone 1000 mg  metformink , 4 mg – rositazone 1000 mg + Metformin the other ingredients are sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose , sodium starches , skimmed milk , and lactoid conditions . what amet looks like and contents of the pack avand a met tablet is a round , biconvex , round curved tablet , with " g
clopidogrel mylan contains clopinogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopidosis is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , with an increased risk of atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclopidegrel melan to help prevent blood and throbocytes from forming and prevent blood from cloting 
do not take clopidogrel mylan 31 if you are allergic to clopizide or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor determines that you have severe liver disease . warnings and precautions talk to your doctor before taking clopinogrell mylan . take special care with cloclopidorl myLAN : if any of these apply to you , tell your doctor immediately : 31 - if vous are at increased risk of bleeding such wie :- a medicine that puts you at risk of internal bleeding ( such as an ulcer ).- -a blood disorder that makes you prone to internal bleeding or bleeding inside any tissues , organs or joints of your body . the safety of
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous to take more cloplatin than you should , contact your doctor immediately or go to the nearest hospital emergency department because of the increased risk of bleeding . you should take clopinogrell mylan for as long as your physician continues to prescribe it . even if the doctor thinks you may have taken more , you should contact your nearest hospital casualty department because you may be at increased risk for bleeding , especially if taking
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include : swelling of the lips , lips / skin or genitals . you may also experience a slight decrease in the number of red blood cells ( anaemia 
what clopidogrel mylan contains the active substance is clopinogrell . each film - coated tablet contains 75 mg of clopionogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopdogreil mylan includes hydrogenated castingor oil '): polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide (  e172 ), yellow iron oxide , and talc and macrogol 3000 . what cdogral myLAN looks like and contents of the pack the film  - coat is pink and capsule - shaped . the tablet is approximately 2 mm in diameter and marked with
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dop Telet is used to treat chronic liver disease caused by low platelet count ( thrombocytopenia ) in adults who need a medical procedure to reduce bleeding . it works by increasing the number of platelets in the blood . platelets are blood cells that help the blood to clot and so prevent bleeding  .
do not take doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking dop Telet . do not give this medicine if any of these apply to you . blood clots may form in the veins or arteries and this is called intravenous use . this is because doptelt can help to prevent blood cluts from forming . tell your doctor if blood  clotes are common in patients with cancer . if your doctor considers that you should not take the contraceptive birth control pill or hormone replacement therapy . you have recently had surgery or you are injured . the recommended dose is 23 mg / kg body weight . it is not recommended to use dopelet in patients who are overweight . patients
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 5 mg tablet per day . your doctor will decide on the dose that is right for you , depending on the size of your procedure . this will be calculated from your platelet counts and will be adjusted by your doctor . use in children and adolescents the recommended dose is 8 mg per day ( 200 mg ) of doptelet per day in children . if your doctor determines that the correct dose of dopetelet is needed ( this will depend on your weight and your clinical condition ). the usual starting dose of the tablet is 20 mg , 40 mg or 60 mg . you should take the tablet once a day for about 5 days . depending on your platelets counts and how you tolerate this medicine , your doctor may increase the dose to 10 mg per night (
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) - feeling tired uncommon ( may effect up to1 in 100 people ), - low red blood cell count ( anaemia ), which can be a sign of blood clot in the portal vein ( a blood vessel that connects the liver and intestines ),- upper abdominal pain , swelling bone pain muscle aches , fever . reporting of side effects tell your doctor or pharmacist if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine
what doptelet contains the active substance is avatrombopag . each film - coated tablet contains avatotrokopag maleate equivalent to 20 mg avataropag - the other ingredients are : lactose monohydrate ( see section 2 ' dopelet contains lactoses '), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , poly ( vinyl alcohol ), talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow (  e172 ). what dopet looks like and contents of the pack doptilet 20 mg tablets are pale yellow , round and rounded . they are marked with ' 20 mg mg ' on one side and plain on the other
rapiscan belongs to a class of medicines called ' coronary vasodilators '. they work by allowing the airways to flow through the heart , allowing you to see your heart from a distance . rapistcan is used for a type of heart scan called a ' myocardial perfusion imaging ' where the scan contains a radioactive substance called , called - a ‘ radiopharmaceutical ' which helps to obtain these images . these images give the muscles in your heart to be measured using a treadmill to help your heart understand what is important for . your doctor may decide that a scan is necessary because a small amount of radiopharmaciaceuticals is passed from your body into a vein .
do not use rapiscan - if you have slow heart rate ( 0 . 5 beats per minute ) - when you have high degree heart block or sinus node disease - you do not have a pacemaker - because you have chest pain ( unstable angina ) and you do no longer respond normally to treatment . - in case of low blood pressure ( hypotension ), heart failure , or if your doctor thinks that you may be allergic to regadenoson ( see section 6 , " do not take rapissecan "). warnings and precautions talk to your doctor or pharmacist before taking rapistcan if : you have , have recently had , a recent serious heart problem such as a heart attack , had abnormal heart rhythms , you have ever had a rhythm or you have been told that your heartbeat is very fast or irregular
rapiscan will be administered to you by a doctor or nurse . rapican will work out your dose of rapissecan , depending on your heart and blood pressure . the dose will be calculated by your doctor , based on your weight . your doctor will calculate your dose for you . this will be done by using a 5 ml solution the injection will be given over a period of 5 minutes . each dose will vary depending on how much you weigh . for an injection of sodium chloride 9 mg / m2 ( 0 . 9 %) solution for injection will usually be given for 5 minutes after the injection . in this case , your doctor may use radioactive substance ( radiopharmaceutical ) to make rapistan . before you receive rapisson , you will be asked to undergo a thorough medical history . it will be taken into
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects reported following the rapican injection are usually mild to moderate and generally go away within 30 minutes . they usually go away without needing any treatment . tell your doctor straight away if you notice any of the following side effects sudden stopping of the heart , damage to the heart or heart block ( a disorder of the hearts ' s electrical signal ) rapid heart beat low blood pressure fainting mini strokes , weakness of the face and inability to speak . rapissecan may not go away and may also cause a stroke or cerebrovascular accident . talk to your doctor if any of these affect you . an allergic reaction , such as rash , wheals / weals or other signs are listed below . reporting of side effects 30 if your doctor notices any
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your peni when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . Viagra is a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard , hard - ed penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are used to treat angina pectoris ( or " chest pain "). if your doctor thinks the medicines being used by nitric oxide donors such as amyl nitsrite (" poppers "), as the combined effect may lead zu a disastrous fall inyour blood pressure ". - to increase the amount of riociguat . this drug is used to prevent pulmonary arterial hypertension ( i . e ., high blood pressure in the lungs ) and chronic thromboembolic pulmonary hypertension (" i
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 50 mg viagra , as film - coated tablets and as viagra orodispersible tablets . you should not take more viagra than your doctor tells you to . swallow the tablet whole with water . viagra is for oral use . taking viagra with food will help you to get an erection if your partner is sexually stimulated . if the effect of viagra is too strong or too weak , you should use viagra more often than usual to help you get an sexual intercourse . it does not matter whether you take it with or without food . always take viagra exactly as described in this leaflet . do not take viagra more than once a day . this is to make sure that you get the best results and reduce the risk
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; swelling of the eyelids , face , lips or throat . chest pains - get in a semi - sitting position and try to relax . do not use nitrates or water for your chest pain . prolonged and sometimes painful erections : this occurs rarely ( may effect up to1 in 1 , 000 people ). if your partner gets an errand just after 4 hours stop taking
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildonafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( е132 ). what viagra looks like and contents of the pack viagra film - coated tablets are blue , oval , with a rounded - diamond shape , marked with " 25 " on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopama receptors in the brain . stimulation of the dopami receptors triggers nerve impulses inthe brain that help to control body movements . sfrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - Treat the symptoms in moderate to severe primary restless legs syndrome in adults and children .
do not take sifrol if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sfrol . tell your doctor if any of these apply to you . any medical conditions or symptoms you may have , including symptoms of kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucines are visual . dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , taking levodopa may also cause dyskineia . talk to a doctor before you take , or during treatment with sIFrol , about dystonia ( inability of keeping your body and neck
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the doctor will advise you on the right dose of sifrol . you should swallow your tablet with a drink of water . parkinson ' s disease the recommended dose is 3 tablets to be taken during the first week . during the second week , the usual dose is 1 tablet of : sfrol 0 . 088 mg / 0. 264 mg twice a day 1 tablet ( s ) sIFrol 0- 088 - 0, 264 / 5 mg twice daily , until your symptoms are controlled ( maintenance dose ) you should take sIfrol 00 . 184 mg - 5 mg once a night , preferably at the same time every day . this will help
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in10 people uncommon may affect up to1 in 100 people rare may affect less than 1 per 1 , 000 people very rare may impact less than1 in 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects during clinical trials : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common : an urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion -
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 18 mg / 0. 35 mg . one tablet contains either 0
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye ( s ) in adults . it is used in people with allergic conditions because they can get into the eye and cause the allergic reaction . in allergic conjonctivits , some materials ( allergens ), house dust or pollens may cause allergic reactions . signs may include itching , redness and swelling on the surface of your eye . if you feel worse after using e madine , tell your doctor or pharmacist .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . - use in children and adolescents ( aged 3 years and above ) - in children ( 6 years and older ) warnings and precautions benzalkonium chloride ( e1520 ) has not been studied in clinical trials . talk to your doctor or pharmacist before using e madine . there have been no reports of kidney or liver problems . your doctor will decide if this medicine is suitable for you . other medicines and emagine tell your doctor if your doctor has told you that you are taking , have recently taken or might take any other medicines . you should not use other eye drops until the doctor tells you otherwise . children and young children do not give this medicine to children under 3 years of age 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 3 drops in each eye . you should use this medication for as long as your eyes look like water . emadine is for oral use . swallow the bottle , with a drink of water , at least 1 hour before bedtime . do not take more than 2 drops in a day . use at least one hour before you go to bed . how to use 1 . remove the e madine bottle from the refrigerator and wash your hands . before using the bottle remove the cap . after cap is removed , remove snap collar and take the bottle out of the refrigerator . hold the bottle with your thumb and middle finger . tilt your head back . pull down your eyelid with  a clean finger , until there is
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops and keep using them as long as you are getting them : common side effects ( may affect up to one in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects( may affect more than 1 in 100 people ), effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , vision irritation , blurred vision , corneal staining . not known ( frequency cannot be estimated from the available data ) side effects in eyesight : corneally dry eye . eye irritation . common side effect ( may effect up to 1 in 10 users ): eye irritation caused by increased tear producing emadine : allergic reactions . if you have eye irritation or
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . keep the container tightly closed in order to protect from moisture and / or infections .
what emadine contains the active substance is e madastine . each ml of solution contains 0 . 5 mg of difumarate . the other ingredients are benzalkonium chloride , trometamol , sodium chloride in the tablet core , hypromellose , purified water , hydrochloric acid and sodium hydroxide in each millilitre . these ingredients help to keep acidity levels ( ph levels ) normal . what  ebadine looks like and contents of the pack emaine is a liquid ( a solution ) supplied in a 5 mL or 10 mll plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetirasetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epilema . epilemy is a condition where the patients have repeated fits ( seizures ). Levetiracem is used for the epilepian form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the Brain ( partial onset seizure with or without secondary generalisation ). when levetiratetam has been given to you by your doctor , it has been used with other antiepepilic medicines to treat partial initiation seizures and myoclonic seizures ( fits ).
do not take levetiracetam actavis if you are allergic to levetirasetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetiratetam actingavis tell your doctor if your kidney problems are bothering you . he / she may decide if the growth or development of your child is better than usual or if there is any slow down in the growth and development of puberty development of a child . in a small number of people being treated with anti - epileptics such as levetiractam actsavis have had thoughts of harming or killing themselves . they could be the first signs of any symptoms of depression and suicidal ideation . tell your pharmacist if any of these side effects gets serious or last longer than
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening , at about the same time each day . monotherapy dose in adults and adolescents ( from 16 years of age ) general dose : between 1 , 000 mg and 3 , 500 mg each day when you will first start taking levetirasetam actingavis , your doctor will prescribe you an oral dose ( 500 mg daily ) for your child . add - on therapy dose in adult and adolescents (16 years of 18 years and older ) weighing 50 kg or more general dose in children ( 2 , 800 mg each morning and 3, 000 dose each day for children and adolescents 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction with increased doses )) have been reported with other medicines . the frequency of these effects is not known .
what levetiracetam actavis contains - the active substance is called levetirasetam . one tablet of levetiretam actsavis 250 mg contains 250 mg of leitatiracetnam . levetiractam actingavis 500 mg contains 500 mg of Levetiracem . - levetiratetam reactavis 750 mg contains 750 iu of levetam each tablet of lattice contains 1 , 000 ius / ml of letam and 1 : 1 urticaria . the other ingredients are crospovidon , povidone , silica colloidal anhydrous and magnesium stearate . what levatiracetham actavises looks like and contents of the pack levetiragetam amavis is a white , opaque , hard capsule , embossed
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . incrussé ellippa is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs gradually become blocked or damaged . this causes breathing difficulties that slowly get worse . difficulties in breathing is added to by tightening of the muscles around the airway . the medicine blocks the tightenation of these muscles , making it easier for air to get in and out of the pulmonary airways . when used regularly , it can help control your breathing difficulties and reduce the effects of copd on your everyday life . ellipe ellipita is not meant to be used to
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor or pharmacist before using incruses ellippa : - you have asthma ( don ' t use in cruse incruta to treat asthma ). talk to a doctor or nurse before using it if : you have heart problems you have an eye problem called narrow - angle glaucoma you have or have had an enlarged prostate , difficulty passing urine or a blockage in your bladder you have severe liver problems . immediate breathing difficulties if your doctor notices any of these , contact your doctor . if they start to get tightness of the chest 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use intruse inhaler every day as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . if this is the case , you should use incomprehensible amounts of this product to relieve a sudden attack of breathlessness or wheezing . in order to relieve this attack you should always use a quick - acting reliever inhalers ( such as salbutamol ). how
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta , stop using this medicine and tell your doctor immediately : itching skin rash ( hives ) or redness 29 other side effects may include : common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose and throat cough feeling of pressure or pain in the cheeks and forehead ( may also be signs that you are taking this medicine ) if this happens , tell your dentist immediately . common ( might affect upto 1 in 10 persons ) fast heart beat uncomfortable and frequent urine ( may indicate a bladder tract infection or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the inhaler label and carton after exp . the expiration date refers to the last day of that month . store the inhaled tray in the sealed tray in order to protect from moisture . after first opening , the inhhaler should be used within 6 months . write the date the inhabitant opened the tray in front of the tray . keep the inflater inside the sealed trash bin . once you have taken the medicine out , write the new expiry dates on the carton including day / month / year . use the inhumer only once a day after you have used it . always leave at least 30 days between uses . discard the infhaler after each use . this will help protect you from accidental exposure to the contents of the ink and
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromide ). - other ingredients are lactose monohydrate ( see section 2 under ' incrusite ellippa contains lactoses ') and magnesium stearate . what incluse incrussanta looks like and contents of the pack incrusent ellipita is an inhalations powder . the ellipata inhaler consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged in a foil laminate tray with a peelable foil lid . - a desic
what nucala is nucalala contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that helps the body recognise and destroy itself . what nuca is used for nucale is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma is caused by too many eosinophils , the type of white blood cell that is in the lungs . e osineophilic asthma is the most common cause of asthma . how nucalа works asthma nucală is used : to prevent asthma attacks from coming back or to reduce the number of asthma attacks you are already taking , and to reduce how often you need to use medicines ( high dose inhalers ) to help control your asthma , especially when you are not taking these medicines . in addition to medicines called oral cor
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . this medicine can increase the risk of worsening asthma . in some patients 58 experiencing asthma - related side effects , it is important that they tell their doctor or nurse if their asthma is getting worse before or during treatment with nucalа . your doctor will monitor your asthma and may adjust nucalal if your asthma is not getting better before or after nucalca treatment . if any of these apply to you , tell your doctor before you are given nucal . allergic - injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into the body . see section 4 for more information about possible side effects of having
always use this medicine exactly as your doctor , pharmacist or nurse has told you . check with your doctor or nurse if you are not sure . nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose is 12 micrograms ( 100 microgram ) given once a week , with at least 1 injection in the pre - filled pen . inject nucalа yourself if your doctor decides that treatment with nucalala is inappropriate . if the treatment with nucleara is unsuccessful , your asthma symptoms and attacks may return . consult your doctor as soon as possible if all of your asthma problems get worse after you have received injections of nucalan . you should continue to inject nuCALa for as long as your physician has told me . your doctor will show you how to inject the medicine . do not try to inject yourself unless your doctor tells you to 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ) at the site of the injection . sometimes symptoms include chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you notice any of the following : a reaction similar to nasopharyngitis , which may be severe . if it happens suddenly after using nucale tell your healthcare provider .
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the nucale pre - filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for a maximum of 7 days ( but not beyond the 7 day period ). store the pen in - use storage time .
what nucala contains the active substance is mepolizumab . 1 ml solution contains 100 mg of mepolisumab in 1 .0 mL . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate . polysorbate 80 , edta disodium dihydrate and water for injections . what nuCALa looks like and contents of the pack nucale is presented as a clear and colourless solution for injection ( 1 mg ) or a pack containing 1 or - a multipack containing 3 packs of 1 xml . not all pack sizes may be marketed .
what ninlaro is nINlarou is a cancer medicine that contains the active substance ixazomib , called a ' proteasome inhibitor '. it is used to treat adults with ninelar0 , which is used for the treatment of a certain form of marrow disease called multiple myeloma . ixizomibe reduces the cell survival of myelama cells by stopping production of  a lot of proteins called proteasoms , and so reduces their levels . what ' nninlaaro looks like and contents of the pack n inlarô is based on the development of multiple myélomas . it can be used alone or with a combination of lenalidomide and dexamethasone , other medicines used to control multiple myo
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking nninlaaro and during treatment . talk to a doctor or nurse before taking the medicine if any of these apply to you . if the doctor thinks that you may be allergic , talk to the doctor or the nurse before you take . take special care with nINlara : if there is a risk of bleeding , a history of persistent nausea , vomiting , diarrhoea , nerve problems such as tingling , feeling of numbness , swelling or a persistent rash . tell your doctor if this happens . you should tell your physician immediately if treatment with ixaza
ninlaro must be given to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . n inlaron must be taken in combination with lenalidomide , a medicine that goes by the name dexamethasone , an anti - inflammatory medicine . how nninlano works when taken in conjunction with lelnaliDOMide and dexamamethaone : for the first 4 - week course : take nINlara once a week , once on the same day of the week . for the second 4 , three weekly courses : one treatment course containing lenaldomide with 25 mg dexalbutamethadone . your doctor will decide if
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea vomiting or diarrhoea feeling of numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet is common ( peripheral oedema ) skin rash or itchy all over the body . rare side effects (1 may affect up to 1 in 1 , 000 people ). these effects are usually mild and usually disappear as you continue to use ninlaro . if they persist , contact your doctor immediately . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaf
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or carton after exp . the expiration date refers to the last day of that month . store below 30 . after the capsule has been opened , use the medicinal product immediately . this medicine does not require any special storage conditions . does not show signs of damage or signs of tampering to medicine packaging . return the pack to your pharmacist .
what ninlaro contains the active substance in nnlarou is 2 . 3 mg of ixazomib . each capsule contains 2 , 3 mg ixizomibe ( as 3 . 4 mg x ixazamibid citrate ). the other ingredients are microcrystalline cellulose , magnesium stearate and talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( é172 ). printing ink contains shellac , propylene glycol , potassium hydroxide and black iron oxide . nINlaron 3 mg hard capsules contain ixozomibat . they are supplied in blister packs containing 3 capsules of xazomimib each . not all pack sizes may be marketed .
do not use palforzia if you are allergic to peanuts or arachis hypoogaea . warnings and precautions talk to your doctor or pharmacist before using palforizia : - if your dose is too low . use in children and adolescents ( aged 4 months to 17 years ) the dose may need to be adjusted . - during treatment , your doctor will check if the treatment is suitable for you . talk to you doctor if there is any evidence of peanut allergy . this is because peanut ( desensitisation ) can affect the way palforziea works . you will be observed carefully by your doctor . allergic reactions are rare in children when palforzaa is used in children with food allergies . it is not known whether palforzya passes into human milk .
do not take palforzia - if you are allergic to peanut allergy or any of the other ingredients of palforizia ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking palfor zia . if your asthma is severe , you should tell your doctor right away . you may have a problem swallowing . there may be some risk that your stomach is not working properly . tell your physician if any of these apply to you . some people with long term problems with your digestive system . your doctor may want to change your palforzaa dose . talk to you doctor if : you have  a severe mast cell disorder or severe or life - leading anaphylaxis . the first dose should be taken 60 days after the first course of treatment . do not stop taking your palForzia without talking to your physician
always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . this is because palforzia can cause allergy . allergic reactions ( anaphylaxis ) can occur within 3 months of starting treatment with palforzaa and can be initiated as initial dose escalation . you will have to complete both of these treatment phases : the initial dose elevation and up - dosing phases are called cycles . it is very important that you do not stop taking palforizia before talking to your doctor or pharmacist . initially you should continue to take palfor zia until your doctor tells you otherwise . if the patient is not feeling unswell after your asthma , the doctor will decide if this should be continued . initial dose evolution and initial dose escalated can be continued with pal for at least 4 to 5 hours after the first day of treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions . tell your doctor straight away if you get any of the following symptoms after taking palforizia . they usually start with the reaction : trouble breathing - throat tightness - feeling of fulness - trouble swallowing or speaking - changes in voice - dizziness or fainting - serious or severe stomach cramps or pain - vomiting , diarrhoea - extreme flushing or itching of the skin palforza may also cause problems with the stomach and digestive system . these include : fever , chills , feeling sick , vomiting / diarresthooeal - sudden difficulty in breathing , or feeling weak - fainting or feeling sick ( nausea or vomiting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store below 25 . discard this medicine if you notice any hard lumps of powder . this medicine is for single use only . any unused solution should be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance of palforizia is 0 . 5 mg , 1 g , 10 mg or 20 mg . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palforzaa 100 mg : powder in capsules opening microcrystalline cell , coloidal anhydrated silicca , and magnesium STEarate pahnaud 300 mg / ml oral powder in sachet microcrystalline microcrystalline silicA , co - administration by healthcare professionals , dental implants , doctor ' s advice on preparing the medicine , including dosage , initial dose escalation ( see section 2 ). pallet size : 3 , 13 and 5 single - dose blisters . not all pack sizes may be marketed .
zerene belongs to a class of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions , and sleeping problems . it is usually given at the start of treatment , but gradually increases as you continue to get better . the duration of treatment should usually vary from a few days to two weeks . if you still have problems sleeping after you have finished your capsules , tell your doctor .
do not take zerene - if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zere sleep apnoea syndrome ( see section 4 ). warnings and precautions talk to your doctor or pharmacist before taking zerent if : you have severe kidney or liver problems , such as myasthenia gravis ( very weak and tired muscles ), severe breathing or chest problems . children and adolescents do not give this medicine to children and teenagers under 18 years of age . there is no experience with zerence in this age group . the safety and efficacy in this population , however , it is not known whether it will have any harmful effects . you should tell your doctor if any of these apply to you . your doctor may decide to reduce the dose , or may decide not to give zerenne
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day , taken with or without food . if your doctor thinks you may have difficulty falling asleep , talk to your doctor about other ways to take zeene . use in elderly people ( 65 years of age and older ) if the medicine is not suitable for you , or you are more likely to have mild to moderate liver problems : 65 years or older : take the capsule ( s ) once , once - daily , with or just after food , until your stomach is empty . do not take the hard capsule , if it is cloudy or if there are particles in the capsule . an overdose may make you increasingly drowsy , leading to a com
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( impacts 1 to 10 users in 100 ) uncommon ( impacts1 to 10 Users in 1 , 000 ) rare ( impacts in 1 to10 users in 10 million ) very rare ( affectations less than 1 patient in 10 10 ,000 ) not known ( frequency cannot be estimated from the available data ). all medicines may not be marketed . side effects are related to any other change in your healthcare professional . in particular , the following side effects have been reported : drowsiness , memory difficulties and sensations like tingling and numbness in the extremities 
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( е171 ). ingredients of the capsule shell : gelatin , titanium dioxide . printing ink : shellac , lecithin , simethicone , yellow iron oxide ( k25 ). what zeene looks like and contents of the pack zerent is a white to almost white powder . it is printed with " gs - 1203 " in black ink and has " pfizer " in white ink on the body . zere is available in blister
